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ABSTRACT 
Objectives: 
We conducted a mixed methods study of delayed access to emergency obstetrical care 
among preeclamptic and non-preeclamptic women in Port au Prince, Haiti, grounded in 
the Three Delays model of Thaddeus and Maine.  The primary objectives were to identify 
factors affecting delays in accessing care and clinical consequences of delays. 
Methods: 
524 surveys were administered to women admitted to the Médecins Sans Frontières 
(MSF) obstetric emergency hospital.  Survey questions addressed demographic, clinical, 
and behavioral risk factors; first (at home), second (transport) and third (health facility) 
delays; and clinical outcomes for women and infants.  Bivariate statistics were used to 
assess relationships between preeclampsia status and delay, and between risk factors and 
delay.  Twenty-six survey participants with lengthy delays (> 6 hours) were chosen for 
interviews, which elicited details about delays women experienced.  Data were analyzed 
using a grounded theory approach. 
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Results: 
We found long delays to accessing care for preeclamptic women (median 5.0 hours, IQR 
10.5, vs. 4.0 hours, IQR 5.0, for non-preeclamptic women, p<0.01), primarily due to 
delays at home before leaving for the hospital (median 2.6 hours, IQR 10.6). No 
demographic, clinical, or behavioral factors were related to access to care.  Women's 
health prior to pregnancy was not associated with delays, with the exception of 
preeclamptic women who had previously seen a doctor, who had significantly longer 
delays than women who had not previously seen a doctor (22.8 hours versus 11.2 hours, 
p=0.02).  Long delays for both preeclamptic and non-preeclamptic women were not 
associated with poorer clinical outcomes.  Although the MSF hospital is free of charge, 
financial barriers at other hospitals limited access to emergency obstetric care for many 
women, who commonly experienced non-evidence-based care, including inappropriate 
education from antenatal care providers when diagnosed with hypertension or 
preeclampsia. 
Conclusions: 
Pregnant women with preeclampsia in Port au Prince reported significant delays in 
accessing emergency obstetric care.  Many delays stemmed from poor quality antenatal 
care services, which fail to screen, treat, or educate women appropriately.  Improvements 
should be made in education and supervision for antenatal care providers, and in 
accessibility of emergency services at public hospitals in Port au Prince. 	  
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Chapter 1: Significance and Study Aims 
 
Case Presentation: 
 On October 1, 2014, Marie (not her real name) arrived at the 
Médecins Sans Frontières hospital in Port au Prince, Haiti.  Marie, 16 
years old and pregnant with her first child, had suffered an eclamptic 
seizure.  She and her baby died within minutes of arriving at the hospital, 
despite the best efforts of the staff.  Marie's death, and that of her baby, 
most likely could have been prevented with earlier medical care.  
However, Marie did not arrive at the hospital in time.   
 
Introduction 
 Women and babies die at higher rates in Haiti than anywhere else in the Western 
Hemisphere.  Though just an hour plane trip away, Haitian women have a one in eighty 
lifetime risk of dying of pregnancy complications, as compared to one in 1,800 in the 
United States.1 The availability and use of emergency obstetrical care in the context of 
maternal health problems such as preeclampsia are essential to prevent both maternal and 
neonatal mortality.  The lack of this appropriate emergency obstetrical care in Haiti leads 
to preventable deaths.  Though some progress has been made, much is still unknown 
about why some women and infants do not receive appropriate care to prevent death.   
 Delays to access emergency obstetric care often mean the difference between life 
and death when a pregnancy complication occurs.  The majority of Haitian women 
deliver their infants at home, either due to preference or lack of other options.  When 
complications occur, women need access to emergency care.  Delays to leaving home, or 
delays to reaching the hospital are related to individual, family, cultural, and contextual 
factors.  Women in urban Haiti may face many delays to receive appropriate emergency 
obstetric care, but there is no research examining these risks.  Research in rural Haiti has 
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found a wide range of obstacles that women need to overcome, but corresponding 
research in urban Haiti is lacking. 
 Access to emergency obstetric care is especially important in Haiti, where 
complications of pregnancy such as preeclampsia are very prevalent.  Preeclampsia, 
when not treated correctly and swiftly, can lead to both perinatal and maternal morbidity 
and mortality.  However, little research exists that describes the particular risks for 
women with complications of pregnancy like preeclampsia. 
 Medécins Sans Frontières (MSF) has been providing health care in Haiti since 
1991.  An international medical humanitarian organization, MSF's presence in Haiti 
assures adequate emergency obstetric care for the large population of women living in 
urban Port au Prince.  Despite the presence of several large state-run university hospitals, 
the availability of emergency obstetric care in Port au Prince is limited due to human 
resource constraints and budget shortfalls within the Haitian Ministry of Public Health 
and Population (MSPP).   
 MSF offers free care to any pregnant woman meeting admission criteria for 
obstetric emergencies, including preeclampsia and eclampsia.  In 2014 MSF delivered, on 
average, more than four hundred women per month, more than twenty-five percent of 
whom had preeclampsia or eclampsia.  Despite the best efforts of MSF staff, some of 
these patients experience poor maternal or neonatal outcomes.  However, the current 
program is not organized in a way to identify those women or neonates most at risk for 
poor outcomes.  The program only cares for women and infants at the moment of labor 
and birth; as such, limited data is available regarding antepartum risk factors.   
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 This dissertation will examine the research surrounding maternal and perinatal 
mortality in Haiti, and the effects of delayed access to care during obstetrical 
emergencies.  While researchers have examined some of the risks for delayed access to 
obstetric care in rural Haiti, no corresponding research exists for urban Haiti.  This study 
will examine behavioral, clinical and demographic risk factors for delayed access to 
emergency obstetrical care.  Preeclampsia and eclampsia, hypertensive disorders of 
pregnancy, are especially prevalent in Haiti.  A detailed examination of the risks of 
preeclampsia and eclampsia, and the risks of delayed access to care among this 
population will be outlined. 
 Chapter two will examine the Haitian context, public health system and problems, 
focusing on maternal and perinatal mortality.  Chapter three will discuss the research 
regarding maternal and perinatal mortality in Haiti, the programs that have attempted to 
address the problem, and the specific risks for women with preeclampsia or eclampsia.  
The Three Delays model, which describes delays to accessing emergency obstetric care 
in low-income settings, will be discussed in relation to the Haitian context.  Chapter four 
will present the research methodology by which we examined the risks for delayed access 
to emergency obstetrical care among urban Haitian women.  Chapter five presents the 
results of the quantitative survey of women who were admitted to the MSF CRUO 
hospital, and Chapter six provides the findings from the qualitative interviews with a 
subset of those women who experienced long delays.  A discussion of the study’s 
findings, and its limitations, follows in Chapter seven.  Finally, Chapter eight reviews the 
study’s conclusions, and offers recommendations based on the study findings. 
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Study Aims 
 This dissertation aimed to identify and analyze predictors of delayed access to 
emergency obstetrical care in women and neonates admitted to an obstetric referral 
hospital in Port au Prince, Haiti.  Specifically, clinical, demographic and behavioral risk 
factors were identified that led to delays in deciding to seek care or to reach the hospital.  
Poor maternal and perinatal clinical outcomes were measured, and their associations with 
the risk factors and with delayed access to care were assessed.  Women with 
preeclampsia, and women with normal pregnancies who were admitted to an MSF 
obstetric hospital were questioned about their demographic, clinical and behavioral risk 
factors.  A subset of preeclamptic women participated in in-depth interviews to add 
nuance and depth to the understanding of delayed access to care.  The results of the study 
will be used to inform MSF surveillance activities, to target women most at risk for 
delayed access.   
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Chapter 2: Background 
Haitian Context and History 
 Maternal and perinatal mortality are intimately linked with the context in which 
they occur.  The deaths of pregnant women and babies in Haiti stem most proximately 
from poor access to emergency obstetric care.  However, more distally, the context and 
history of Haiti are as much at play. 
 The history of the small island nation of Haiti is closely linked with the themes of 
slavery, colonialism and racism that have affected many other countries around the 
world.  First "discovered" by Christopher Columbus in 1492, the island of Hispaniola, 
which includes the current nation of Haiti, quickly became a profitable source of many 
products for its colonizers.  Brutal repression of the transplanted African slaves by their 
colonial masters led the way for the world's first free black nation, after the slaves 
defeated their captors in 1804.  However, interference by world powers, along with 
ongoing political upheaval continued throughout the next 200 years.  Haiti was led by a 
succession of short-lived dictators, and power was transferred by force. 
 Modern Haiti (Figure 1) has been shaped by the long rule of two dictators, the 
father-son Duvaliers.  Francois Duvalier, or “Papa Doc” led Haiti from 1957 to 1971.  He 
is known today for his brutally repressive regime.  His son Jean-Claude Duvalier, or 
“Baby Doc”, continued those practices after taking over control of the “presidency for 
life” from his father, from 1971 to 1986.2  After a long period of stable but autocratic 
rule, Haiti entered another period of turmoil after the end of the Duvalier era.  Jean-
Bertrand Aristide came to power twice, and was exiled twice.  Military rule, United 
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States military interventions, and widespread brutalization of the population led to 
migrations of Haitians to neighboring countries.  After the 2004 coup d’état overthrowing 
Aristide, the Haitian army was disbanded, and the United Nations peacekeeping force 
installed. In 2015, another period of instability began in Haiti, as contested elections left 
the country without an elected president.   
Figure 1. Map of Haiti 
 
 Political turmoil was augmented by natural disaster following the massive 
earthquake of January 12, 2010.  The 7.3 magnitude quake struck just off the coast of the 
capital city Port au Prince, and killed hundreds of thousands of people instantly.3 Millions 
of people were left homeless after large sections of the urban area were flattened.  As of 
2014 more than 100,000 people remained in internally displaced person camps, more 
than four years after the earthquake.4 The massive humanitarian influx that followed the 
earthquake has been well documented, and continued for years after the event, although 
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with reduced intensity. 
 Even before the earthquake struck, urbanization trends in Haiti had increased the 
numbers of Haitians living in Port au Prince.  Migrations to the city continued even after 
the earthquake; people were perhaps encouraged to come by the provision of 
humanitarian aid that was delivered.  At the end of 2014, almost 200 camps remained.4  
However, the distinction between the camps and the urban slums also found in Port au 
Prince is now academic.  Many people in Port au Prince, whether in slums or camps, live 
in extremely vulnerable conditions, without access to safe water, adequate sanitation, or 
hygiene measures.  
 Haiti also suffers from extreme income inequality, which is nowhere more evident 
than in the capital city.  Residents living in flooded, sewage-filled slums are pressed up 
against the luxury hotels and mansions of affluent Haitians, as well as the houses and 
offices of the many international aid agencies.  The United Nations Human Development 
Index ranks Haiti 168 of 187 countries.5 This multidimensional score includes such 
metrics as average years of schooling, life expectancy, and measures of inequality.  
Haiti's low ranking on the Human Development Index reflects the many challenges 
facing this country, including in public health. 
 In addition to low measures on health and education, Haitian society has also been 
described as oppressive to women.  Davis and Bookey write that “[g]ender discrimination 
in Haitian society systematically obstructs women from preventing or addressing 
injustice against them, and strengthens other forms of structural oppression such as 
economic and political discrimination.”6 This discrimination can lead to increased 
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vulnerabilities of women and girls, including limiting their access to healthcare, and how 
healthcare services are made available to them. 
Haitian Public Health System 
 Income and gender inequality are two of many risks facing the Haitian people.  
Haiti's population suffers from some of the highest rates of disease and has the lowest life 
expectancy outside of Sub-Saharan Africa.  Public health care systems throughout Latin 
America, and specifically in Haiti, have not succeeded in easing the suffering of the 
poorest, who are most at risk for disease.7 Lack of access to health care is also identified 
by Haitians themselves as a major concern.8   
 Haiti's public health system has been characterized as one of the weakest in the 
Western Hemisphere.9 Chronic underfunding and understaffing have led to Haiti's wide 
range of poor health indicators.9 Maternal and child health indicators are particularly 
worrisome.  Haiti’s maternal mortality ratio and its infant mortality rate are the worst in 
the Western Hemisphere.10 There are less than 500 obstetricians or midwives in the entire 
country, far below the World Health Organization recommendation.11 
 The MSPP has ten health branches, one for each of the country's ten departments, 
equivalent to a state or province.  Each of these ten MSPP branches is responsible for 
independently managing the health staff and structures in their department, with funding 
from the MSPP.  The West department, which includes the capital city Port au Prince, has 
the majority of hospitals in the country, as well as the highest concentration of doctors 
and nurses.12 About 45% of the Haitian population lives in Port au Prince.  The rate of 
urban population growth is almost 4% per year, as compared to an overall Haitian growth 
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rate of 1.3%.13  
 However, as in many poor countries, the presence of public hospitals does not 
necessarily translate into access to quality health care for poor people.  Haiti's public 
hospitals are crowded and poorly managed, suffer from staff shortages and strikes, lack 
appropriate supplies and medications, and are poorly funded.14 Haiti's affluent population 
typically seeks care in private hospitals, or travels abroad for care.  Obstetric and neonatal 
care is typical of many public health services in Haiti—insufficient and of poor quality.12  
While almost all Haitian women receive antenatal care, almost two thirds of women 
(67%) deliver at home.  Even in Port au Prince, where access to care is nominally better, 
thirty-eight percent of women continue to deliver at home.3 
Health Issues in Urban Haiti  
 Access to obstetrical care is one of many health issues affecting Haitian people.  
Urbanization in Haiti has led to greater and greater proportions of the country's 
population living in Port au Prince.  There are specific health consequences of this 
urbanization trend, which may also affect pregnant women.  Port au Prince is a sprawling 
city of approximately two and a half million people.  As in many low-income countries, 
many urban residents live in slums characterized by shoddy housing, limited sanitary 
facilities, poor drinking water availability, and violence. 
 Urban areas are increasingly the focus of public health interventions, as the risks 
of urbanization are further described.15 The majority of the world's population now lives 
in urban zones, as will soon be true in Haiti.16 The World Health Organization has 
recognized the specific health issues facing urban residents, like those in Port au Prince, 
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in creating their Healthy Cities initiative.17 Increased health risks of urban areas can 
include greater exposure to both indoor and outdoor air pollutants, obesity, natural 
disasters, poor sanitation and workplace dangers.18 On a structural level, themes of 
violence and marginalization create inequalities in cities.19  These inequalities, in turn, 
worsen other health risks. 
 Health risks of urban living include risks of natural disasters having more 
concentrated impact, like the earthquake that struck Haiti in 2010.  The damage to Haiti's 
public health system—both in terms of physical buildings as well as loss of life——was 
significant.  Although Haiti became the recipient of billions of dollars of foreign aid, 
scars of the earthquake still remain.  For example, five years after the earthquake, the 
University General Hospital in Port au Prince remained under construction.  
 A number of research studies have examined the specific health issues faced by 
residents of Port au Prince.  Specific research articles have noted increased risks of 
violence20, cholera21, HIV risk, STI risk22, vector borne disease22, disaster risk23, sexual 
violence24, anemia25, environmental risk, and lower rates of health care access due 
specifically to violence20, and lower coverage of mass-drug administration for filariasis26. 
No comparable research has addressed the specific risks of urban living for pregnant 
women living in Port au Prince. 
 The experience of pregnancy for a woman living in Port au Prince is likely quite 
different than that of a Haitian woman living in a rural area.  Urban pregnant women 
must understand and negotiate a range of context-specific barriers, including 
transportation, gang violence, corruption among health staff, and overcrowding of public 
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hospitals.  High levels of inequality, as are found in Port au Prince, are also known to 
worsen health.  While the number of obstetric hospitals suggest that urban Haitian 
women have better access to emergency obstetric care27, myriad factors may inhibit 
access.  Many wealthy, urban Haitian women choose to leave the country to deliver, 
speaking to the difficulty of receiving quality health care in Haiti, even for those with 
means. 
Global Efforts to Improve Maternal and Child Health  
 Understanding the causes of maternal and infant mortality, and addressing them, 
has been a major focus of public health efforts around the globe, including in Haiti.  The 
Millennium Development Goals (MDGs), adopted by world leaders in 2000, targeted 
reductions in both maternal and infant mortality.28 Haiti is one of many low-income 
countries that attempted to achieve these goals by 2015.   
 Starting with the Safe Motherhood Initiative in 1987, several worldwide 
initiatives have focused attention, funding and resources on lowering both maternal and 
neonatal mortality. Most programs operating at the time of the study to address these 
problems used the MDG framework, which helped countries plan approaches to meeting 
their targets.29  The MDGs number 4 and 5 set goals for reductions in both child and 
maternal mortality.28  Worldwide targets were not met by the 2015 deadline, though 
many countries, like Haiti, made some progress towards many of the objectives.  The 
Sustainable Development Goals, developed by the United Nations in 2014, set new 
global targets, and also include a continued effort to achieve reductions in maternal and 
child mortality.30   
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Maternal Mortality 
 Maternal mortality is defined as the death during pregnancy or within forty-two 
days of the end of a pregnancy due to any cause related to the pregnancy or its 
management.31 Accidental deaths, for instance due to a road traffic accident, would not 
be considered related to pregnancy.  The worldwide burden of maternal mortality has 
decreased by about half since 1990.32 Ninety-nine percent of the almost 300,000 deaths 
yearly occur in low-income countries such as Haiti, where poor public health 
infrastructure, among other problems, prevents timely and effective treatment of obstetric 
complications.  Leading causes of maternal death include postpartum hemorrhage, 
hypertensive disorders of pregnancy, infections and obstructed labor  
(Figure 2). 
Figure 2. Causes of worldwide maternal deaths 
 
Source: Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. 
Heal. 2, e323–e333 (2014). 
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 Millennium Development Goal 5a aimed to reduce by three quarters the maternal 
mortality ratio.  Worldwide maternal deaths dropped by 47% from 1990 to 2010, with 
greater gains made in Asia.32 Some regions, notably Africa, have had much smaller 
reductions in maternal deaths.  Haiti made progress in lowering the maternal mortality 
ratio, though the reported maternal mortality ratio figures are very unreliable.  The MSPP 
reported maternal mortality figures that were more than 50% lower than United Nations 
interagency estimates.12  Interagency estimates of maternal mortality in Haiti show a 43% 
reduction in maternal mortality between 1990 and 2013.12 
Perinatal mortality: Early neonatal death 
 The World Health Organization defines the perinatal period as twenty-eight 
completed weeks of gestation to one week post-delivery—encompassing both the fetal 
and early neonatal period.33  Emergency obstetric care is designed to prevent perinatal 
mortality.  Deaths during the perinatal period are closely linked to maternal health and 
interventions, including timely treatment of obstetric complications.  Perinatal deaths 
after twenty-eight weeks gestation and prior to delivery are defined as stillbirths, while 
deaths after delivery up to seven days of life are considered early neonatal deaths.34 
Every year, about three million babies die in the first month of life, and another three 
million are stillborn.  As with maternal mortality, ninety-nine percent of those deaths 
occur in low income countries.34 Programs to reduce child mortality, which includes 
neonatal mortality, have been successful at reducing under-five deaths by thirty-five 
percent since 1990.35 However, these gains have not been as successful for the first 
month of life, which now accounts for forty percent of all child deaths under five years.35  
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Neonatal mortality is caused, to a large extent, by factors associated with labor and 
delivery, including prematurity, infections, and birth asphyxia (Figure 3). 
 Millennium Development Goal 4a aimed to reduce child mortality by two thirds 
between 1990 and 2015.35 Worldwide efforts to reduce under-five mortality have 
included reductions in neonatal deaths, though they did not specifically address fetal 
death prior to delivery (stillbirth). After the development and introduction of the 
Millennium Development Goal 4, worldwide reductions in child death followed. 
However, MDG 4 was not accomplished in many countries.  Effective interventions to 
reduce child mortality, such as the Integrated Management of Child Illnesses program, 
were not systematically implemented in the countries needing them most, due to 
problems with implementation.36 
Child mortality has fallen much faster in children ages two months to five years 
than in infants and neonates. Many child mortality programs have focused on efforts to 
reduce child mortality in ways that have not lowered infant and neonatal mortality, an 
important component of under-five deaths. Many programs to reduce child mortality have 
focused on vaccine-preventable diseases, diarrhea, and malaria, which are unlikely to 
reduce deaths (other than neonatal tetanus) in the neonatal period.34 Deaths in the 
neonatal period have not declined at the same pace as deaths in older children, and now 
make up forty percent of all child mortality.  	  
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Figure 3. Causes of deaths among children under 5 years, 2013 
 
Source: World Health Organization. Global Health Observatory: Causes of child mortality. 
(2014). at <http://www.who.int/gho/child_health/mortality/causes/en/> 
   
 Deaths in the neonatal period are closely tied to labor and delivery complications, 
and as such are less sensitive to programs targeting vaccine-preventable disease or 
diarrhea, and more sensitive to the treatment of maternal complications and access to 
obstetric care. Moreover, recommendations for postpartum care of the woman also 
include continued surveillance of the infant.  Both fetal and neonatal mortality are closely 
tied to the appropriate and timely identification and treatment of maternal 
complications.34 As such, reductions in under-five mortality for the Millennium 
Development Goal 4 also depended on strategies to address maternal morbidities and 
mortality, and provision of appropriate emergency services. 
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Perinatal mortality: Stillbirth 
 The World Health Organization defines stillbirth as the death of the fetus after 
twenty-eight weeks completed gestation, and before delivery.  Worldwide, there are 
about 2.6 million stillbirths per year, ninety-eight percent of which occur in the 
developing world.37 A recent review found a reduction in the worldwide incidence of 
stillbirth of 400,000 stillbirths per year since 2000.  Along with neonatal death, stillbirth 
has recently become a larger priority in maternal and child health research, as evidenced 
by a 2011 series in the medical journal The Lancet.  
 Unlike neonatal mortality, published national data on the causes of stillbirth are 
generally unavailable.  There is no consensus in the literature on how to classify the 
causes of stillbirth, and multiple categorization tools exist.38 Some classification systems 
were developed for high-income settings and are not useful in low-income countries.  
Therefore, limited data is available on the worldwide causes of stillbirth.38 Additionally, 
lack of resources for post-mortem investigation in low-income settings may create biases 
in reported causes of stillbirth.  For instance, infection is listed as a cause of stillbirth less 
frequently in low-income settings than high-income settings, though this may reflect 
detection bias.38 
 Despite the challenges in attributing stillbirth, maternal hypertensive disorders are 
clearly a major cause.38 A recent review of almost 8,000 pregnancies in six developing 
countries found hypertensive disorders to be the second leading cause of stillbirth.39 
Causes of death in this review were similar between the fetal death and early-neonatal 
death groups. 
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 Stillbirth and early neonatal death are closely linked, as the precursor factors for 
both are similar.40 In fact, there are very similar numbers of stillbirths and neonatal deaths 
worldwide, almost three million per year.34 
Emergency Obstetric and Neonatal Care 
 A key component to reducing maternal and perinatal mortality is emergency 
obstetric and neonatal care (EmONC).  Most women in low-resource countries deliver 
their infants at home.  If complications arise during the pregnancy or delivery, women 
and their infants need timely access to a series of medical interventions to prevent serious 
morbidities and mortality.  
 The “E” in EmONC has been defined as either “essential” or “emergency” care; 
“Emergency Obstetric and Neonatal Care” will be used in this paper.  The WHO defines 
two types of emergency obstetric case (EmONC): basic emergency obstetric and 
newborn care (BEmONC) and comprehensive emergency obstetric and newborn care 
(CEmONC) (Table 1).41 Current recommendations indicate the need for at least four 
BEmONC facilities, and one CEmONC facility, per 500,000 population.41 EmONC 
facilities are identified based on their performance of signal functions, such as 
administration of intravenous antibiotics for BEmONC facilities, or performing cesarean 
section for CEmONC facilities.  The WHO also states that BEmONC and CEmONC 
facilities should be distributed geographically, though there is no specific indicator.  
There continues to be some discussion in the literature about the appropriate indicators of 
effective coverage of EmONC.42 
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Table 1. Signal Functions of Basic and Comprehensive Emergency Obstetric Care 
Basic Emergency Obstetric and Neonatal 
Care (BEmONC) Functions 
Comprehensive Emergency Obstetric 
and Neonatal Care (CEmONC) 
Functions 
1. Administer parenteral antibiotics All BEmONC functions 1-7, plus 
2. Administer uterotonic drugs (i.e. parenteral 
oxytocin) 
8. Perform surgery (e.g. caesarean 
section)  
3. Administer parenteral anticonvulsants for 
preeclampsia and eclampsia (i.e. magnesium 
sulfate) 
9. Perform blood transfusion 
4. Manual removal of the placenta    
5. Remove retained products (e.g. manual 
vacuum extraction, dilation and curettage) 
 
6. Perform assisted vaginal delivery (e.g. 
vacuum extraction, forceps delivery) 
 
7. Perform basic neonatal resuscitation (e.g. 
with bag and mask) 
 
Source: WHO, UNICEF & UNFPA. Guidelines for Monitoring the Availability and Use of 
Obstetric Services. (1997). 
 The evidence is clear that emergency obstetric and newborn care reduces maternal 
mortality.  Paxton et al. (2003) published a systematic review of emergency obstetric 
care, which demonstrated that EmONC was a critical strategy for reduction of maternal 
mortality.  However, it is difficult to separate out the effect of the provision of these 
services from another widely used metric, and Millennium Development Goal (MDG) 5a 
indicator, skilled attendance at delivery.  Emergency obstetric care and skilled attendance 
necessarily complement each other.  Some researchers have suggested that EmONC 
should have been the third indicator to judge the success of MDG 5.43 MDG 5a was 
measured by reductions in the maternal mortality ratio, and the percentage of deliveries 
attended by skilled health personnel.  However, the effectiveness of skilled health 
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personnel varies widely is highly related to the availability of emergency obstetrical care.  
The effectiveness of skilled attendants and emergency obstetric care are necessarily 
highly interrelated.  While not an official MDG indicator, percentage of births occurring 
in emergency obstetric facilities was also an important indicator of progress towards 
reducing maternal mortality. 
Manman Ak Timoun An Sante - Free Obstetrical Care Program 
 Haiti's maternity services are organized under the SONU program: Soins 
Obstetrique et Neonataux d'Urgence (Emergency Obstetrical and Neonatal Care).  The 
SONU program was inaugurated in 2009 after an evaluation showed unequal access to 
emergency obstetrical and neonatal care across Haiti.  Haiti has worked to establish, or 
improve, both SONUB (BEmONC- Basic Emergency Obstetrical and Neonatal Care) 
centers, as well as SONUC (CEmONC- Comprehensive Emergency Obstetrical Care) 
centers.  To date forty-nine SONU centers have been rehabilitated.  However, Haitian 
government reports indicate that very few of these centers actually meet standard 
criteria.12 
 From 2011 to 2013, Haiti was the beneficiary of a major donor initiative to 
improve access to facility based delivery and emergency obstetrical care, with the goal of 
reducing maternal and infant mortality.  The "Manman Ak Timoun An Sante" (Healthy 
Mothers and Children) Program was financed by the Canadian Government, and 
implemented by the Ministry of Public Health and Population, and the Pan American 
Health Organization.44 This was the continuation and expansion of an earlier program, 
established after the 2010 earthquake, called the Free Obstetrical Care program.  This 
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program offered free obstetrical care to women and infants in many public hospitals 
around Haiti.  The funds from the program were used to provide a standard package of 
essential services to pregnant women, including emergency services.45 Given chronic 
budget shortfalls in the MSPP, this financing ensured that women arriving to deliver 
would not be asked to purchase their own medications, or to pay bribes to staff not 
receiving their salaries.   
 The Manman Ak Timoun An Sante program was successful in attracting patients 
to public hospitals.12 This program lowered financial barriers to care, and improved the 
quality of care that was offered.  Although no published literature yet exists to document 
the public health impact of this program, anecdotally, many local providers of maternal 
and child health care noted a large increase in patient numbers to public hospitals 
supported by the program.14   
 Unfortunately, the Manman Ak Timoun An Sante program was initially funded 
for only two years.  The program managed to extend its funding for an extra six months, 
but eventually stopped funding activities at the end of 2013.  Hospitals that had been 
supported were again in the position of struggling to find funding to treat patients.  
Reports from the national maternity hospital stated that the doctors and residents were 
buying patient medications on credit in local pharmacies, and then attempting to recover 
some fees from patients.14 Other hospitals reported a sharp drop in deliveries and 
cesarean sections, as patients were again being asked to purchase medications and 
supplies to cover their care.14 
		 21 
 With the end of the free obstetrical care program, the situation for Haitian 
pregnant women may be more risky than at any time since the 2010 earthquake.  Poor 
women are the group most likely affected by the end of this program.  With most Haitian 
people living on less than one dollar per day, poor women may be less able to access 
services that now require significant user fees. 
Preeclampsia and Eclampsia 
 Preeclampsia and eclampsia are leading causes of maternal mortality.  Despite 
decades of intensive research, the understanding of the pathophysiology and causal 
mechanisms of this deadly disorder are still incomplete.46 Preeclampsia is one of the 
hypertensive disorders of pregnancy.  If left untreated, it can progress to eclampsia, 
characterized by generalized seizures, which can lead to serious morbidities and 
mortality.  Preeclampsia is also characterized by multisystem dysfunction, including liver 
and kidney abnormalities.   
 To be diagnosed with preeclampsia, a woman will have both hypertension 
(persistently elevated diastolic blood pressure >90 mmHg) plus significant proteinuria 
(>0.3g/24 hours) develop during the second half of pregnancy.47  In addition to high 
blood pressure and proteinuria, laboratory findings such as elevated liver enzymes may 
also be present. There is some evidence that preeclampsia and eclampsia may have 
different underlying pathophysiology in high-income versus low-income countries.48  
Risk factors for developing preeclampsia include extremes of maternal age (women over 
forty), first pregnancy, multiple gestation, diabetes, personal history of preeclampsia, and 
chronic hypertension.46 
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 The Latin America and Caribbean region (LAC), which includes Haiti, has the 
highest rates of maternal mortality of any region due to hypertensive disorders including 
preeclampsia (Table 2).49 Almost one quarter (22%) of deaths in LAC are due to 
hypertensive disorders of pregnancy.50 However, one large cohort study of pregnant 
women in LAC found a prevalence of preeclampsia and eclampsia of 5%, about the same 
as worldwide prevalence estimates. 49,51 Risk factors for preeclampsia in this population 
were similar to those found in other studies.  Other researchers also found differences in 
diet52 and calcium intake53 to explain higher incidences of preeclampsia. 
 It is unclear why the Latin American and Caribbean region has higher rates of 
death from preeclampsia, if rates of preeclampsia are about the same as other regions. 
Little data is available regarding how the diagnosis and treatment of preeclampsia in this 
region may differ from other regions.  However, some studies have postulated specific 
indicators of public health system effectiveness54 to explain differences in mortality from 
preeclampsia, including poor antenatal care quality, lack of access to hospital care, and 
lack of properly trained staff.   
 Despite the fact that the LAC region seems particularly at risk for maternal 
mortality due to hypertensive disorders, the quality of the research about hypertensive 
disorders in the region is lacking.  A review of the literature by Peña (2012) found limited 
high-quality evidence about hypertension in LAC.  This paper came a decade after a 
previous study by Ordúñez (2001) also noted the poor quality of the research 
investigating hypertension in LAC. 
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Table 2. Distribution of Causes of Maternal Death by Region  
 
Source: Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Heal. 2, e323–e333 (2014). 
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Perinatal Mortality, Preeclampsia and Eclampsia 
 There are both maternal and infant consequences of preeclampsia and eclampsia.  
Hypertensive disorders, including preeclampsia and eclampsia, are also the second 
leading cause of perinatal mortality worldwide, second only to spontaneous preterm 
delivery,39 causing one quarter of all stillbirths and neonatal deaths in developing 
countries.55  Several fetal problems are associated with maternal hypertensive disorders, 
including stillbirth, intrauterine growth restriction (IUGR), hematologic problems 
including thrombocytopenia (low platelet count), neutropenia (low white blood cell 
count), broncho-pulmonary dysplasia (abnormal development of lung tissue), 
neurodevelopmental changes, and increased risk for some adult-onset diseases such as 
diabetes and cardiovascular disease.56 Conversely, there are some conflicting reports of 
neuro-protective effects of preeclampsia for preterm infants, but there is no scientific 
consensus.56 The pathophysiology underlying many of these fetal risks is decreased blood 
flow to the fetus through the placenta.57  
 Delivery of the infant and placenta is the only treatment for maternal 
preeclampsia, and is necessary to prevent maternal morbidity and mortality.  However, 
when preeclampsia develops before the pregnancy is full term (37 weeks gestation), the 
treatment of preeclampsia can result in premature, often low birth weight, infants.  
Prematurity and low birth weight are both risk factors for infant mortality.  However, 
given restrictions in placental blood flow, there are also risks to the fetus if delivery is not 
completed.  Management of preeclampsia attempts to balance the risks to women from 
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continuing a pregnancy, with those to the fetus, of both hypoxia in utero or prematurity if 
delivery is done.56 
Treatment of Preeclampsia and Eclampsia 
 Once a pregnant woman with preeclampsia arrives at a medical facility, there are 
a number of clinical considerations in the management of her illness.  Among other 
factors, the medical management of pregnant women with preeclampsia depends on the 
context in which she lives.  A pregnant woman with preeclampsia in a high-income 
setting may have intensive clinical or laboratory monitoring of herself and the fetus, or 
consultations with neonatologists and maternal-fetal medicine specialists.  Women in 
low-income settings have access to few of those resources, and a much higher risk of 
death.  However, the only cure for preeclampsia and eclampsia is delivery of the fetus 
and placenta.  
 Among the immediate steps to stabilize and prevent disease progression in a 
patient with preeclampsia, and while delivery is planned, is administration of magnesium 
sulfate.  Whether in high or low-income settings, intravenous magnesium sulfate 
administration is the gold standard to prevent the progression of preeclampsia to 
eclampsia.  Magnesium sulfate is an anticonvulsant, and when administered to a woman 
with preeclampsia, it can prevent seizure activity.58  Administration of magnesium sulfate 
has also been shown to be neuro-protective for preterm infants born to preeclamptic 
mothers.56 However, despite the incontrovertible evidence for magnesium sulfate 
administration for preeclamptic pregnant women, this medication remains difficult to 
access in many low-income settings.59 One district in Nigeria made huge reductions in 
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maternal and perinatal mortality after the introduction of magnesium sulfate.60 
 After a woman with preeclampsia has been administered magnesium sulfate, 
medical providers need to decide how and when to induce labor.  Although delivery will 
treat the mother's condition, it may put the preterm neonate at risk.  Developed countries 
typically have advanced medical facilities in which they can closely monitor a pregnant 
woman with preeclampsia, and support the vital systems of premature infants.  
Developing countries most often do not.  Even "late-preterm" infants who are born just 
before term have a much higher rate of mortality in developing countries.39  Preeclampsia 
and eclampsia cause many of the preterm deliveries at the MSF hospital in Port au Prince, 
leading to high numbers of low birth weight newborns, and high rates of neonatal death. 
 For women whose preeclampsia has progressed to eclampsia, medical 
management includes timely delivery of the infant, either by cesarean section or 
vaginally.61 Other medical priorities include preventing injury to the woman during 
convulsions, preventing further convulsions with magnesium sulfate, and lowering blood 
pressure to safe levels with antihypertensive medications.  Severe clinical consequences 
of eclampsia, including coma, may necessitate the need for intensive monitoring and vital 
system stabilization.  Many low-income settings may not have the human resource or 
infrastructure capacity for these intensive care measures.  There is a much higher case 
fatality rate due to eclampsia in low-income versus high-income countries.62 
Maternal and Perinatal Mortality in Haiti 
 The management of pregnancy complications like preeclampsia is but one of the 
challenges facing the Haitian health system.  The Government of Haiti, in collaboration 
		 27 
with the UN Development Program (UNDP), released a document in 2013 outlining the 
country's progress towards achieving the Millennium Development Goals: “Haiti: A New 
Look”.12  This document describes recent data about Haiti's progress towards reduction in 
child and maternal mortality, among other goals. 
 The report notes a new low in the maternal mortality ratio for Haiti, at 157 deaths 
per 100,000 live births for 2013.  The Haitian MSPP reported this maternal mortality 
ratio, based on reported maternal deaths from facility deliveries in 2013.  However, this 
rate is stated to be incomplete, as it only encompasses maternal deaths that were reported 
to authorities.12 Given the large majority of women who deliver at home in Haiti, this rate 
is likely extremely unreliable.  Interestingly, the report also notes that for the very same 
year of data, a United Nations interagency group estimated a maternal mortality ratio of 
380/100,000 live births, more than double the MSPP figure.12 
 Using either estimate, Haiti's maternal mortality rate has dropped significantly 
from the 1990 rate of 670 deaths/100,000 live births.  Part of this reduction is likely due 
to the increased percentage of deliveries assisted by a trained health professional, up from 
20% in 1995 to 37% in 2012.12  This report directly credits the Free Obstetric Care 
program, which spurred large increases in deliveries in participating facilities. 
 Progress towards reducing maternal mortality in Haiti is hindered by a number of 
factors.  The Government of Haiti/UNDP report places emphasis on the lack of human 
resource capacity, specifically the small numbers of midwives in Haiti.  Haiti is far from 
the goal of one midwife per 5,000 people, with only one midwife per 50,000 people.  The 
United Nations Population Fund's State of the World's Midwifery Report highlight the 
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exodus of Haitian health personnel to other countries.11 Despite a focus on rehabilitating 
obstetric facilities in Haiti, the UNDP report states that only sixty percent of obstetric 
facilities have the essential obstetric medications.  Aside from health system functioning, 
the low rates of contraceptive usage, and high rates of teen pregnancies complicate efforts 
to reduce maternal mortality.12 
 The government/UNDP report states that Haiti's infant mortality rate dropped 
from 100 to 59 deaths per 1,000 live births.12 However, like many countries around the 
world, much more progress was made in reductions in the post-neonatal period (2 months 
to 1 year of age).  Seventy-five percent of Haiti's infant deaths occur in the first six days 
of life, like most developing countries.  The report states that the neonatal mortality rate 
actually rose slightly between 1990 and 2012 (Figure 4).  The report notes the difficulty 
of addressing neonatal mortality, when a large majority of deliveries still occur at home.  
Opportunities for improvements in neonatal care, including neonatal resuscitation, will 
affect a minority of infants in need.12 
 Haiti's infant mortality rate is much higher in urban areas than in rural areas.  The 
infant mortality rate in Port au Prince is 81 deaths/1,000 live births versus 58/1,000 in 
rural areas, while internally displaced person (IDP) camps within the metro area had an 
especially high rate, at 124/1,000.12 Mortality rates were higher for infants of women 
without educational instruction, as well as for infants in poor families.   
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Figure 4. Child Mortality in Haiti from 2002 to 2012, Data from DHS Haiti 2012 
 
Source: United Nations Development Program. Millennium Development Goals, Report 2013: 
Haiti. (2014). 
   
 It is unclear why Haiti's infant mortality rate is higher in the area of the country 
with the highest percentage of facility-based delivery.  The Port au Prince area has two 
and a half times more facility-based deliveries than rural areas of Haiti, but also, 
according to this report, the highest neonatal mortality rate.12 Reporting bias may be 
influencing these figures, as infants that die after delivery at home are less likely to be 
reported to authorities.  However, it is not clear if there are also particular risks to 
neonates in Port au Prince—either from the environment itself, or related to the care they 
receive in the facilities where they are born. 
 Higher rates of infant mortality in Port au Prince speak to the specific, contextual 
issues surrounding pregnancy in this city.  There is no published evidence that describes 
the particular risks to infants and neonates in Port au Prince, or how that differs from 
their rural counterparts.  However, based on the literature from other settings, higher rates 
		 30 
of infant mortality in this population are likely affected by lack of or delayed access to 
emergency obstetric care. 
Médecins Sans Frontières (MSF) in Haiti 
 Médecins Sans Frontières (MSF), or Doctors Without Borders as the organization 
is known in English, is a non-governmental organization providing maternal and neonatal 
care in Haiti.  MSF was established in France in 1971.  MSF's mission is “to provide 
medical assistance to populations in distress, to victims of natural or man-made disasters 
and to victims of armed conflict.  They do so irrespective of race, religion, creed or 
political convictions.”63 MSF's principles are based on medical ethics, independence, 
neutrality, and impartiality.  MSF was originally founded by a group of doctors and 
journalists with the explicit goal of medical care in conjunction with bearing witness to 
extreme acts of violence.  MSF is a worldwide movement comprised of twenty-four 
partner sections, and runs projects in seventy countries worldwide.63   
 In line with its independence, MSF does not typically apply for donor funding, 
and does not accept most government funding of its projects.  Most of the organization's 
billion-dollar annual budget comes from individual donations, allowing MSF to respond 
where and how they determine, regardless of other actors or donor priorities.  To preserve 
this independence, MSF also does not typically partner with other non-governmental 
organizations or governments.  MSF responds to humanitarian emergencies based on the 
organization's evaluation of needs.  Programs are typically designed to reduce mortality 
in a specific population at risk.  MSF has begun to focus more on health program in urban 
settings, and has several programs in Latin America responding to urban violence.64 MSF 
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also works to reduce maternal deaths in many countries with high maternal mortality.65 
 MSF has worked in Haiti since 1991, when a hospital rehabilitation project was 
started in the northeast of Haiti.  In 2013, MSF employed more than 2,000 people in 
Haiti.  Of those employees, the majority were Haitian staff.  There are a number of MSF 
projects throughout Haiti, and the total budget for the organization in 2013 was more than 
30 million euros (about 33 million US Dollars).66 MSF's projects in Haiti focus on 
specialized hospital-based health care, as well as continued emergency treatment of 
cholera.  MSF runs several hospitals in Port au Prince, including an orthopedic 
emergency hospital, a burns hospital, and an obstetric emergency hospital. 
 MSF has run obstetric hospitals in Port au Prince since 2006 at the Jude Anne 
hospital. This was followed by introduction of admission criteria to focus on high-risk 
deliveries when activities were moved to the Solidarité hospital that was later damaged in 
the January 2010 earthquake. Post-earthquake MSF temporarily supported the state 
maternity hospital until the opening of the current structure in March 2011. The Centre de 
Référence des Urgences Obstétricale (CRUO, Emergency Obstetric Referral Hospital) is 
a unique obstetrical structure for MSF as it deals mainly with obstetrical emergencies 
(Figure 5). The aim of the MSF CRUO hospital is to reduce maternal mortality in Port au 
Prince. 
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Figure 5.  Postpartum ward at CRUO 
 
Source: Medecins Sans Frontieres Canada. Haiti: Kangaroo Care - Simple and effective support 
for premature babies. at <http://www.msf.ca/en/article/haiti-kangaroo-care-simple-and-
effective-support-premature-babies> 
 CRUO is designed as a referral hospital, which accepts only women with a 
specified list of obstetric complications.  Women can be referred to CRUO from MSPP 
or private hospitals that may not have the resources to appropriately treat some obstetric 
complications, as well as from other NGO structures that focus on normal deliveries.  
Some women are admitted directly without referral, if they meet the admission criteria.  
The hospital is meeting the need for emergency obstetric care in the city, which MSF 
deems insufficient to prevent many cases of maternal mortality. 
 CRUO admits about 590 women per month, of which about 420 deliver.  In 
addition to a large percentage of women with hypertensive disorders of pregnancy, 
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CRUO also serves women with obstructed labor, antepartum or postpartum hemorrhage, 
infections during labor, fetal distress in labor, post-abortion care and post-partum 
emergencies. A large percentage of admissions (25% in 2013) are for eclampsia and 
preeclampsia. Additionally, CRUO also admits some women with uncomplicated 
pregnancies who are imminently delivering when they arrive at the structure.  These 
women with no known complications of pregnancy represent about twenty percent of 
admissions. 
 CRUO also includes a neonatology unit for infants born at the hospital.  The 
neonatal admission rate is high with a 2013 average of 182 monthly admissions. On 
average fifty-five percent of neonatal admissions are low birth weight (less than 2.5 kg) 
and almost half (46%) of admissions are preterm (< 36 weeks gestation).  Many of these 
small infants are born to mothers with preeclampsia.  They are at risk for higher rates of 
complications after delivery. 
 The MSF CRUO hospital remains one of the only options for free obstetrical care 
in Port au Prince.  However, as a referral hospital, CRUO also depends on a functioning 
referral system from other hospitals.  Are women able to access CRUO in a timely 
fashion when problems arise?  What are the delays that women face?    
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Chapter 3: Literature Review 
Conceptual Model - The Three Delays 
 Women in Haiti suffer from the worst maternal mortality risk in the Western 
Hemisphere.  High rates of preeclampsia and eclampsia, combined with a weak public 
health system and high rates of home deliveries make pregnancy dangerous for many 
women.  As seen at the Médecins Sans Frontières (MSF) hospital in the case of Marie, 
the 16 year-old who died from eclampsia described in Chapter one, timely access to 
emergency care when complications arise is key to reducing maternal and perinatal 
mortality.  Marie is but one of the many pregnant women who die of preventable causes 
in Haiti today.  Organizations like MSF, as well as the Haitian Ministry of Public Health 
and Population (MSPP), seek to prevent these deaths through the provision of emergency 
obstetrical care.  Understanding the causes of these needless deaths is important to 
providing effective programming to prevent them. 
 One of the most widely used and useful concepts for understanding the causes of 
maternal mortality is the Three Delays model, first described in 1994 by Thaddeus and 
Maine in their paper "Too Far to Walk: Maternal Mortality in Context".67 In this paper, 
they examine the factors that lengthen the time between the onset of an obstetric 
complication, and its successful treatment at a medical facility, with an aim to develop 
more effective programs to combat maternal mortality.  
 Most complications of pregnancy, when treated quickly and effectively, are not 
life threatening.  A postpartum hemorrhage can be effectively managed by a range of 
medical and surgical options, and rarely leads to death in a modern healthcare system.  
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However, in those countries where access to quality medical care is limited, these 
complications that are routinely managed in wealthy countries are not managed in time.  
This delay to treat complications leads to much higher rates of maternal and infant 
mortality in many poor countries around the world. 
 In many low-income countries including Haiti, the majority of women deliver 
their infants at home.  Increasing the percentage of women who deliver in a health facility 
is a major focus of worldwide efforts to reduce maternal mortality.  However, until the 
pervasive issues of human resources and infrastructure are improved, many women will 
continue to deliver at home in low-income countries.  Most obstetric complications have 
no warning sign.68 Given this, antepartum screening is not an effective tool to identify 
most women who will have a complication during labor.  Rather than identifying women 
at risk for birth complications, the World Health Organization recommends "focused 
antenatal care" to deliver a range of interventions aimed at reducing risks for morbidity 
and mortality, including iron supplementation to prevent anemia, and tetanus toxoid 
administration to prevent neonatal tetanus.69  However, during the birth process, women 
experiencing a complication of pregnancy at home have to make the decision to seek 
care, and arrive at the hospital in time to prevent maternal and neonatal mortality.   
 Thaddeus and Maine describe three delays to receive medical care after the onset 
of an obstetric complication (Figure 6).67 The first delay is the time elapsed between the 
onset of an obstetric complication and the woman's decision to seek health care.  The 
second delay is the time elapsed between the decision to seek care and the arrival at the 
emergency obstetric facility.  The third delay is the time elapsed between the woman's 
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arrival at the health facility, and the appropriate medical management of the pregnancy 
complication.  Each of the delays will be discussed in greater detail in the following 
section. 
Figure 6. Conceptual Model of the Three Delays 
 
Source: Thaddeus, S. & Maine, D. Too far to walk: maternal mortality in context. Soc. Sci. Med. 
38, 1091–110 (1994) cited in United Nations Population Fund. Emergency Obstetric Care. 
(2014). at <http://www.unfpa.org/public/mothers/pid/4385> 
 
The First Delay 
 The first delay is the delay in the decision to seek care.67 A skilled health provider 
does not attend most births in low-income countries.  Therefore, if a complication arises, 
the woman must journey to find medical help.  However, the woman, or her family, 
needs to first decide that she needs medical help and decide to leave home to seek care.   
 The woman, or her family, is influenced by a number of interrelated and 
contextual factors about when medical help is needed.  The status of the woman in the 
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family, her ability to make decisions, or the status of women in the culture may inhibit 
decision-making to seek health care.70 The woman or her family member's educational 
level may affect her understanding of the obstetric complication she is experiencing, and 
her need for health care.71,72 The woman or her family may not be prepared for an 
emergency, or not have a plan for what to do.73 Some women may have to wait for their 
spouse to accompany them to seek care.73  
 A number of factors related to the accessibility of quality health care can affect 
the first delay.  The distance needed to travel to the nearest health center has been found 
in many contexts to favor or inhibit women's decisions to seek care.73–78 Thaddeus and 
Maine (1994) describe distance as having a duel role in delaying care—first, as the 
distance itself as an actual obstacle, and second, as a disincentive to even leave home.  In 
many studies, the longer the distance to care, the longer women delayed leaving home to 
access care.  Longer distances to access care mean increased travel time, increased 
expense for the family, longer times away from home, and potentially increased risks of 
security problems.  Additionally, for pregnant women in labor with obstetric 
complications, increasing distances also increase the risk that the woman will have to 
deliver on the road. 
 When the woman or her family believes there is a high-quality health center 
available, they are less likely to delay seeking care.  The availability of quality health 
care has been found to overcome some of the barriers of distance in some settings.79 
Thaddeus and Maine, in their original article on the Three Delays, highlight the 
importance of accessible, quality obstetric care, for its impact on reducing all three 
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delays. 
 The cost of seeking care and receiving care may also influence the delay at home.  
If a woman or her family has few economic means, or if the projected costs are expected 
to be high, they may delay the decision.  At a more fundamental level, impoverished 
families may have less access to health care in general, which would also affect care-
seeking for emergency obstetric care.67 
 These factors affecting the first delay are contextual and interrelated.  For 
instance, a lack of understanding of the gravity of a complication may lead to an 
overestimation of the barriers to seek health care.  Individual characteristics, family 
dynamics, and cultural factors have multiple and complex interactions on women's 
decision to seek emergency obstetric care. 
The Second Delay 
 The second delay is the time taken between the decision to seek medical care, and 
the arrival at a medical structure.  As opposed to the first delay, in which distance or cost 
is a psychological barrier to deciding to seek care, in the second delay these issues 
become the obstacles to overcome.67 
 There are several issues, including transportation, infrastructure and distance that 
affect the second delay.  The woman and her family need to find a way to travel from the 
home to the emergency obstetric facility.  Transportation may have to be arranged if the 
family does not own a means of transport.  Especially in rural areas, it may be difficult to 
arrange transport from the house to the hospital.  Pregnant women suffering 
complications may be unable to walk to reach transport.  Finding money to arrange 
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transport can be a major barrier.73 On nights or weekends transport options may be more 
limited, leading to longer delays.  In some areas, insecurity or violence may limit 
transport during certain times. 
 The referral mechanisms for women with obstetric complications may also add to 
delays.73 Women who are being treated by a traditional birth attendant may be kept at 
home for too long prior to referral.  Local health centers may not be adequately staffed, 
leading to further delays in referral.  Health providers living in the woman's area may not 
be available to refer the patient when the complication arises.  After finding money and 
arranging transport, the woman and her family must negotiate the distance to the health 
center.67 Bad roads, and weather-related barriers such as swollen rivers, may inhibit 
travel.  Conflict or violence may limit travel options and routes. 
 The geographic distribution of emergency obstetric facilities is a key factor in 
their accessibility to women.  Many studies have noted the over-representation of 
hospitals in urban areas.  In rural areas, where population density is by definition lower, 
distances to hospitals are often much longer.  However, even in urban areas, women can 
have difficulty accessing emergency obstetric care.  A study in Nairobi, Kenya, found 
that women living in urban slums had to surmount many barriers to access 
transportation.80 Even though women in this study lived in a major city with many 
hospitals, poor road infrastructure in their neighborhood, coupled with seasonal 
difficulties due to flooded streets, meant that women in this urban area struggled with 
many of the same barriers to care that are typically associated with rural living. 
 Transport to emergency obstetric care depends not only on the physical 
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availability of health structures, but also on public safety measures in place.  In areas 
where travel after dark is dangerous, women with obstetric complications are essentially 
limited to daytime care seeking.  Public safety problems can delay women's departure for 
emergency obstetric care, if they cannot leave for the hospital during the night. 
 In a meta-analysis of the first and second delays to care, McNamee et al. (2009) 
found that women's educational level, the family's economic status, and the distance to 
the facility were the most important predictors of the utilization of health services.81 The 
first and second delays are sometimes categorized as "demand-side" delays, as they are 
affected by the patient's desire and ability to access care.   
The Third Delay 
 The third delay noted by Thaddeus and Maine describes the delay in receiving 
appropriate treatment for the obstetric complication once the woman has arrived at the 
medical structure.67 These factors can further delay the administration of appropriate 
emergency obstetric care, further endangering the woman and her fetus. 
 In low-resource settings, emergency obstetric care facilities are often not 
equipped or staffed appropriately.  Knight, Self and Kennedy published a systematic 
review of factors influencing the third delay (2013).  They identified thirty-two barriers to 
timely and appropriate care at the facility level, which they characterized into six themes: 
drugs and equipment, policy and guidelines, human resources, facility infrastructure, 
patient related, and referral related.82 Of these, human resource problems were the most 
prevalent.  Human resource problems include inadequate training, inadequate staffing, 
and lack of twenty-four-hour staffing.   
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 Human resource shortages are a major problem throughout the developing world.  
In particular for obstetric care, lack of qualified obstetricians and midwives are a major 
barrier to reducing maternal mortality.82 Lack of qualified health professionals means that 
even when a woman with an obstetric complication manages to reach a health facility, 
there may not be trained staff available to care for her.  Moreover, inadequate training 
may lead to inappropriate care being given to the woman.83 
 The availability of comprehensive emergency obstetric care, which includes 
cesarean section, is a key component of measures to reduce maternal and perinatal 
mortality.  The availability of these services is related in large part to health system 
financing.  Many low-income countries have not met commitments to fund their health 
departments at adequate levels.84 In these countries, providing adequate coverage of 
comprehensive emergency obstetric coverage may be prohibitively costly.68 In many 
settings, women who manage to arrive at the obstetric facility may still face long delays 
to receive appropriate care. 
 As Thaddeus and Maine note (1994), the availability and quality of medical care 
affects more than the third delay.  Women's understanding and perceptions of the 
availability and quality of medical care influence decision-making on when to leave 
home to seek care.  As several studies have noted, women are willing to travel farther 
when the quality of medical care, or their perception of the quality, is high.79  Other 
studies have noted that greater economic means lead to women to travel longer distances, 
presumably as women seek out higher quality care.71 
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Twenty Years of the Three Delays 
 Since Thaddeus and Maine defined the Three Delays concept, it has been used 
throughout the world to investigate the causes of maternal mortality, and to plan 
programmatic responses.  The Three Delays model has been used in high maternal 
mortality burden, low-income contexts as diverse as Papua New Guinea85, Nepal70, 
Brazil86, and Liberia87, as well as many others.  Twenty years after its publication, it 
remains the predominant conceptual model for maternal mortality in low-income 
countries. 
 There have been some challenges to, and reworking of, the Three Delays model.  
Several authors have noted that the Three Delays model was designed to cover only 
emergency care, but that it can also encompass preventive services and normal 
birth.75,88,89 Gabrysch and Campbell expanded the conceptual model to include both 
emergency and preventive care-seeking.  They note that similar factors may be involved 
in both, though their importance may differ in their impact on each type of delay.75 The 
Three Delays can also be relevant for access to normal delivery.89 However, the relative 
importance of delays to care for preventive services or normal delivery has not been 
evaluated for its effect on maternal morbidity or mortality. While delays and barriers to 
access preventive care are important to understand, they are unlikely to have the same 
impact on maternal and neonatal mortality as delays to emergency care. 
 Other authors have questioned the usefulness of the Three Delays model for 
prospective, program-oriented solutions.88 They suggest that the model is most useful as a 
retrospective tool to review causes of mortality, and that there are no specific responses 
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for surveillance efforts or program responses. However, it is clear from the literature that 
the Three Delays model has, in fact, been used by many programs to plan programs to 
reduce specific delays to care.90,91 
 Other critiques of the Three Delays model have focused on the power dynamics 
and structural issues inherent in maternal deaths.  Iyer, Sen and Sreevastha offer one 
challenge to the Three Delays model's focus on timeliness (2013).  In their perspective, 
the focus on women's decision-making delays obscures the power dynamics and health 
system issues at play.  Additionally, they state that the focus on delays can distract from 
the appropriateness of the actions taken, regardless of the time taken to make them.92 
D'Ambruoso, Byass and Quomariyah also expand on the Three Delays model using 
qualitative data from interviews with family members of women who died in pregnancy.  
They call attention to structural issues of access that create delays to obstetric care, 
stemming from and causing the systematic exclusion of poor people.93 
Maternal “Near-Miss” 
 There has been a renewed interest in the Three Delays model as researchers have 
used the model to review not only maternal death, but also "near-miss" events.94 A new 
taxonomy has recently been created by the WHO to standardize discussion of these 
events.95 The WHO defines a maternal near-miss, or severe acute maternal morbidity, as 
"a woman who nearly died but survived a complication that occurred during pregnancy, 
childbirth or within 42 days of termination of pregnancy."95 The WHO has recommended 
using the term "maternal near-miss" to describe these events. 
		 44 
 However, standardization of the diagnostic criteria for maternal near-miss is less 
clear.  The WHO recommends using criteria for organ-system dysfunction to diagnose 
cases of maternal near-miss.  They present a list of criteria that can be used in low-
resource settings that translate organ-system dysfunction into clinical criteria that can be 
used without advanced resources.  They augment this list with laboratory and 
management-based criteria (Table 3).96   
 Near-miss cases share many of the same precursors as maternal deaths, but are 
much larger in number, so they are useful for researchers given that maternal deaths are 
relatively rare, and it is difficult to design a study with adequate power to identify 
significant predictors of maternal death.  By studying maternal near-miss, researchers can 
increase knowledge on the causes and prevention of maternal death.  Say, Lale, and 
Pattinson (2009) report on the usefulness of maternal near-miss.  Near-miss cases can be 
used to monitor the quality of obstetric programs.  Survivors of maternal near-miss are 
also uniquely placed to report on breakdowns of the public health system that may have 
occurred in their cases.  Finally, maternal near-miss indicators can be used to compare 
settings, and monitor progress over time.96  Researchers have used maternal near-miss 
cases to investigate delayed access to care, using the Three Delays model.88 
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Table 3. WHO Maternal Near-Miss Criteria  
 
Source: Say, L., Souza, J. P. & Pattinson, R. C. Maternal near miss--towards a standard tool for 
monitoring quality of maternal health care. Best Pract. Res. Clin. Obstet. Gynaecol. 23, 
287–96 (2009). 
 
Conceptualizing Perinatal Mortality with the Three Delays Model 
 Many of the same complications of pregnancy that cause maternal mortality, such 
as infections, preeclampsia or prolonged labor, also cause perinatal mortality.97 The 
solution to these problems is also the same: facility based delivery with a skilled 
attendant.  For deliveries starting at home, access to emergency obstetric care is key. 
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 The Three Delays model has also been used to conceptualize stillbirth and early 
neonatal mortality, the components of perinatal mortality.98,99 Stillbirth is directly related 
to the delay to appropriate treatment of maternal complications.  Several researchers have 
discussed the link between stillbirth and delayed access to emergency obstetrical care.  
One group of researchers published a series of articles showing that maternal delays to 
accessing appropriate obstetrical care was a critical risk factor for stillbirth.100 A 
retrospective review of maternal near miss in Afghanistan found an association between 
delay to care and stillbirth.101 A qualitative study of perinatal death in rural Gambia found 
that many of delays reported by participants increased their risk for stillbirth.102 Research 
in India has also noted the link between stillbirth and delays to appropriate emergency 
obstetric care.103 
 Furthermore, treatment of neonatal complications can be hindered by delays in 
much the same way that delays to recognize the need for care, access care, and receive 
care hinder appropriate treatment of obstetric complications. In a direct corollary to 
maternal deaths, infant deaths are rare when delivery occurs in well-equipped health 
facilities and attended by skilled providers.100  Infant problems after delivery are a 
leading cause of neonatal mortality, as two thirds of all neonatal deaths occur in the first 
week of life, and of these deaths, two thirds occur in the first twenty-four hours.104  
 Some researchers have focused on the Three Delays model to conceptualize 
neonatal deaths. As with maternal mortality, the vast majority of infants faced with life-
threatening complications can be treated if the appropriate medications, supplies and 
human resources are available.105 Wall et al. note that delays to appropriate emergency 
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care to reduce perinatal mortality are very time-sensitive, as every minute of delay can 
worsen fetal injury.57  
Preeclampsia in Haiti  
 Among the Latin America and Caribbean region (LAC), Haiti has some of the 
worst health indicators, including maternal and neonatal mortality.106,107 Preeclampsia is 
estimated to be the leading cause of maternal death in the Latin America and Caribbean 
region.49 Preeclampsia and eclampsia are also major causes of death in Haiti. Despite the 
lack of comprehensive understanding of the causes of preeclampsia, the risk for this 
disorder is clearly higher in individuals with a history of chronic hypertension.  Haiti has 
an extremely high prevalence of hypertension, with less than twenty-five percent of 
adults over forty having normal blood pressure.108 Programs aiming to reduce maternal 
and perinatal mortality in Haiti, like that of MSF, treat many obstetric emergencies 
related to preeclampsia and eclampsia.109 
 The Government of Haiti published a report in 2013 that stated that preeclampsia 
was a major cause of maternal death.12 Unfortunately, no data or research was cited for 
this claim.  However, this report, which was written in conjunction with the United 
Nations Development Program, speaks clearly to the magnitude of the problem of 
preeclampsia in Haiti. 
 Only two published studies have evaluated the prevalence of preeclampsia in 
Haiti.  In both of these studies, retrospective diagnosis data was evaluated for women 
delivering at the Albert Schweitzer Hospital, a highly respected non-governmental 
facility in a rural area of Haiti.  In the first study, which evaluated 3,000 births, 
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preeclampsia or eclampsia affected 18% of births.110  In the second study, which 
evaluated more than 1,700 births, preeclampsia or eclampsia affected 17% of births.111  It 
is likely that selection bias affected the prevalence of preeclampsia and eclampsia in 
these studies, leading to an over-estimate of the prevalence of preeclampsia.  In rural 
areas of Haiti, like the location of Albert Schweitzer Hospital, the majority of women 
continue to deliver at home.  It is likely that women with complications of pregnancy, 
like preeclampsia or eclampsia, were more likely to seek medical care, at the hospital so 
the estimates may be over-estimates. Nonetheless, as the only two published estimates of 
these disorders among Haitian pregnant women, these studies points to the potentially 
large number of cases in the country.   
Other Pregnancy Complications in Haiti 
 One of the best resources for data on pregnant women in Haiti is the Demographic 
and Health Survey (DHS), a survey of households and women conducted by ICF 
International periodically in many low and middle income countries worldwide.  The 
DHS provides the only recent population-level data about pregnancy in Haiti (2012).  
However, the DHS does not investigate specific complications of pregnancy like 
preeclampsia, although it does report on vaccine-preventable illness like tetanus.  The 
DHS data shows that a large majority (90%) of Haitian pregnant women had received 
antenatal care for their last pregnancy, and more than two thirds had received the 
recommended four visits (67%).  However, a little more than one third of women 
delivered their last infant in a health center (36%), or with a skilled birthing attendant 
(37%).  Low rates of facility-based delivery and skilled attendance at birth are noted risk 
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factors for maternal and infant mortality.  With most women delivering at home, access 
to emergency obstetric care in the case of complications is crucial for avoiding maternal 
and infant death.  
 The DHS does not report on the incidence of pregnancy complications such as 
preeclampsia.  Very little other literature describes specific complications of pregnancy 
facing Haitian women, including the prevalence of preeclampsia.  The limited research 
that is available reports high rates of preeclampsia (as described above), heart failure, 
sexually transmitted infections, and intimate partner violence in Haitian pregnant women. 
 Several articles have described Haitian pregnant women's risk factors for HIV and 
other sexually transmitted infections (STI's).  The Caribbean region has the highest 
prevalence of HIV infection outside of Africa, and in this region, Haiti has the highest 
prevalence.112 The current prevalence in Haiti is estimated at two percent10, with women 
infected at twice the rate of men.113 Prevention of maternal to child transmission 
(PMTCT) has been a major focus of HIV/AIDS and maternal health care activities.  
PEPFAR, the President's Emergency Plan For AIDS Relief funds PMTCT activities at 
public maternity hospitals throughout Haiti.114 GHESKIO, the Groupe Haïtien d’Étude du 
Sarcome de Kaposi et des Infections Opportunistes (Haitian Group for the Study of 
Kaposi's Sarcoma and Opportunist Infections), is a Haitian non-governmental 
organization dedicated to reducing the HIV/AIDS epidemic in Haiti.  Since 1999, 
GHESKIO has been providing PMTCT services to pregnant women in Port au Prince, 
reducing transmission rate among their population from 27% to 9% in the early years of 
the program.115 In 2013, more than 3,500 Haitian pregnant women throughout the 
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country were started on antiretroviral therapy during their pregnancy, and the 
transmission rate from mother to child was seven percent.116 
 Haitian women are also at risk for other types of infectious diseases during 
pregnancy.  In particular, other sexually transmitted infections (STI's) have been 
documented as very prevalent in Haiti, and have been the focus of several research 
studies. A 1995 study by Behets et al. found that pregnant women attending an antenatal 
clinic in a slum of Port au Prince had very high levels of STI's.  Almost half of the 996 
women seen (44%) tested positive for an STI.117 Another study found that 40% of 
pregnant women attending antenatal care were pregnant with at least one sexually 
transmitted infection.118 Syphilis infection, which can cause severe newborn morbidity, 
remains a major problem among Haitian women, despite cost-effective testing and 
treatment measures.119  One study found that of women tested during antenatal care, 
eleven percent tested positive for syphilis, which can have devastating effects on the 
growing fetus.118  A number of other studies have also found significant numbers of 
syphilis-affected women, ranging from five to eight percent of pregnant women.118,120,121 
While the data from some of these studies on STIs are almost twenty years old, they 
demonstrate the risk of these infections among Haitian pregnant women.  The prevalence 
of STIs may be lower today, given the work in Haiti to increase awareness and usage of 
condoms related to HIV-prevention efforts. 
 Magee et al. (2006) described risky sexual behaviors among expectant fathers in 
Haiti, helping to explain some of the high rates of sexually transmitted infections among 
pregnant women.122 In this study, about 30% of the expectant fathers, who had been 
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referred to the study by their pregnant partner, had more than one sexual partner in the 
previous year.  More than two thirds (68%) reported they had not used a condom in the 
past year.  Even among the men with more than one sexual partner, the majority did not 
use condoms in the last year.  The authors report that Haitian cultural norms include both 
the desire for many children and multiple sexual partners for men, both of which reduce 
the likelihood of condom usage.  These factors also increase the risk of HIV and other 
sexually transmitted infections for women.   
 Progress has been made towards reducing, with a goal of eventually eliminating, 
other infectious diseases in pregnancy.  Measles and rubella were targeted for eradication 
in Haiti, and current data indicates very high levels of immunity.123 Cholera, introduced 
into Haiti after the earthquake by United Nations peacekeepers, has been declining in 
incidence.  Cholera was also a risk for pregnant women.  A study published by MSF 
showed an eight percent risk of intrauterine fetal death in pregnant women positive for 
cholera.124 
 In addition to a high prevalence of infectious diseases, Haitian women are also at 
risk for other complications of pregnancy.  Peripartum cardiomyopathy is a deadly and 
poorly understood type of heart failure that affects pregnant women.  Peripartum 
cardiomyopathy is ten times more prevalent in Haiti than in the United States.125,126 
 Violence also appears to be a major problem affecting Haitian pregnant women.  
The most recent Demographic and Health survey indicates that of women pregnant 
during the survey, six percent had experienced physical violence during that pregnancy.3 
Almost a three in ten (29%) of women had experienced emotional, physical or sexual 
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violence by their partner since the age of 15.3 Small et al. (2008) describe the results of a 
cross-sectional survey of 200 women accessing antenatal care at rural dispensaries served 
by the Albert Schweitzer Hospital.  They found that 44% of respondents had experienced 
violence in the previous six months, with 77% of those women reporting intimate partner 
violence.   Women experiencing intimate partner violence had statistically significantly 
higher measures of pregnancy discomforts.127 Additionally, another study in Haiti that 
examined DHS data showed a prevalence of 25% of intimate partner violence.128  This 
contributed to an extremely high overall rate in the Latin America and Caribbean region, 
estimated as the highest in the world.  These researchers identified intimate partner 
violence as a risk factor for poor maternal and fetal outcomes.  Intimate partner violence 
was also associated with a higher rate of preeclampsia.129 
 One study in Haiti found that many pregnant women self-medicated during 
pregnancy, many with potentially harmful medications.  Jules et al. (2010) found that 
75% of women surveyed in the postpartum ward of a maternity hospital reported taking 
medication during the pregnancy.  A significant percentage (13%) of women delivering 
had taken a medication that was potentially harmful to their fetus.130 Most of these 
harmful medications were pharmaceuticals that were purchased from a pharmacy or in 
the market without a prescription.   
 While the evidence is not complete on the complications of pregnancy faced by 
Haitian women, the picture painted by these studies is of some serious risks to the health 
of both mother and child.  Due to the lack of data about pregnancy complications, one 
researcher asked Haitian pregnant women directly about their experience of 
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complications of pregnancy.  This study found bleeding, fever, pain and perineal 
lacerations were the most commonly cited complications of pregnancy.131 Adding to 
these risks are the many problems associated with preeclampsia and eclampsia.  Risk 
factors for these disorders, like chronic hypertension, can be detected during antenatal 
care. 
Antenatal Care Utilization in Haiti 
 According to the most recent DHS data, pregnant women in Haiti have high rates 
of antenatal care utilization, and the percentage of women receiving antenatal has steadily 
increased over the last fifteen years.  Ninety percent of women in Haiti reported receiving 
antenatal care during their most recent pregnancy.  Of interest for this study, this 
percentage was slightly higher for women living in the Port au Prince area (92%).3  
However, inequalities are still present.  Among women with no education, a much 
smaller percentage (81%) received antenatal care, versus those with secondary school 
education or higher (97%).  The WHO recommends four visits to accomplish the 
evidence-based recommendations for antenatal care in low risk women.  In Haiti, 78% of 
urban women received at least four visits, as compared to 62% in rural areas.3   
 Perhaps counter intuitively, despite high levels of antenatal care coverage, a much 
smaller percentage of women delivered their infants in a health center or hospital.  Haiti 
is among a number of low income countries where antenatal care coverage is much 
higher than skilled attendance at birth, or facility-based birth.  However, there are many 
factors that may hinder access to delivery care even when antenatal care access is 
possible.  If quality of delivery services is low, or if financial barriers to accessing care 
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are high, women may have different motivation and ability to access delivery versus 
antenatal services.  In Haiti, antenatal services are very low-cost or free.  However, 
women are often asked to purchase medication and supplies for deliveries, and may also 
have to pay bribes to hospital staff.14 
Postpartum complications in Haiti 
 Quality postpartum care is an important aspect of preventing maternal and 
neonatal mortality, including from preeclampsia and eclampsia.  Almost half of eclamptic 
seizures can develop during the postpartum period.61  Newborn care is also an essential 
component to postpartum care.  Therefore, delayed access to care can still be an 
important predictor of maternal and neonatal mortality even after delivery.  The DHS 
reported very low rates of utilization of postpartum services in Haiti, including just (39%) 
by women and (31%) for their infants A trained health care provider saw little more than 
a third of women or infants in the recommended timeframe.  Not surprisingly, among 
women who did not deliver in a health structure, only 12% received appropriate 
postpartum care.   
 Two studies have focused specifically on needs of postpartum women in Haiti.  
Lathrop et al. (2011) found that in a sample of about 300 women delivering in a hospital 
in northern Haiti, the vast majority (98%) of women were interested in receiving 
contraceptive counseling before discharge, but only a very small percentage (6%) 
received counseling.  Eighty percent of women wanted to receive a contraceptive method 
prior to discharge from the hospital; however, there was no mechanism for contraception 
provision.132 Birth spacing and family planning is an important aspect for the prevention 
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of maternal mortality.  Poor postpartum care in Haiti may be undermining these 
possibilities.   
 Another study of postpartum women in Haiti focused on the outcomes of HIV-
positive pregnant women.133 Of the cohort of 500 HIV-positive women who delivered at 
the non-governmental organization GHESKIO between 1999 and 2005, almost one 
quarter (22%) were lost to follow-up.  Another group (25%) were not started 
appropriately on anti-retroviral medications according to protocol.  GHESKIO is one of 
the most respected and effective health care organizations in Haiti; even in this setting, 
postpartum follow up and care for this at-risk population were limited. 
Delayed Access to Health Care for Haitian Pregnant Women 
 Given high rates of maternal and infant mortality, and low rates of coverage to 
skilled birth attendance, many researchers have focused on Haitian women's access to 
emergency obstetric care.  These access problems are compounded by high rates of 
preeclampsia among Haitian pregnant women.  For women with complications like 
preeclampsia, accessing emergency obstetric care may be difficult.  Haiti has a 
centralized, weak public health system, and the majority of doctors and hospitals are in 
urban areas, so women in rural areas have been assumed to have less access to health 
care.  As such, research on access to obstetric care in Haiti has focused almost 
exclusively on pregnant women living in rural areas. 
 Barnes-Josiah (1998) published a seminal study of delayed access to emergency 
obstetric care in rural Haiti in 1998.  In this study, cases of maternal deaths were sampled 
from a nationwide, prospective study of causes of maternal death.  More than 10,000 
		 56 
pregnant women were enrolled in this prospective study.  Follow-up visits identified 
cases of maternal death among the enrolled participants.  Study personnel then conducted 
verbal autopsy to determine the medical cause of death, as well as a “social autopsy” to 
determine the non-medical circumstances surrounding the death.74 Unfortunately, 
political violence and a coup d’état interrupted the second round of study data collection.  
However, the study authors were able to use the social autopsy to investigate the delays 
faced by these women who ultimately died. 
 This study found that Haitian women faced many types of delays in accessing 
emergency obstetrical care.  All cases of death investigated were in rural areas.  Eight of 
the twelve women delayed or did not seek care.  Reasons given included distance, lack of 
transportation, and economic concerns.  Families of two other women also reported that 
they did not have confidence that there would be a doctor available at the nearest health 
center, or that they would be referred to a further hospital.  This study also found that 
most women died of causes that could have been treated had they received appropriate 
health care.74 
 The study authors report that the perception of inadequate or ineffective health 
care influenced the decision and delay to seek health care.  “Typically, families must 
balance the time lost in domestic labor and child care, the costs of transportation, 
services, meals, bribes and fees, and the emotional stress of travel, with the dubious 
benefits of unproven care.” (Barnes-Josiah 1998, p. 987).  Of the twelve cases of 
maternal death investigated, six women who did arrive for care received ineffective or no 
treatment at all.  Barnes-Josiah interprets the results of the study to make the case that the 
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low quality of medical care available underlay most of the cases of maternal death.  
While delays taken at home contributed to the deaths, these delays were often 
underpinned by the lack of confidence in the medical system.   
 Gage et al. (2006), in a secondary analysis of DHS data collected in 2000, found 
that increased distance to health care in rural Haiti was associated with a lower facility-
based delivery, though rates of antenatal care were not affected.  They also found 
associations between lower socioeconomic status, poor road conditions and mountainous 
terrain, with measures indicating low uptake of health services, including antenatal care, 
skilled birth attendance, and facility based delivery. 134 
 Among the existing studies examining access to emergency obstetric care, none 
have been published on access to care for urban Haitian women.  However, despite the 
concentration of resources in Port au Prince, almost forty percent (38%) of pregnant 
women choose to deliver at home.3  These women, when faced with a pregnancy 
complication, like preeclampsia, may face delays and obstacles to reaching emergency 
obstetric care.  The latest DHS survey (2012) indicated that of pregnant women living in 
Port au Prince, 71% had difficulty accessing health care when they had a medical 
problem.3 However, no studies are available that examine these difficulties or their 
effects on maternal and perinatal health. 
Addressing Access Problems for Pregnant Women in Haiti 
 Haiti, through both government-run and international efforts, has implemented 
various programs to reduce maternal and perinatal mortality.  The MSPP has used 
strategic government planning to focus energy and financing on improving maternal and 
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child health. Specifically, the Politique Nationale de Sante (National Health Plan) has 
specific objectives related to improving health coverage for women and infants 
throughout Haiti.  The MSPP has also been the recipient of donor funding for various 
maternal and child health initiatives, evident in the number of different programs 
targeting maternal and child health.  The Plan Stratégique National de Sante de la 
Reproduction et Planification Familiale (National Strategic Plan for Reproductive Health 
and Family Planning) has specific objectives related to reduction of maternal mortality. 
Plan Stratégique National Sur la Santé Intégrale de L’Enfant en Haïti (National Strategic 
Plan for Integrated Child Health in Haiti) elaborates objectives for the reduction of infant 
and neonatal mortality.  Haiti also has an integrated childhood illness program, a national 
vaccination program, a social insurance program, a national family planning program, the 
SONUB/SONUC (emergency obstetric care) program, and the now-defunct Manman Ak 
Timoun An Sante (Healthy Mothers and Children) program.12 
 Even with this long list of government-sponsored programs, there remain 
significant obstacles to accessing appropriate maternal and child health care.  The 
Government of Haiti itself describes the lack of coherence among the various national 
programs listed above, each of which has its own objectives and indicators for maternal 
and child health.12  Part of this may be due to the realities of donor-funded programs, 
which come with their own set of requirements, which the Government of Haiti may or 
may not be able to adjust to meet their own objectives.  Additionally, lack of funding for 
some of the most important projects, including the rehabilitation of emergency obstetric 
facilities, and the free obstetric care program, are major barriers.12 
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 Two studies describe non-governmental programs for pregnant women that were 
planned or implemented to address the issues of difficult access to health services in 
Haiti.  Hossain et al. (2014) and Shaffer, Fryzelka and Obenhaus (2007) both 
implemented services to reduce delays to emergency obstetric care.  Hossain et al. report 
on results of a survey in Northern Haiti.135 Women in this study had very high coverage 
of antenatal care (94%), but only half of them (54%) delivered in a health care facility.  
Women reported that their decision to deliver at home was mostly due to financial 
barriers, unexpected labor, and convenience.  These women reported that they would be 
willing, and they believed their families would be supportive, if they stayed in a 
maternity waiting home for a future pregnancy.  Maternity waiting homes have been 
implemented around the world to address the difficulty of offering emergency obstetric 
care to women living in remote and rural areas.136,137 These programs typically offer a 
home-like area close to the hospital where high-risk women spend the last few weeks of 
their pregnancy.  The woman who stays at the maternity waiting home has close to 
immediate access to facility based delivery and emergency obstetric care at the time of 
delivery.  There are no published reports of maternity waiting homes in Haiti. 
 The birthing home model implemented in the study described by Shaffer, 
Fryzelka and Obenhaus (2007) is a pilot program that attempted to address some of the 
barriers to access faced by Haitian pregnant women, although it was not a maternity 
waiting home.  In this model, a community-based birthing home offered delivery care to 
low-risk women, and referrals to emergency obstetric care when needed.  However, 
several issues limit the feasibility and acceptability of this program.  This program aimed 
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to deliver only low-risk women at the birthing home.  However, a wide number of studies 
have demonstrated that most complications of childbirth have no antecedent risk factors.  
In this birthing home pilot, in fact, they did not find any reduction in maternal mortality.  
Furthermore, it is unclear from the reported study whether this birthing home was 
equipped with the necessary supplies and medications to qualify as a Basic Emergency 
Obstetric and Neonatal Care center (BEmONC).  If it did not, in fact, offer the basic 
emergency services as outlined by the World Health Organization41, then it seems 
questionable that this program worked to attract deliveries to a health center that was not 
equipped to basic standards. 
Summary: Synthesis of the literature and remaining gaps  
 The maternal and child health research that is available for Haiti is incomplete, 
despite high levels of maternal and perinatal mortality.  Despite the lack of published 
evidence, unpublished reports and anecdotal evidence speak to the hard realities of 
pregnancy in urban Haiti.  These difficulties are in evidence every day at the MSF 
hospital in Port au Prince, where women and their infants suffer and die from preventable 
causes. 
 There is evidence from the DHS, and from limited other published research, that 
pregnant women in Haiti face a range of health problems, for which there is limited 
access to emergency obstetrical care.  The available research on pregnancy in Haiti paints 
a picture of women at risk from preeclampsia, peripartum cardiomyopathy, sexually 
transmitted infections, and intimate partner violence, among other issues.  Data about the 
availability of health services to treat these problems, and others, show high levels of 
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coverage for antenatal care, but low facility-based delivery.  There is evidence from other 
countries that the provision of emergency obstetric care, alongside skilled attendance at 
delivery, is a crucial element to reduce maternal mortality.   
 Pregnant women in urban Haiti face contextually-specific risks, many of which 
may be unknown; they may also have different obstacles to seeking care.  Research in 
rural Haiti has found distance to be the most important factor in delayed access to 
emergency obstetrical care.  While rural residents must navigate mountainous terrain, low 
coverage of emergency obstetric care, and transport obstacles, urban residents also face 
barriers to receive emergency obstetric care.  The lived experience of women in Port au 
Prince differs substantially from those of their counterparts in rural areas. 
 Missing from the published research is evidence regarding the risks and delays 
faced by pregnant women in Haiti's capital city, Port au Prince.  With forty-five percent 
of Haiti's population, the city's residents face a host of environmental, safety and health 
concerns that are quantitatively and qualitatively different than their rural counterparts.  
While some researchers have examined the barriers to emergency obstetric care faced by 
rural Haitian women, to this date no research has been published outlining barriers to 
access for urban Haitian women.  Although some of the concerns of rural women may 
also apply to their urban counterparts, particularly financial barriers or cultural 
preferences for home birth, there may also be other, urban-specific concerns.  Other 
researchers have examined the urban-specific risks for delays in emergency obstetric 
care80, but this evidence does not yet exist for the Haitian context. 
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 The Three Delays model suggests a number of factors that can cause delays to 
access emergency obstetric care, including distance to care, cost, women's educational 
level, women's status in the family, transportation, distribution of facilities, and the 
woman's perception of the quality of care available.67 There is no evidence about how 
these factors influence urban Haitian women's access to emergency obstetric care. 
 Port au Prince is a crowded and traffic-congested city.  How do transportation 
options in this city serve to either hinder or facilitate access to emergency obstetric care?  
Massive new slums are sprouting up on the fringes of the city. Are women who live in 
these locations able to access hospitals located in the center city?  Some areas of Port au 
Prince are controlled by gangs, and are extremely dangerous, especially at night.  How do 
women living in these areas access emergency obstetric care?  These questions are 
specific to the Port au Prince area, though they apply to women living in many urban 
areas.    
 Though Port au Prince is the site of most major hospitals in the country, access to 
these hospitals may still be limited.  Public hospitals, while nominally offering 
comprehensive emergency obstetric care, are often faced with budget shortfalls and 
human resource problems.  With the end of the Manman Ak Timoun An Sante program, 
women in Port au Prince may face extra barriers to receive emergency obstetric care.  As 
Thaddeus and Maine wrote when they developed the Three Delays model, the experience 
and risks for delay are contextual.  Understanding the specific risks facing women in Port 
au Prince can help program planners at MSF, and within the Haitian MSPP, to develop 
programming to address these context-specific concerns. 
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Study Questions 
 This study aimed to identify behavioral, demographic, and clinical risk factors for 
first or second delays to access emergency obstetric care.  This study addresses 
limitations in the available research on pregnant women's access to emergency obstetrical 
care in Port au Prince, Haiti.  With no published literature reviewing the barriers to access 
for women with complications of pregnancy, this study helps to elucidate the specific 
contextual issues at play in this urban environment.  
 Research in other settings has found specific demographic, behavioral or clinical 
factors associated with increased risk of delayed access to emergency obstetrical care.  
No corresponding research exists for the urban Haitian context.  What are the context-
specific risk factors for delayed access to emergency obstetric health care in Port au 
Prince?  Who are the women who have the most barriers to accessing care?   
 The types of delays to care in urban Haiti are not known.  Are women 
experiencing long delays at home prior to deciding to access care?  Is distance or 
transportation to the hospital a barrier to timely care?  These first and second delays are 
contextually based, and the risk in this setting is not known.  The types of delays 
experienced by women before receiving appropriate medical care for complications are 
unknown.  Many studies reporting on first or second delays to accessing emergency 
obstetrical care fail to report on the length of delay.138 The literature on the Three Delays 
has not developed a consensus on what time frame is clinically relevant for each of these 
delays.  This study aims to measure and report on the time taken for each the first and 
second delay. 
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 Pregnant women with preeclampsia represent an especially vulnerable group.  
There is no research in urban Haiti on the risks or barriers these women face to access 
emergency obstetric care.  Additionally, data from other settings indicate that women 
with preeclampsia may have other demographic risk factors, including poverty and low 
educational levels.  No research in Haiti has identified the specific characteristics of 
women with preeclampsia in this setting.   
 Finally, delayed access to health care has been shown to increase maternal and 
perinatal morbidity and mortality in many settings, including in rural Haiti.  However, the 
link between delayed access to health care and poor maternal and infant outcomes in 
urban areas in general has few published reports139–141, and none in Haiti.  Is delayed 
access to emergency obstetrical care associated with poor maternal or neonatal 
outcomes?   To answer these questions and address these critical limitations of evidence 
in the urban Haitian context, we conducted a study on delays to access emergency 
obstetric care for pregnant women admitted to the Centre de Références des Urgences 
Obstétricale (CRUO) hospital in Port au Prince.   
  
		 65 
Chapter 4: Methods 	
 We conducted a mixed methods study on delays to access emergency obstetric 
care for preeclamptic and normal pregnant women admitted to the Centre de Références 
des Urgences Obstétricale (CRUO) hospital.  Quantitative surveys were used to identify 
clinical, behavioral and demographic risk factors, as well as delays to access care.  
Qualitative in-depth interviews (IDIs) were employed to understand the meaning behind 
the identified factors.  Interviews allowed researchers to probe individual experiences and 
perceptions of women.142 Medical records review were used to collect maternal and 
neonatal outcomes. 
 In 2013, three percent of women at CRUO had an eclamptic seizure.109 One in 
twenty infants delivered at CRUO were stillborn, and seven percent died before discharge 
from the hospital. Although many of these neonatal deaths can be attributed to 
prematurity caused by preeclampsia, it is unclear why some women experience poor 
maternal or neonatal outcomes, and why others with the same diagnoses do not.  The 
CRUO hospital collects routine medical data for women admitted to the structure, but 
does not systematically collect demographic, clinical or behavioral data prior to 
admission that might shed light on women’s risk factors prior to admission. 
  
Study Objectives 
Primary objective: 
To describe delays to care among preeclamptic women and women with normal 
pregnancy admitted to the Centre de Référence des Urgences Obstétricale 
(CRUO) in Port au Prince, Haiti.  
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Secondary objectives: 
1. To identify demographic, clinical and behavioral predictors of delays to care 
for women diagnosed with preeclampsia versus those with normal pregnancy; 
2. To analyze the relationship between delays in care for preeclamptic women and 
associated clinical consequences in the Haitian context; 
3.  To inform MSF’s outreach and clinical care activities at CRUO in order to 
better target these activities to reach the highest risk pregnant women and to 
reduce their delays to receiving appropriate emergency obstetric care. 
General study design 
 This study utilized a comparative cross-sectional design comprised of a 
quantitative survey, medical records review, and qualitative in-depth interviews to 
examine delays to care among women with preeclampsia versus those with normal 
pregnancy.  Additionally, the study examined demographic, clinical and behavioral risk 
factors for delay to care, as well as the association between delay to care and poor 
maternal or neonatal clinical consequences. 
 A survey was administered to 502 women after delivery.  After survey 
administration, medical records review was completed for each participant.  Twenty-six 
of those selected women were recruited for qualitative in-depth interviews.   
  Women were interviewed after delivery, during the time of their postpartum stay 
at CRUO.  The survey consisted of questions related to clinical, demographic, and 
behavioral risk factors, as well as questions related to delays to care.  (Survey instrument 
Annex 9).  Sample questions for each risk factor are found in Table 6.  The survey was 
administered to the postpartum patient herself, or in cases of death or severe medical 
disability, to a legal representative who was able to give consent. 
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 Additional information was collected from the medical chart, including maternal 
and infant outcome measures (Table 5).   
Outcome measures 
 There are no guidelines in the Three Delays literature about the specific amount 
of time that qualifies as a first or second delay.  In fact, even a very short amount of time 
could be categorized as a delay, as it lengthens the time between the onset of symptoms, 
and the administration of appropriate treatment.  However, The United Nations 
Population Fund (UNFPA) gives a guideline of 6-12 hours for most complications of 
pregnancy (not postpartum). (http://www.unfpa.org/public/mothers/pid/4385 )  The 
World Health Organization states that most non-postpartum complications should be 
treated within 12 hours. 
(http://whqlibdoc.who.int/publications/2009/9789241547734_eng.pdf?ua=1 ) 
However, despite limited use of the six hour limit in the literature, there remains a lack of 
guidance in the published literature for what length of time qualifies as a delay.143 
 For this study, given the above limitations of the literature, and that we did not 
study postpartum complications, we used the more conservative, UNFPA-supported limit 
of six hours from the onset of symptoms to arrival at the MSF hospital.  However, delay 
was recorded as a continuous variable, so that the association of delay to poor clinical 
outcomes could be investigated as a "dose-response" relationship, where longer delay 
would more likely lead to poorer outcomes. 
 This delay represents the total amount of time between the onset of complications 
or labor, and the administration of appropriate treatment at the hospital.  If six hours or 
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greater has passed between the onset of complications and the patient's admission to 
MSF, that person would be characterized as having a delay.  This delay could be due to 
either a delay in deciding to leave home (first delay), a delay in reaching the hospital 
(second delay), or a delay in receiving appropriate treatment (third delay).   
 The amount of time for the first and second delay were self-reported by 
participants in the survey.  Participants were asked to report the amount of time elapsed 
between the onset of symptoms (or the precipitating event requiring health care) and 
when they left for the hospital- the first delay.  They were also asked to report on the time 
to reach health care (whether MSF or another structure) - the second delay.  The time 
each patient spent in the triage unit prior to being admitted was recorded from the 
medical chart - the third delay. 
 The onset of symptoms triggering the need for health care was different for each 
woman, and reflected individual and contextual factors, such as her level of education, 
previous experience with childbirth, and any relevant teaching about obstetric danger 
signs during antenatal care.  The onset of these symptoms was necessarily subjective.  
The subjectivity in the understanding of biomedical pregnancy complications is an 
acknowledged component of the Three Delays model.92  
 Clinical results, including maternal and neonatal diagnoses (see Table 5) were 
transcribed from the patient's or infant's medical chart by study personnel after the 
participant gave consent.  These secondary outcomes were recorded from the chart to 
reduce any reporting bias on the part of the participants, who may not be able to report 
medical terminology.   
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 Clinical, demographic and behavioral risk factors were collected from the survey 
questionnaire (see Table 6).  Clinical pregnancy history, such as history of medical or 
surgical problems in previous pregnancies, were self-reported by participants, because 
medical charts at CRUO do not always contain a complete medical or pregnancy history.   
Table 4. Study Outcomes: Primary Outcomes 
First Delay 
 
How long did it take to decide to seek health care? 
Second Delay 
 
How long did it take to reach the hospital after deciding to seek 
care? 
 
Table 5. Study Outcome: Secondary Outcomes, Poor Clinical Consequences 
Maternal • Eclamptic seizure 
• Coma 
• Death 
• ICU admission 
• Blood transfusion 
• Cesarean section 
Neonatal • Stillbirth 
• Neonatal death 
• Low APGAR score (<7 at 5 
minutes) 
• NICU admission 
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Table 6. Risk Factors for Delays to Care, Examples of Demographic, Behavioral and 
Clinical Factors 
Demographic  • Age  
• Neighborhood 
• Travel distance to CRUO (time) 
• Socioeconomic status   
• Employment  
• Marital status 
Behavioral • # visits to antenatal care  
• Use of traditional birth attendant  
• Visits to other health structures prior to MSF in labor 
(public hospital, private hospital) 
• Use of medications in pregnancy   
• Method, cost, and time of transport to MSF 
Clinical • Medical  (history of hypertension) 
• Pregnancy history (previous cesarean section)  
 
 After approximately one month of quantitative data collection, qualitative 
interview participants were identified from women who had completed survey 
questionnaires.  Potential interview participants were identified who had experienced 
long (>6 hour) delays to care.  A random sample of interview participants was asked to 
participate in an hour-long interview to describe their experiences before and during 
admission to CRUO.  Data was not collected that identified the number of women who 
declined to participate in an interview, or who were not available.  In-depth interviews 
were scheduled during the second half of the data collection period.  Both qualitative and 
quantitative data collection happened simultaneously during this time.   
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Study site 
Study settings 
 The study took place in the postpartum department of the CRUO hospital in Port-
au-Prince, Haiti. All surveys and interviews took place in private settings to ensure 
confidentiality.  All survey interviews and in-depth interviews took place before the 
participants' discharge from CRUO.  Survey administration and in-depth interviews 
occurred during free time at the hospital (i.e. not during medical rounds).   
Participants- Case Definitions for the study population 
 We drew the study sample from two groups of women delivering at CRUO: 
women diagnosed with preeclampsia or eclampsia, and women diagnosed with a normal 
pregnancy in labor.  
Case definition of Normal Pregnancy in Labor:  A pregnant woman admitted to CRUO 
during study recruitment, with the diagnosis of "Physiologic Labor" or "Imminent 
Delivery" on admission. 
 
Case definition of preeclampsia:  A pregnant woman admitted to CRUO during study 
recruitment, with hypertension (blood pressure > 140/90) and significant proteinuria (> or 
= ++ on dipstick). 
 
Case definition of eclampsia: A pregnant woman admitted to CRUO during study 
recruitment, with evidence of seizures, as well as a diagnosis of preeclampsia. 
 
 To ensure that women who died during labor or after delivery were not excluded 
from the analysis, which could bias study results, women were identified for inclusion at 
admission to CRUO.  However, women were not approached for consent until after 
delivery.  Women were not asked to consent for participation until their medical 
condition was stable and they were medically able to provide consent and participate.  
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For women under the age of eighteen, consent was also obtained from a parent or 
guardian. (see section - Minors) There was one survey administered to a family member 
in the case of a maternal death.  All surveys were administered confidentially. 
Participants- Inclusion and exclusion criteria 
 All women who delivered a baby at CRUO and had a medical diagnosis of 
preeclampsia or eclampsia, or physiologic pregnancy, were eligible for inclusion in the 
study.  Qualified CRUO staffs that admitted the patient made the medical diagnosis and 
determined if the woman met the case definition. 
 Exclusion criteria for the study were women not diagnosed with either 
preeclampsia or eclampsia or normal labor, women who did not deliver an infant (i.e. 
women with preeclampsia who are discharged home before delivery), or women who did 
not speak Haitian Creole or French.  Exclusion criteria also excluded women who were 
admitted to CRUO after delivery for postpartum problems, or those admitted to CRUO 
with gynecologic problems.  Exclusion criteria included women who were conscious, but 
who were not mentally capable of understanding or giving informed consent. 
Participants- Withdrawal 
 Consent to participate in the study could be withdrawn at any point and the patient 
did not suffer any negative implications for non-participation. Patients continued to 
receive the same standard of medical care from CRUO whether or not they decided to 
participate in the study.  The consent process reviewed this information with prospective 
study participants.  Study participants could also be withdrawn from participation by 
study personnel if they were unable to answer the majority of study questions.  These 
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participants were excluded from data analysis, and excluded from the overall study 
sample. 
Participant selection and enrollment 
Identifying participants for the cohort 
 Study personnel created a list of names of women who met the study inclusion 
criteria from the triage register.  This list was kept confidential, and was used only to 
identify women for potential inclusion.  The list ensured that women who were admitted 
to CRUO, but who were not present in postpartum (cases of maternal death or Intensive 
Care Unit admission) were not missed.  Study personnel used this list to identify women 
or their legal representatives in the postpartum ward, or the Intensive Care Unit.  The list 
of potential study participants was cross-checked with the postpartum staff prior to 
approaching potential participants, who ensured that potential participants were medically 
able to participate in study activities.  Participants were recruited after the end of morning 
medical rounds, to ensure that medical activities were not disrupted by study activities.   
Consenting participants 
 Prior to consent, the Haitian research assistant informed each potential participant 
about the study rationale, objectives, duration, and possible implications for the 
participant. This information was given verbally and in writing in either French or Creole 
depending on the preference of the person. Implications included the benefits and risks of 
the study, which were clearly explained. Any question related to study involvement was 
answered. The subject understood that they had a choice regarding their participation in 
the study and that refusal to participate in the study would not affect their access to the 
standard of medical care given to all women in CRUO.  The consent form was read 
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aloud, and, if agreed, signed. (See consent form Annexes 1-6). 
 After consent was obtained, the survey was immediately administered in a private 
location to ensure confidentiality.  After the end of the survey, study personnel recorded 
selected medical data from the participant's medical chart on an attached form (see Annex 
11).   
 For women with preeclampsia or eclampsia, the consent process was initiated as 
soon as the mother was well enough to give informed consent. For well-women the 
discussion began as soon as possible after birth as the mothers tended to stay in hospital 
only twenty-four to forty-eight hours. 
Minors as study participants 
 Women who were less than eighteen years old were included for participation. 
There was no minimum age for participation.  Adolescent mothers are at increased risk 
for complications of pregnancy, as well as being more at risk to develop preeclampsia 
and eclampsia, and it therefore was important to include their experiences in our analysis.  
However, to ensure protection of this vulnerable population, additional measures were 
needed, based on Haitian law.  For the case of minor participants, surveys were still 
administered confidentially, even if consent was required from their parent or guardian. 
 In Haiti the mother is considered an adult at eighteen years of age. For mothers 
younger than eighteen years of age, the Bioethics Committee in Haiti gave the following 
guidelines:  
o   <18 years old living with and/or accompanied by parents (legal guardian)—The 
parents/legal guardians give consent. 
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o   <18 years old NOT living with parents but living with a legal representative (family 
member, etc.)-- Legal representative can consent. 
o   <18 years old NOT living with parent and no legal representative- can be considered 
emancipated minor, and can give consent  
 If the minor participant had consent given by a legal guardian or legal 
representative, assent for study participation was still required of the participant herself. 
Study personnel read through the assent document with the minor participant and asked 
for their written assent (Annexes 7 and 8).  The assent process occurred in a confidential 
space after legal guardian or representative had signed consent for participation.    
 For minor participants whose parent or guardian signed a consent form, assent, 
surveys and in-depth interviews took place between the patient and the study personnel in 
a confidential environment. 
Consenting legal representatives of patients who are unconscious or dead 
 CRUO has a small number of maternal deaths or near-misses (i.e. patients 
admitted to the intensive care unit) every month.  Information on their risk factors is 
crucial to understand barriers and delays to access care.  Women who died prior to study 
admission, but who met other inclusion criteria, were included in the study through 
interviews with their legal guardians or legal representatives.  Women who were 
unconscious and admitted to the Intensive Care Unit, but who meet other inclusion 
criteria, were also included in the study through interviews with their legal guardians or 
legal representatives. The Haitian Bioethics Committee gave the following guidelines: 
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o   <18 years old and unconscious/dead: Same procedure as consenting a minor for 
participation, except no assent given by the patient 
o   >18 years old and unconscious/dead: If married, husband can give consent. 
o   >18 years old and unconscious/dead: If not married, then this would remain with next 
of kin (whether parents or family) but not friends. 
The legal representative of the patient was asked to answer all survey questions to the 
best of their recollection, in place of the patient. 
Ineligible and unrecruited participants 
 Women who did not meet inclusion criteria or who were ineligible for the study 
received the standard of care offered to all patients in CRUO.  CRUO offers free medical 
care to women suffering a variety of obstetrical complications, which continued 
regardless of study inclusion. 
Study and Clinical procedures 
General 
 The study combined self-reported information from the participants, with 
information recorded from the medical chart.  Surveys and interviews were arranged in a 
way to minimize the impact on time for the participants, and to minimize any interference 
with the medical care given to participants.  Participation in the study did not alter the 
medical services offered to participants. 
Training and pre-testing 
 Two research assistants were recruited.  The research assistants were Haitian 
women with previous university attendance.  It was not possible to recruit research 
assistants with previous research experience, given human resource constraints in Haiti.  
Haitian women were recruited, given that the vast majority of interviewees were also 
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women, leading to greater comfort for participants. 
 The recruited candidates underwent a weeklong training in research ethics, study 
protocols, and qualitative interview techniques (See Annex 13 for a detailed description).  
The qualitative research training occurred as a discursive, engaged conversation between 
the PI and two researchers.  The group worked collaboratively through each section.  
Role-play between the PI and researcher was used to elaborate on concepts introduced in 
the curriculum.  Both research assistants performed mock interviews with PI observation 
and supervision prior to the start of data collection. 
 Before the start of participant recruitment, the survey instrument, in-depth 
interview guide, and consent forms were piloted at CRUO, and necessary modifications 
were made.  Modifications were submitted for IRB review, and approved. 
Procedures for survey administration 
 Recruitment for survey participants occurred in the postpartum wards of the 
Emergency Obstetric Referral Hospital (CRUO) after the end of morning medical 
rounds.  Study personnel had a list of women fitting the inclusion case definitions.  Study 
personnel approached postpartum staff in CRUO to see if any woman on the list was not 
present (who may have died) or who was not medically cleared to be consented for 
participation.  Women not able to independently walk, or be out of bed for an hour, or 
have any other medical risk factor as determined by CRUO staff were not medically 
eligible.  Qualified CRUO staff decided who was medically eligible to participate.  All 
participants had already delivered an infant at that time.  Study personnel approached 
participants who were present and medically eligible at their bedside for study 
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recruitment.  Study personnel identified themselves, and explained individually to each 
woman the purpose of the study and asked if they were interested to participate.  If the 
woman responded affirmatively, study personnel asked the woman to either read, or be 
read, the informed consent form.  The woman had at least fifteen minutes to read and 
consider the form.   
 Legal representatives of women who were admitted to the intensive care unit and 
who met other inclusion criteria were also approached for potential participation.  If no 
legal representative was present, the woman was excluded from participation.  Legal 
representatives were asked to participate on behalf of women who were cognitively 
impaired (i.e., unconscious).  Women who were not unconscious, but who were not 
medically able to participate were approached for study participation when they were 
medically cleared, but still in the hospital. 
 Legal representatives of women who died at the hospital were also hoped to be 
included for study participation.  However, almost all cases of maternal death that did 
occur during the data collection period either occurred to women who did not meet the 
inclusion criteria (i.e. did not have preeclampsia), or the family representatives were not 
available to interview (i.e. the woman died overnight).  One survey was administered to a 
family member of a patient who died. 
 Study personnel verbally administered surveys in Haitian Creole or French, 
depending on the participant's preference.  Responses were initially recorded on the paper 
survey.  The primary investigator entered survey data into JMP (SAS Institute, Inc.) for 
analysis.  Paper surveys are stored at the CRUO coordination office in a locked file for 
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five years after the end of study inclusions. 
Procedures and data collection from medical chart 
 Patients admitted to the study already had a patient file from CRUO that included 
an in-depth account of their birth history and hospitalization. Data that was collected as 
part of the program that was used for the study included information about the woman's 
age; gravity and parity; her diagnoses of preeclampsia, eclampsia, multiple gestation, 
diabetes or obesity; whether or not she was admitted to the intensive care unit (ICU); 
whether she received a blood transfusion or a cesarean section; and whether or not she 
was in a coma. (See Annex 11 for complete instruments)  Additionally, information about 
her infant was recorded from the chart, including neonatal intensive care unit (NICU) 
admission; estimated gestational age; weight; and heartbeat and APGAR at delivery.  If 
the infant was admitted to the NICU, the admitting diagnosis was noted, though it was 
often missing from the chart. 
 The clinical data collection form was attached to the survey questionnaire.  At the 
end of the survey, study personnel immediately filled out the medical data collection 
form using the patient’s medical chart, which was located at the patient's bedside. 
Procedures and data collection for in-depth interviews 
 Purposeful sampling was used to identify women for qualitative interview 
inclusion, from among participants who had completed the survey.  While the planned 
sample size was thirty, interviews were suspended once data saturation was reached.  
Extreme case sampling144 was used to recruit participants who had experienced delays to 
care, or poor maternal or neonatal outcomes, as identified through the survey and medical 
record review.  These participants were ideally placed to report on barriers to accessing 
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care.  
 Women participating in the survey in months two and three of data collection, and 
who reported having delayed access to care or poor medical outcome, were consented for 
inclusion in the qualitative portion.  Study personnel administering surveys prospectively 
identified interview participants with the identified factors.  These women were 
approached for inclusion immediately following their survey participation.  Interviews 
were then scheduled for a time later in the same day.  Study personnel used an in-depth 
interview guide to question women (Annex 10).  Interview guides included the same 
sequentially- assigned questionnaire number, to be able to link interview responses to risk 
factors identified in the survey.  No personally identifiable information was recorded. 
Qualitative subjects participated in both the survey and the interview, for a total time 
commitment of one hour and thirty minutes, plus time for consent procedures. 
 Recruitment of qualitative participants started in the second month of study 
recruitment.  At that time, both the qualitative and quantitative components ran 
simultaneously, with one research assistant focusing on each component.   
 The in-depth interview process was a guided conversation, which allowed the 
study participant to guide the direction of the conversation.  As such, the interview guide 
prompted the interviewer to introduce themes to the participant.  The participant's 
response guided the interviewer to ask follow up or probing questions to better 
understand the response.  The interviewer sought to understand in detail the experiences 
of the research subjects, using non-verbal and verbal cues as well as non-judgmental 
listening techniques to encourage participants. 
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 Haitian study personnel were trained before the start of qualitative data collection 
using a free curriculum developed by the Johns Hopkins Bloomberg School of Public 
Health (see Annex 13).145   Interviews were conducted in Haitian Creole or French, 
depending on the participant's preference.  Interviews were transcribed in the original 
language, and translated into English.  Study personnel digitally recorded using 
commercially available digital technology. Back translation of selected transcripts 
ensured accuracy of translations. The researcher who conducted the in-depth interview 
used interview recordings to transcribe qualitative data in Haitian Creole into a Microsoft 
Word document.  Each interview was then translated into English and then transcribed 
into another Microsoft Word document.   
Potential confounders and effect modifiers 
 Some of the risk factors that we identified in this study may also function as 
confounders or effect modifiers of other risk factors.  Our analysis plan took into account 
this possibility.  However, based on the preeclampsia literature (see Chapter 3), we 
assumed that the following factors as potential influences: 
o Age 
o Multiple gestation 
o Previous history of preeclampsia 
o Diabetes 
o Previous history of hypertension 
o Obesity  
 
 Women admitted to CRUO for preeclampsia/eclampsia or normal pregnancies do 
not represent a random sample of all Haitian pregnant women, or even all Haitian 
pregnant women residing in Port au Prince.  Only those women who are well-enough 
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informed to know of CRUO's presence, those with the ability to reach the hospital for 
admission, those with the specific admission criteria, and those well enough physically to 
make the journey were admitted.  With an estimated forty percent of Port au Prince 
women delivering their infants at home, we cannot claim to draw conclusions for all 
pregnant Port au Prince women from our study.  However, based on existing surveillance 
data,109 CRUO does admit a large proportion of all women delivering in hospitals every 
month in Port au Prince.  
 Our study cannot draw conclusions for barriers faced by all pregnant women in 
Port au Prince, only those who are admitted to CRUO.  Further research would be needed 
to identify and analyze barriers to access for those women who deliver in other health 
structures, or at home. 
Statistical Considerations 
Sample size for the quantitative survey 
 This study included a group of women with no known complications of 
pregnancy, and a group of women with their current pregnancies complicated by 
preeclampsia or eclampsia. The study aimed to identify delays to care and poor clinical 
consequences in the group of women diagnosed with preeclampsia or eclampsia and 
compare them to a group of women with no known complications, "normal" women. 
 The sample size for this descriptive study was calculated using delay to care as 
the outcome.  The population-based DHS, conducted in 2012, showed that almost 
seventy-five percent of urban pregnant women in Haiti experienced a difficulty accessing 
health care during their most recent pregnancy.3  Although the DHS does not specify 
whether these difficulties led to delay in accessing health care, it is a reasonable 
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assumption. We can expect that women with complications of pregnancy at CRUO may 
have a similar likelihood of delay to care, regardless of whether or not they were 
diagnosed with preeclampsia.   
 It was expected that clinical, demographic or behavioral risk factors, or exposures, 
contributed to these delays.  The prevalence of these risk factors is unknown.  Distance to 
the nearest health center was found in one study in rural Haiti to be the largest factor in 
access to prenatal care.  We assumed that distance to the hospital could have been the 
most important factor in delay to emergency obstetric care.  Even in the urban setting of 
Port au Prince, the logistics and cost constraints of transport remain an issue.  This 
question has never been addressed in this context for emergency obstetric care.  We 
assumed that twenty percent of women live more than an hour away from the hospital, a 
conservative estimate given the logistical challenges of travel in Port au Prince.  This 
prevalence would likely be similar between women diagnosed with preeclampsia, and 
those with low-risk pregnancies.  Women not exposed to this risk factor (of living far 
away) could be assumed to have a lower risk of delay, estimated at a 50% risk of delay. 
 The exposed group, the women who live far away, were measured in the amount 
of time taken for them to reach the hospital, by whichever method they chose to 
come.  Women who took one hour or longer to reach the hospital (whether by walking, 
public transit, or other means), were categorized as "exposed".  Therefore, the 
"unexposed" group comprised women whose travel time to the hospital in this instance 
was less than one hour. 
  Given the logistical challenges of travel in Port au Prince, it was determined that 
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time was the best indicator of distance to the hospital, rather than kilometers.  Different 
neighborhoods that may be equidistant to the hospital have different access to public 
transportation, and traffic patterns in this congested city can lead to long travel times 
even for short distances. 
 The sample size was calculated to show differences in delayed access to care 
between the women exposed to a behavioral, demographic or clinical risk factor, and 
those who did not have a risk factor. We used the following assumptions then for the 
calculation of the sample size: 1) two-sided significance level of 95%; 2) power of the 
study 80%; 3) ratio of unexposed/exposed (4:1); 4) expected relative risk of delayed 
access in the exposed group 1.5; 5) expected proportion of outcome in unexposed group 
50%. This generates a sample size calculation of 42 women in the exposed group 
(women who live far away) and 168 women in the unexposed group (women living close 
to the hospital), a total of 210 women.   
 Three months were available for data collection, given CRUO and primary 
investigator constraints.  Two research assistants worked during that time.  Both research 
assistants recruited, consented and administered survey questionnaires during the first 
month of data collection.  During the second and third month of data collection, one 
research assistant continued full time with survey administration, while one research 
assistant focused on qualitative interviews. With these constraints, surveys and in-depth 
interviews were completed in the three-month data collection time-frame.   
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Analytic methods - Quantitative data analysis 
 We first calculated the proportion of women who experienced either first or 
second delay in accessing obstetric care.  We then calculated the proportion that 
experienced a long total delay (first, second and third delay).  Proportions were stratified 
by medical diagnosis, preeclampsia or no preeclampsia.  The relative risk of experiencing 
long delay was calculated for the preeclamptic and normal groups. 
 We then examined the association between delays and poor clinical outcomes.  A 
bivariate analysis was conducted to calculate the association between the exposure of 
delayed access to health care to the outcome of a poor clinical result. Findings were 
presented as relative risks with 95% CI.  
 The analysis also examined the relationship between clinical, demographic and 
behavioral risk factors and delay.  We calculated the association between the exposures 
of each individual antecedent risk factor (whether behavioral, demographic or clinical) to 
the outcome of delayed access to health care.   
Analytic methods - Qualitative data analysis 
 Transcripts of in-depth interviews were entered into NVivo, a qualitative data 
analysis software program, for data analysis (QSR International).  Analysis of qualitative 
data occurred in an iterative fashion, as data was collected, allowing researchers to 
formulate new lines of inquiry.142 Interview data analysis included coding the transcripts 
for themes, using principles of grounded theory.  Words or phrases describing an idea or 
phenomena were given a code, which was then compared and examined.  Codes were 
data-driven, meaning they developed from the themes emerging from the data.  In-depth 
analysis of coded data developed conceptual models to understand barriers to access for 
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pregnant women.  Qualitative data was linked to the respondent's survey responses by a 
sequentially numbered "questionnaire number", which was recorded on the interview 
transcript. 
Quality control 
 Assuring the quality of our data collection and compilation was a top priority. 
This was managed at field level by the principal investigator. 
 Quality control measures for the quantitative data collection included spot checks 
of hospital data by the primary investigator and ongoing training and coaching of 
research assistants.  Study personnel double checked clinical data from surveys against 
hospital medical data in the chart (for instance, number of children delivered) to ensure 
accuracy.  
 Quality control measures for qualitative data collection included the use of 
recording devices to ensure accurate transcription of interviews.  Interviews were 
transcribed in the original language before translation to English.  All quantitative and 
qualitative data was stored in password-protected files, and only accessed by the PI. 
Ethical Considerations 
Benefit for participants and community 
 There were no direct benefits to participants. 
Confidentiality 
 Any and all data collected throughout the study remained strictly confidential. 
The digital recordings, which did not include any identifying information, were saved to 
an external hard drive, which is locked with the paper consents and surveys at 
CRUO.  This external hard drive will be deleted after five years. 
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  The paper forms- surveys and consent forms- are being kept in a locked box for 
five years beyond the end of the study.  At the end of this time, the paper forms will be 
burned in the biomedical incinerator on site at CRUO. 
 The patient’s identities were not recorded on any study documentation. The 
patients' age and diagnosis were recorded, but not the date of delivery.  Given the large 
number of patients with the same diagnosis, it would be impossible to deduce the identity 
of any patient from this information.  All documentation and files contained only the 
patient’s file number, which was not linked in any way to personally identifiable 
information.  
 Recordings of in-depth interviews were also kept locked.  Recordings did not 
include personally identifying information, including name or address. 
 Participants were assured that there is no way that information in the study files 
could lead to identification of the participant. This statement was also included in the 
consent form and was verbally discussed when consent was signed. Data was entered into 
databases that are password protected and did not include personally identifiable 
information. All paper versions of patient forms, and recordings of interview data, will be 
kept in secure medical data storage facilities for five years following the completion of 
the research.  After five years, the information will be destroyed in CRUO's biomedical 
incinerator. 
Cooperation with national and local partners 
 The study of preeclampsia and hypertension in Haiti is a national priority.146 Dr. 
Roger Jean-Charles, professor of internal medicine at the State University of Haiti, and 
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past president of the Haitian Hypertension Center, is a consultant for this study.  Dr. Jean-
Charles will assist with the dissemination of research findings within the MSPP and 
among Haitian health care providers.   During the study implementation phase, meetings 
were planned with Dr. Jean-Charles to discuss the research.  
 The study was also discussed with the department of maternal and child health at 
the MSPP.  The MSPP supports the implementation of the study, although they did not 
take an active role.  All results of the study will be shared with this department. 
Benefits for the program, community and nationally 
 Preeclampsia is estimated by one Haitian study to affect almost one in five 
Haitian pregnant women.  Understanding the risk factors for poor outcomes in the Haitian 
context is crucial to developing effective programming to prevent infant and maternal 
mortality.  With no current research available on these risk factors, this study will help 
lay the groundwork for further research, and for more effective public health 
programming.   
 MSF, as a leading provider of emergency obstetric care in Port au Prince, was 
ideally positioned to host this research study.  As urban migration towards the capital city 
of Port au Prince continues, the issue of effectively targeted emergency maternity 
services will only continue to increase in importance.  As an emergency obstetric service, 
CRUO needs information on its patients and their risk factors in order to efficiently and 
effectively offer services.  This study offers important insights into the groups of women 
most at risk. 
 Current outreach and surveillance activities at CRUO focus on the programs and 
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capacities of other maternal health actors, but have limited abilities to assess medical 
needs of potential patients. The surveillance teams that are implementing these activities 
at present have limited understanding of the reasons that make women admitted to CRUO 
vulnerable to high levels of morbidity.  Analysis of data collected in this study will 
inform MSF strategic planning to target women most at risk for poor pregnancy 
outcomes, and to improve access to timely emergency obstetric care. Haiti is one among 
many countries in the world facing a growing urban population.  Identification of factors 
associated with delays to care among urban women in Haiti may also inform programs in 
other urban areas where MSF works.  
 Understanding the humanitarian context and experiences of CRUO patients helps 
deepen the understanding of risks and barriers to access.  This information can be used to 
develop prospective data tools to collect and analyze data on future CRUO patients. 
Incentives and compensation 
 No financial incentives were offered to participants.  All study activities took 
place during the period of the patients' hospitalization.  Therefore, participants did not 
incur travel costs or loss of time other than that already spent in the hospital.   
Potential risks 
 We see very few potential risks of this study. This was a survey and interview to 
examine the risk factors for women who received medical care in the facility. All women 
were offered the same level of care based on their medical needs. The minimal risk to 
study participants included the risk of a breach of confidentiality and the time lost 
completing the survey or in-depth interview.  Women were not directly questioned about 
sensitive topics, such as experiences of violence, though they could have chosen to 
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divulge them during in-depth interviews.  Any woman divulging experiences of violence 
or other sensitive topic was offered a referral to the mental health department available to 
all women at CRUO. 
 We interviewed some women who experienced poor outcomes for themselves or 
their infant.  The fact of questioning these women after a poor outcome, especially the 
death of an infant, was potentially very upsetting.  The informed consent procedure 
emphasized the voluntary nature of participation, and the ability to withdraw from the 
study at any time.  For any woman who appeared upset during the survey or interview, 
study personnel offered to stop.  Any woman who requested to stop participation, or who 
was upset during or after participation had access to CRUO's mental health services. 
 To minimize the risk of a breach in confidentiality, several measures were in 
place.  Neither the survey nor the interview asked participants any personally identifying 
information.  The recorded interviews did not record the subjects' names or other 
identifying information.  Medical data from the chart was collected at the end of the 
survey, so that names or other identifiers were not needed to locate this information at a 
later time.  All surveys and interviews took place in a private, confidential environment to 
ensure confidentiality.  Consent forms, which did include patient names, were stored in a 
locked file, but were not linked in any way to survey or interview responses. 
 To minimize the risk of time lost, all study activities took place during a woman’s 
postpartum hospitalization.  The study minimized the risk of disrupting medical activities 
by coordinating participant recruitment and interviews with CRUO medical personnel.  
Consent, questionnaires and interviews took place after the end of daily medical rounds 
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in the postpartum ward.  Additionally, study personnel asked for medical clearance from 
the postpartum supervisor to approach women for potential study inclusion. 
 This study took place at the same time, and in the same location, as another 
research study investigating long-term outcomes of low-birth weight infants.  Both 
studies recruited participants simultaneously, so measures were put in place to ensure 
both random selection of participants, but not recruiting participants into more than one 
study (for instance, alternating weeks of inclusion for each study).  Both the medical 
director of the hospital and the medical coordinator of the mission were involved to 
ensure that both studies did not impose greater risks on hospital operations or on potential 
study subjects. 
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CHAPTER 5: QUANTITATIVE RESULTS 
 
Overview 
 This mixed methods study, involving a quantitative survey and interviews with 
post-partum Haitian women, identified delays to care for preeclamptic and normal 
women, as well as numerous obstacles women overcame to reach care.  Qualitative data 
enriched quantitative findings by allowing women to describe in detail their experiences 
in their own words.   
 To ground the presentation of findings, we present the study objectives again 
here. The primary study objective was to describe delays to care among preeclamptic 
women and women with normal pregnancy admitted to the Centre de Référence des 
Urgences Obstétricale (CRUO) in Port au Prince, Haiti.  Secondary objectives included 
identifying demographic, clinical and behavioral predictors of delays to care for women 
diagnosed with preeclampsia versus those with normal pregnancy; and analyzing the 
relationship between delays in care for preeclamptic women and associated clinical 
consequences in the Haitian context.  Finally this study aimed to inform MSF’s outreach 
and clinical care activities at CRUO in order to better target these activities to reach the 
highest risk pregnant women and to reduce their delays to receiving appropriate 
emergency obstetric care. 
 A total of 502 surveys were administered to women admitted to the Médecins 
Sans Frontières (MSF) obstetric emergency hospital in Port au Prince.  Surveys aimed to 
identify and quantify delays to access care, as well as the risk factors for those delays.  
Surveys asked women a series of questions regarding their demographic, clinical and 
		 93 
behavioral risk factors.  The results were then stratified by preeclampsia status. Analyses 
included univariate and bivariate statistical modeling.  
The initial sample size for the quantitative survey was 420 women.  After one 
month of survey data collection, about 30% of preeclamptic women were not able to 
report on either the first or second delay, based on preliminary data analysis.  Those 
women were sick at the time they came to the hospital, and some of them may have also 
been unconscious (i.e. women who had an eclamptic seizure).  After approval from 
relevant IRB, more preeclamptic women were recruited, in order to ensure adequate 
statistical power.  The sample size of 210 women was augmented by an additional 82 
women, a total of 292 preeclamptic participants, to account for a 30% non-response 
rate.  This assumes a similar rate of non-response to the first or second delays among the 
additional participants.   
Twenty-two women were withdrawn from the study who could not complete the 
study questionnaire.  All of these women had suffered eclamptic seizures and were 
unable to remember enough information about the events prior to their hospitalization to 
answer survey questions.  These women were withdrawn from participation by study 
personnel after their participation in the study started, and it became clear that they were 
unable to answer the majority of survey questions.  Some other participants were unable 
to answer the length of first or second delay but responded to most other questions; they 
were not withdrawn. 
 Qualitative interview participants were chosen from among the survey 
participants.  A random sample of participants who had experienced a long delay (> 6 
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hours) were asked to participate.  A total of twenty-six interviews were conducted, 
eighteen with women, and eight with caregivers, which were recorded, transcribed, 
translated, and analyzed as previously described. The total sample size depended on 
theoretical saturation, the point at which no new themes emerged. We estimated, based 
on other qualitative research, that the total sample size would be about thirty women.  
Finally, twenty-six qualitative interviews were conducted.   
 
Quantitative Results 
Background characteristics of survey respondents 
 Demographic characteristics of the entire sample are presented in Table 7.  The 
majority of women who participated in this study were married, Christian, had finished at 
least primary school education, and were unemployed.  The vast minority of the study 
participants self-reported "doing well" or "good" socioeconomic status (7.3%).  About a 
quarter (22.9%) of study participants were living with family members or friends at the 
time of the survey (data not shown).     
 Preeclamptic women in this study were on average older than normal women 
(29.7 years versus 27.2, p< 0.01), despite similar proportions of multiparous women in 
each group (data not shown).  Eight percent of the women in the preeclampsia sample 
were age forty or older, versus only 2.4% in the normal sample (p<0.01).   Age greater 
than forty is a risk factor for preeclampsia. 
 A greater proportion of preeclamptic participants reported having a religious 
affiliation (95.2 % versus 88.0% , p <0.01), owning their own home (47.3% versus 
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30.5%, p<0.01) and being internally displaced (2.8% versus 0.5%, p = 0.04), compared to 
normal women.  Of the women with a religious affiliation, all but one identified as 
Christian. 
Some demographic indicators were similar between the preeclamptic and normal 
groups.  Preeclamptic and normal women were similar in terms of marital status, 
educational completion, and formal employment.  In both groups, only a very small 
proportion of women reported “doing well” or "good" economic status (5.8% normal and 
8.7% preeclamptic participants, n.s.). 
Table 7. Demographic characteristics of study participants, by preeclampsia status 
 Normal 
n (%) 
Preeclamptic 
n (%) 
p-value 
 n = 210 n = 292  
Mean age (SD) 27.2 (6.2) 29.7 (6.8) <0.01 
Married or cohabitating 149 (71.3) 223 (76.4) 0.20 
Attended some secondary school or 
university 152 (73.1) 206 (71.3) 0.66 
Employed in formal sector  15 (7.4) 16 (5.6) 0.43 
Had religious affiliation  184 (88.0) 276 (95.2) <0.01 
Own home 64 (30.5) 138 (47.3) <0.01 
Internally displaced 1 (0.5) 8 (2.8) 0.04 
“Doing well” or “good” (reported 
economic status)1  
12 (5.8) 25 (8.7) 0.22 
																																																								
1 Economic status self-reported via four-item scale using locally appropriate terminology, choices 
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 A large proportion of preeclamptic participants were not able to report delays to 
care.  Neither these women nor their relatives could complete the majority of the study 
questions (because they had been unconscious as the result of an eclamptic seizure during 
part of the first or second delays) and so were withdrawn by researchers from the study.  
Demographic characteristics of these women were compared to women in the 
preeclampsia subgroup (Table 8).  There were smaller proportions of women who were 
married, who had a religious affiliation, or who reported “doing well” or “good” in terms 
of economic status among the preeclamptic women who could not report first delays, and 
the women who withdrew. 
Table 8. Demographic characteristics of study participants who could not report 
first delay (including women who withdrew), compared to other preeclamptic 
women 
 Preeclamptic women who 
did not report first delay, 
or who withdrew 
n (%) 
All Preeclamptic 
n (%) 
p-value 
 n=29 n=285  
Mean age (SD) 28.1 (7.3) 29.6 (6.6) 0.28 
Married or cohabitating 17 (58.6) 220 (77.2) 0.04 
Attended some secondary 
school or university 17 (58.6) 201 (71.3) 0.17 
Employed in formal sector  0 (0) 16 (5.7) 0.08 
Had religious affiliation  23 (79.3) 269 (95.1) <0.01 
Own home 16 (55.2) 133 (46.7) 0.68 
Internally displaced 0 (0) 9 (3.2) 0.18 
“Doing well” or “good” 
(reported economic 
status)b  0 (0) 25 (8.9) 0.03 																																																								
b Economic status self-reported via four item scale using locally appropriate terminology, choices 
included "doing well", "good", "not too bad" and "no money" 
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Health history 
 As seen in Table 9, a slightly higher proportion of preeclamptic women in this 
study were giving birth for the first time (nulliparous) compared to normal women, 
though the difference was not statistically significant (48.1 % to 43.0% for normal, 
p=0.27).  Among multiparous women, preeclamptic participants were also much more 
likely to have a history of a birth complication than the normal participants (21.6% versus 
2.7%, p<0.01). A slightly greater proportion of preeclamptic participants had a history of 
health problems or previous doctor visits, although this difference did not meet the level 
of statistical significance.    
 The women in the preeclamptic subgroup were also much more likely to have had 
a diagnosis of preeclampsia in a previous pregnancy (38.6% versus 8.8%, p<0.01).  
However, almost ten percent of normal women in this study also reported a previous 
history of preeclampsia, roughly double the expected proportion of preeclampsia found 
among pregnant women in most settings, according to published estimates.49 
Table 9. Health history prior to current pregnancy, by preeclampsia status.  
 Normal, n (%) Preeclamptic, n (%) p-value 
Entire Sample n= 502c n=208 n= 292  
Previous doctor visit 48 (23.1) 85 (29.1) 0.13 
Previous health problem 48 (23.1) 83 (28.5) 0.17 
No prior delivery (nulliparous) 86 (43.0) 139 (48.1) 0.27 
Among multiparous mothers only n=253  n=113 n = 140  
Prior preeclampsia 10 (8.8) 54 (38.6) <0.01 
Birth complication in prior pregnancyd 3 (2.7) 30 (21.6) <0.01 
Prior home birth 33 (29.5) 39 (27.9) 0.78 																																																								c	Due to non-response to some questions, sample does not include all survey respondents 
d Birth complications were self-identified by participants and included a history of cesarean 
section, fetal death, and eclampsia	
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 Despite having higher rates of complications and preeclampsia in previous 
pregnancies, preeclamptic women in this study had comparable rates of prior out-of-
hospital birth.  
Behavioral risk factors 
 Participants were surveyed about their health behaviors during the current 
pregnancy, including antenatal care usage, visits to traditional birth attendants, and 
medication usage.  Table 10 presents behavioral risks by preeclampsia status, compared 
to relevant DHS data, and indicates that preeclamptic and normal women in this study 
reported comparably high rates of antenatal care (ANC) usage (96.7% normal, 96.2 % 
preeclamptic group), mirroring trends among women in Port au Prince overall (91.9%, 
DHS data).3  Adequate ANC, defined by the WHO as four or more visits, was achieved 
by a slightly lower proportion of women, similar between both the preeclamptic (83.1 %) 
and normal (84.2%) women.  This is higher than expected based on DHS survey data of 
women in Port au Prince, which found that 74.6% of women had four or more ANC 
visits.3  Similar proportions of both women who delivered preterm (<37 weeks gestation), 
and  women who delivered very preterm (<32 weeks gestation) reported receiving four 
visits of ANC as women who delivered at term (84%, data not shown). 
 Almost half (46.9%) of preeclamptic women in this study had received a 
diagnosis of preeclampsia prior to their admission to CRUO.  Despite this, less than one 
third (31.9%) of preeclamptic women were able to recall any danger sign of worsening 
preeclampsia, such as headache or facial swelling, although some of the preeclampsia 
diagnoses may have been made by the referral facility at the time of the labor and birth.  
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In comparison, only 7.2% of women in the normal group reported having received a 
diagnosis of preeclampsia during the current pregnancy.    
Table 10. Behavioral risk or protective factors of study participants, by 
preeclampsia status, compared to relevant DHS data 
Factor 
Normal: n (%) Preeclamptic: 
n (%) 
p-value Women in Port au 
Prince3 (DHS, 2012, 
%) 
 n = 210 n = 292  n= 1 037 
ANCe with health 
professional 203 (96.7) 281 (96.2) 0.80 91.9 
Adequate ANC (4+ 
visits) 171 (84.2) 231 (83.1) 0.74 74.9 
Diagnosis of 
preeclampsia in 
current pregnancy 15 (7.2) 136 (46.9) <0.01 
 
Birth plan made with 
health professionalf 191 (91.0) 258 (89.0) 0.35 
 
Birth plan made with 
TBA 35 (77.8) 38 (66.7) 0.18 
 
ANC with TBA 43 (20.6) 61 (20.9) 0.77 
0.4% (ANC with 
untrained health staff) 
Remembered any 
preeclampsia danger 
signs  31 (14.8) 93 (31.9) <0.01 
 
Any medications 
taken in pregnancy 193 (91.9) 266 (91.1) 0.34 
 
Medications 
prescribed by health 
professional 191 (91.0) 267 (91.8) 0.20 
 
Antihypertensive 
medications reported 0 (0) 38 (13.0) <0.01 
 
Did not remember 
the name of 
medications taken 86 (41.0)  102 (34.9) 0.17 
 
																																																								e	ANC = Antenatal care. DHS= Demographic and Health Surveys. TBA= Traditional birth 
attendant. 
f Birth plans refer to a discussion between provider and patient about her intentions and plans for 
her birth.	
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 Almost all women in this study (91.0% normal, 91.8% preeclamptic group) 
reported taking medication that was prescribed by a doctor or nurse during the pregnancy.  
Most participants reported taking prenatal vitamins (data not shown).  Thirty-seven 
women (13.0% of preeclamptic women), all from the preeclampsia group, also reported 
taking anti-hypertensive medications, such as methyldopa (identified as "AMD" by study 
participants).  Five women in the preeclamptic group (1.6%) reported taking aspirin, 
which is recommended for women at high risk of preeclampsia to prevent maternal and 
neonatal morbidity and mortality.147  No participant reported taking calcium, which is 
another recommended prevention measure.148  About two hundred women (38.2%) were 
unable to name or had forgotten the name of the medication they took (data not shown).    
 Traditional birth attendants (TBA, or "matrone") were also used by many women 
in this study.  About a quarter of women reported seeing a TBA for antenatal care during 
this pregnancy.  Of these women who saw a TBA for antenatal care, the vast majority 
(96.4%) also saw a doctor or nurse for antenatal care.  The proportion of women seeing a 
TBA was similar between the normal (20.6%) and preeclamptic (20.9 %) groups.  Most 
women who had seen a TBA for antenatal care reported that the TBA discussed their plan 
for where and how they would give birth, more for the normal (77.8%) than the 
preeclamptic (66.7%) group, though the difference was not statistically significant 
(p=0.18).  The percentage of women reporting antenatal care with a TBA in our study 
was more than fifty times greater than that found by the DHS in 2012.  Prenatal care 
services by untrained health staff, which corresponds to both "traditional birth 
attendants", as well as "relative or friend" in the DHS survey questionnaire, was reported 
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as 0.4% of women in the Port au Prince area.3  It is unclear why the reported percentage 
of women using TBA in this study is so much greater than women surveyed by DHS. 
 
Primary Outcome - Delay to Accessing Obstetric Care 
First Delay (deciding to leave home to seek care) 
 Table 11 presents the summary of data concerning the Three Delays.67 The first 
delay is defined as the time period between the start of the obstetric emergency, and the 
decision to leave home.67  The survey instrument first asked women to identify the sign 
or symptom that indicated there was an emergency, and then asked them to identify the 
amount of time that passed before they decided to leave for the hospital.  For some 
women, primarily those who had experienced a normal delivery and not diagnosed with 
preeclampsia, the sign was the onset of labor.  For preeclamptic women, and those not at 
term (less than nine completed months of pregnancy as determined from the medical 
record), the reported signs included headache, edema and convulsions.  
 The women in this study reported a mean 11.5 hours first delay (SD 22.2 hours).  
Preeclamptic women had a significantly longer mean delay than normal women (13.5 
hours (SD 30.0) versus 5.5 hours (SD 10.5), (p< 0.01).  The median delay for both groups 
was much shorter, however and similar for the two groups, (2 hours, interquartile range 
(IQR) = 12 for preeclamptic women versus 3 hours, IQR=5 for normal women).  
Second Delay (the time from the decision to leave to the arrival at the hospital) 
 The second delay was defined as the time it took women to arrive to the hospital 
once they had decided to leave home.  Women in this study experienced a mean second 
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delay of about an hour.  The mean second delay was similar for preeclamptic women (1.2 
hours) than normal women (1.0 hours, p=0.20).  
 
Table 11. First, Second, Third, and Total Delay in Preeclamptic and Normal groups 
 Normal Women Preeclamptic Women p-value 
First Delay (hours) n = 207 n = 285g  
Mean (SD) 5.5 (10.5) 13.4 (30.0) <0.01 
Median (interquartile range) 3.0 (5.0) 2.0 (12.0)  
Second Delay (hours) n = 194 n = 251  
Mean (SD) 1.0 (0.6) 1.2 (1.0) 0.20 
Median (interquartile range) 1.0 (0) 1.0 (0)  
Third Delay (minutes) n = 208 n= 292  
Mean (SD) 11.6 (38.1) 49.7 (60.2) <0.01 
Median (interquartile range) 0 (0) 35.0 (70.0)  
Total Delay (hours) n= 191 n= 235  
Mean (SD) 6.8 (10.5) 14.6 (27.9) <0.01 
Median (interquartile range) 4 (5.0) 5 (10.6)  																																																								g	Some participants were unable to recall the length of delays, so not all survey respondents are 
included in the analysis of each delay. 
 
Third Delay (length of time spent in triage before being admitted to hospital) 
 The third delay was defined as the time the woman spent in triage prior to 
admission.  The length of third delay was significantly longer for preeclamptic women 
(49.7 minutes) than normal women (11.6 minutes) (p< 0.01).  Normal women admitted to 
CRUO were typically admitted because they were very close to delivery.  A sub-analysis 
of preeclamptic patients found that the sickest women in this group, who had eclampsia, 
had a significantly shorter third delay than preeclamptic women overall (17.5 minutes 
versus 53.6 minutes, p<0.01, data not shown). 
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Total Delay (Sum of First, Second and Third Delays) 
 Preeclamptic women in this study experienced a longer total delay in accessing 
emergency obstetrical care than the normal women (mean 14.6 hours versus 6.8 hours, 
p<0.01). The median total delay was five hours for preeclamptic women, and four hours 
for normal women (p < 0.01).  Longer delays among the preeclamptic group were 
attributable primarily to longer first delays.  Waiting longer to leave home led to longer 
delays to emergency care for preeclamptic participants than the normal participants in 
this study.  When evaluated as a dichotomous variable (long delay >6hrs, not long delay), 
preeclamptic women also were more likely to experience long delay (43.8% preeclamptic 
women versus 33.5% normal women, p=0.03, RR 1.3, 1.0-1.7 95% CI, data not shown). 
 Mean delays for the preeclamptic group were longer than median delays due to 
the skewed distribution of the data.  Twenty-four preeclamptic participants had delays 
longer than 48 hours, and for thirteen of those women, their delay was longer than 72 
hours (see Annex 14).  An analysis of this subgroup of women with extremely long 
delays (greater than seventy-two hours) shows that they had generally developed 
preeclampsia at an earlier gestational age.  A greater proportion of these women were 
admitted preterm (84.6% versus 38.6%, p<0.01), and had a low birth weight baby (83.3% 
versus 46.3%, p<0.01) than women in the preeclampsia subgroup overall.  Analysis of 
the relationship between delays greater than twenty-four hours, or forty-eight hours did 
not show any statistically significant differences among these outcomes. 
 In addition to the women with extremely long delays to care, many more of the 
preeclamptic participants experienced long delays.  Almost half of these study 
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participants had a clinically relevant (>6 hour) delay to accessing emergency obstetrical 
care when faced with a life-threatening complication.  Almost one-fifth (17.0%) of the 
preeclamptic women had a delay of at least twenty-four hours before receiving care.  The 
difference in total delay between the preeclamptic and normal groups is primarily the 
result of a longer first delay in the preeclamptic group.  However, the third delay was also 
longer in the preeclamptic group than in the normal group.   
 Demographic indicators were also evaluated for the group of preeclamptic women 
who experienced very long delay (>24 hours).  No demographic differences were found, 
with the exception of economic status.  There was a smaller proportion (0%) of women in 
the very long delay group who reported "doing well" or "good" economic status than 
compared to the preeclampsia group overall (9.5%, p<0.01).  All other demographic 
indicators, including occupation, housing, and education were similar between the groups 
(data not shown). 
 
Secondary Outcomes 
 In addition to identifying and quantifying delays to care, the study also assessed 
the risks factors for delayed access to care, as well as the impact of these delays on the 
clinical outcomes of mothers and babies.   
Maternal outcomes 
 Large proportions of women and infants experienced poor clinical outcomes.  For 
women, preeclampsia was associated with greater likelihood of cesarean section (RR = 
10.5, 6.2 - 18.0 95% CI) , intensive care unit admission, coma, eclampsia, and 
transfusion, compared to non-pre-eclamptic women, although the numbers of poor 
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outcomes for the normal group were very small (Table 12).  Almost one in nine (10.7%) 
of preeclamptic women in this study also experienced an eclamptic seizure, not including 
the twenty-two women who were withdrawn, who all had eclampsia. 
Table 12. Distribution of poor maternal outcomes for normal and preeclamptic 
women 
 
Normal 
Group  
n (%) 
Preeclamptic 
Group      
n (%) 
Relative risk of 
preeclampsia 
exposure (95% CI) 
p- 
value 
 n = 210 n = 292   
ICUh admission 1 (0.5) 31 (10.7) 22.4 (3.1-162.6) <0.01 
Coma 0 (0) 5 (1.7) - 0.02 
Transfusion 1 (0.5) 10 (3.5) 7.3 (0.9-56.4) 0.01 
Eclampsia  0 (0) 31 (10.7) - <0.01 
Cesarean section 13 (6.2) 190 (65.3) 10.5 (6.2-18.0) <0.01 																																																								
h ICU= Intensive Care Unit 
 
Neonatal outcomes 
 For newborns, a preeclampsia diagnosis for their mothers was associated with 
greater likelihood of neonatal care unit (NICU) admission, stillbirth, low birth weight 
(<2.5 kg), and APGAR score less than 7 at 5 minutes of life (Table 13). 
Table 13. Distribution of poor neonatal outcomes among normal and preeclamptic 
groups 
 
Normal Group  
n (%) 
Preeclamptic 
Group      
n (%) 
Relative risk of 
preeclampsia exposure 
(95% CI) 
p-value 
 n = 210 n=292   
NICU admissioni 32 (15.4) 131 (45.6) 3.0 (2.1-4.2) <0.01 
Stillbirth 1 (0.5) 29 (9.9) 20.9 (2.9-151.9) <0.01 
Low birth weight 31 (15.0) 144 (50.0) 3.3 (2.4-4.7) <0.01 
APGAR <7 at 5 minj 21 (10.1) 67 (25.6) 2.5 (1.6-4.0) <0.01 																																																								
i NICU= Neonatal Intensive Care Unit 
j Excluding stillbirths	
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Risks for delay 
 None of the demographic, clinical or behavioral risk factors had significant 
associations with total delay (Table 14).  Although there were longer delays for women 
with some of these risk factors, the small numbers in many of the categories limited 
statistical power.  The lack of statistical significance for most factors was true regardless 
of whether delay was measured as a binary or continuous outcome.    
Table 14. Length of total delay (in hours) by preeclampsia status and demographic 
risk factor. 
 Normal Group Preeclamptic Group 
 
Yes:   
length of 
delay (n)k 
No:   
length of 
delay (n) 
p- 
value 
Yes:   
length of 
delay (n) 
No:    
length of 
delay (n) 
p- 
value 
Partnered 6.3 (134) 7.1 (56) 0.66 14.0 (180) 16.5 (53) 0.57 
Secondary/ 
University 
Education 
6.7 (139) 7.2 (50) 0.74 14.3 (169) 15.9 (62) 0.69 
Formally employed 6.9 (15) 6.9 (170) 0.99 18.5 (14) 14.3 (214) 0.59 
"Doing well" or 
"good" economic 
status 
12.1 (9) 6.6 (179) 0.13 4.9 (18)  15.2 (211) 0.13 
Owns home 6.2 (58) 7.4 (122) 0.39 16.2 (110) 13 (114) 0.69 
Internally displaced 4.0 (1) 6.9 (187) 0.79 13.1 (6) 14.8 (223) 0.88 																																																								k	Survey participants were excluded who did not answer length of delay 
 
 There was a slight trend towards shorter delay among preeclamptic women with 
good economic status (4.9 hours versus 15.2 hours for those with poor economic status), 
although this did not reach statistical significance and the median differences were much 
more similar (3.9 hours normal women versus 5 hours for preeclamptic women). This 
trend was opposite among the normal group, with longer delays among the women with 
good economic status (mean 12.1 hours versus 6.6 hours), although again, not statistically 
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significant.    
 Among preeclamptic women with very long total delays (>24 hours, n= 40), 
demographic factors were similar to the rest of the preeclampsia group.  Women with a 
very long delay were even less likely than the other preeclamptic women to report "doing 
well" or "good" economic status (0% versus 9.4%, p<0.01), and were more likely to 
report a religious affiliation (100% versus 81.9%, p=0.03).  Other demographic factors 
were not statistically different between the two groups (data not shown).   
 Participants' neighborhood of residence was also evaluated as a risk factor for 
delay.  Neighborhoods were categorized by zone within Port au Prince (see Annex 12).  
Delays by neighborhood were compared between preeclamptic and normal participants 
(see Table 15).  Women from different neighborhoods did not experience statistically 
different delays, but there were trends towards longer delays from some neighborhoods 
among the preeclamptic participants.  Long total delays in this sample were mostly due to 
first delay (delay in leaving home) and not second delay (travel time). 
Table 15. Length of delay (hours, [SD]) in preeclamptic and normal groups by 
neighborhood of residence 
 Normal Group Preeclamptic Group p value 
East (Delmas)  6.8 (11.5) n= 73 14.3 (28.2) n=69 0.04 
North (Bon Repos) 6.7 (12.4) n= 36 9.1 (15.8) n=37 0.48 
Downtown Port au Prince 5.1 (4.6) n= 32 22.7 (37.3) n=47 0.01 
South (Petionville) 8.7 (11.4) n= 22 10.3 (19.5) n=29 0.74 
West (Carrefour) 8.9 (11.3) n= 18 12.9 (22.7) n=28 0.48 
Outside Port au Prince 5.0 (3.1) n= 8 12.2 (31.2) n=22 0.53 
 
The difference between the delay for preeclamptic and normal participants was also 
assessed.  Statistically significant longer delays for preeclamptic women were found for 
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two neighborhoods: East (including the Delmas neighborhood where the CRUO hospital 
is located), as well as downtown Port au Prince, which is the neighborhood adjacent to 
the CRUO hospital (see Annex 12).   
 Table 16 presents data on associations between participants' health history and 
their delay to accessing care.  Only about a quarter (26.4%) of women in this study 
reported that they had previously visited a doctor.  This same group, minus two 
participants, also reported having a history of a medical problem prior to the pregnancy.  
A history of a doctor visit or health problem prior to the current pregnancy was 
associated with longer delays among preeclamptic women only.  A doctor visit, or a 
diagnosed health problem, may be indicative of more health care utilization prior to the 
current pregnancy.  Participants who had more contact with health care providers also 
had longer delays (median 8.8 hours, IQR=23.4 for women with a history of a doctor 
visit versus 4.0 hours, IQR=7.8 for women with no doctor visit).  The length of delay to 
access care in the current pregnancy was unrelated to other health history factors.  For 
instance, even women who had a history of delivering at home, who might be expected to 
wait longer to come to the hospital, did not have longer delays to care in this study. 
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Table 16. Length of delay (hours) for preeclamptic and normal women by health 
history 
Health history factor Normal Group Preeclamptic Group 
 
Length of 
delay (n)l 
p-value Length of 
delay (n) 
p-
value 
Previous doctor visit Yes 7.4 (44) 0.69 23.1 (63) 0.02 
Previous doctor visit No 6.7 (145) 11.4 (167) 
Previous health problem Yes 7.3 (44) 0.74 
 
24.0 (61) 0.01 
Previous health problem No 6.7 (145) 11.4 (169) 
Preeclampsia yesm 9.8 (9) 0.45 13.2 (49) 0.80 
Preeclampsia No 5.7 (92) 10.7 (65) 
Other previous birth complication Yes 5.6 (3) 0.95 8.1 (27) 0.64 
Other previous birth complication No 6.0 (101) 13.0 (86) 
History of home birth Yes 4.8 (31) 0.39 8.2 (29) 0.42 
History of home birth No 6.5 (73) 12.9 (86) 																																																								l	Survey participants were excluded who did not answer length of delay 
m History of preeclampsia, birth complication and home birth calculated for multiparous 
participants	
 
 As seen in Table 17, most clinical factors affecting the current pregnancy, such as 
whether or not a woman received antenatal care, were not associated with delay among 
study participants.  The exceptions were adequate antenatal care (four or more visits), 
which was associated with lower risk of delay, but only among normal women.  
 Participants also reported whether or not they had been diagnosed with 
preeclampsia during the pregnancy.  Some participants who were not identified as 
preeclamptic by their MSF medical chart reported having been earlier diagnosed with 
preeclampsia (13 participants).  These women experienced a statistically significant 
longer delay to access care compared to the rest of the normal women.  However, this 
small sample was skewed by two participants who had total delays of seventy-two hours.  
An analysis of this subset of women shows that five of these thirteen women had a blood 
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pressure reading on admission to CRUO that could have been indicative of hypertension 
or preeclampsia.  It is possible that some of these women who were categorized as 
normal may have actually had preeclampsia.  However, blood pressure can be normally 
elevated just prior to delivery; and some of these women's elevated blood pressure may 
have represented a transient, normal elevation. 
 
Table 17. Length of total delay (hours) by clinical risk factor and preeclampsia 
status 
 Normal Group Preeclamptic Group 
 Yes:   
length of 
delay (n)n 
No:   
length of 
delay (n) 
p- value Yes:   
length of 
delay (n) 
No:   
length of 
delay (n) 
p-value 
ANC with health 
professional 
6.8 (185) 8.9 (6) 0.63 14.2 (225) 25.2 (8) 0.28 
Adequate ANC (4+ 
visits) 
5.9 (157) 10.2 (28) 0.04 13.6 (187) 15.3 (36) 0.73 
Diagnosis of 
Preeclampsia this 
pregnancy 
16.8 (13) 6.1 (177) <0.01 13.1 (115) 16.3 (105) 0.70 
Birth plan with 
health professional 
6.8 (174) 6.9 (17) 0.97 14.9 (210) 10.7 (17) 0.84 
Any preeclampsia 
danger symptoms 
remembered 
9.4 (30) 6.4 (161) 0.15 16.4 (74) 13.8 (159) 0.45 
ANC with TBA 7.9 (40) 6.5 (150) 0.46 13.4 (48) 14.9 (185) 0.75 
Birth plan with TBA 6.2 (32) 6.7 (9) 0.84 14.0 (27) 17.0 (15) 0.71 
Medications taken in 
pregnancy 
6.9 (175) 6 (16) 0.73 14.5 (218) 16.8 (13) 0.89 																																																								n	Survey participants were excluded who did not answer length of delay	
 
 Visits to health centers prior to admission at MSF were not associated with longer 
delays to access care (Table 18).  In fact, visiting more than one health center prior to 
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MSF was associated with shorter delay to care among the preeclamptic group, although 
this association was not statistically significant.    
Table 18.  Length of total delay (hours) for preeclamptic and normal women based 
on behavioral risk factor 
 Normal Group Preeclamptic Group 
 
Yes:   
length of 
delay (n)o 
No:   
length of 
delay (n) 
p- 
value 
Yes:   
length of 
delay (n) 
No:   
length of 
delay (n) 
p-
value 
Visit to one health 
center prior to MSF 
4.7 (58) 7.7 (132) 0.07 15.2 (115) 14.0 (118) 0.76 
Visit to more than 
one health center 
prior 
8.9 (9) 6.7 (181) 0.55p 7.2 (16) 15.1 (217) 0.27 
																																																								o	Survey participants were excluded who did not answer length of delay	p		There is a statistically significant difference between these two groups (those who visited more 
than one health center, and those who did not) when delay is evaluated based on a dichotomous 
variable (long delay > 6hrs, not long delay) (p = 0.03) 
 
 We found no significant differences among total delays by transport method, with 
the exception of preeclamptic women who walked to the MSF hospital, who had a 
statistically significant longer total delay (Table 19).  There were no significant 
differences in the second (transport) delay by transport method.  Preeclamptic women 
had some differences in the transport they used versus normal women.  Fewer women 
with preeclampsia used a private car (44.0% versus 60.8%, p < 0.01, data not shown). 
More women with preeclampsia walked to MSF (6.5%) than normal women (1.4%, p 
<0.01, data not shown), and they had a longer delay to reach care. Use of ambulance 
services, public transportation, or motorcycles were not statistically different between 
preeclamptic and normal women.   
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Table 19. Length of total delay by transport method and preeclamptic or normal 
status 
 Normal Group Preeclamptic Group 
 
Yes: 
length of 
delay (n) 
No:   
length of 
delay (n) 
p- 
value 
Yes: 
length of 
delay (n) 
No:   
length of 
delay (n) 
p-value 
Walking 2.3 (3) 6.9 (188) 0.46 28.1 (18) 13.4 (215) 0.03 
Motorcycle 11.7 (12) 6.5 (179) 0.10 10.0 (12) 14.8 (221) 0.56 
Public 
transport 
6.4 (37) 6.9 (154) 0.77 13.9 (64) 14.8 (169) 0.82 
Car 6.0 (117) 8.2 (74) 0.16 14.4 (105) 14.8 (128) 0.92 
Ambulance 10.4 (21) 6.4 (170) 0.09 11.0 (32) 15.2 (201) 0.44 
 
Risks for poor clinical outcomes- Maternal outcomes 
 Longer total delays were not associated with poorer clinical outcomes. (Table 20).   
There was a small, non-significant trend towards a relationship between longer delays 
and cesarean section (60.2% versus 65.4%, p=0.42) and ICU admission (7.5% versus 
10.9%, p=0.37) among preeclamptic participants with long delays.   
 
Table 20. Maternal outcome by length of delay for preeclamptic and normal women 
 Normal Group Preeclamptic Group 
 
Delay < 6 
hours: nq 
(%) 
Delay > 
6 hours: 
n (%) 
p- 
value 
Delay < 6 
hours: n 
(%) 
Delay > 6 
hours: n 
(%) 
p-
value 
ICU admission 1 (0.7) 0 (0) 0.45 9 (6.9) 11 (10.9) 0.28 
Coma no cases no cases  1 (0.8) 1 (1.0) 0.86 
Transfusion 1 (0.7) 0 (0) 0.45 5 (3.9) 2 (2.0) 0.41 
Eclampsia  no cases no cases  13 (9.9) 9 (9) 0.81 
Cesarean section 7 (4.9)  5 (10.4) 0.19 80 (61.1) 66 (65.4) 0.50 																																																								q	Survey participants were excluded who did not answer length of delay 
 
 Among participants in the preeclampsia cohort, women who experienced an 
eclamptic seizure were not more likely to have experienced a delay to care.  In fact, the 
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trend, although not statistically significant, was towards shorter delay to care among 
women experiencing an eclamptic seizure.  However, only twenty-three of the eclamptic 
participants (out of fifty-two in total) were included in the analyses of delay, either 
because they were withdrawn from participation (twenty-two women), or they could not 
respond to the question about either first or second delay.  Many women who 
experienced an eclamptic seizure were unable to remember the events leading up to their 
admission at MSF, either because they had a seizure at home and were unconscious, or 
because they were experiencing memory loss secondary to seizures experienced at the 
hospital. 
Delay and the risks for poor clinical outcomes: Neonatal outcomes 
 Longer delays to accessing emergency obstetrical care were not associated with 
poor neonatal outcomes (Table 21), with the exception of stillbirth.  Measures of poor 
infant outcomes, including NICU (Neonatal Intensive Care Unit) admission, low birth 
weight, and low APGAR scores were unrelated to the length of delay for either the 
preeclamptic or normal groups.  However, there were more stillbirths for preeclamptic 
women with delays less than six hours, as compared to preeclamptic women with delays 
of greater than or equal to six hours (14.5% versus 5.9%, p=0.03). 
 There were 30 total stillbirths in the study, 29 of which occurred to women with 
preeclampsia.  Stillbirths were associated with women delivering at earlier gestational 
ages (32 weeks versus 37 weeks, p<0.01), indicating earlier onset and perhaps more 
severe preeclampsia.  Additionally, stillborn babies were more likely to have low birth 
weight compared to the babies of all preeclamptic mothers (88.5% versus 46.2%, 
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p<0.01), which could also indicate more severe disease (data not shown). 
Table 21. Neonatal outcome by length of delay for preeclamptic and normal women 
 Normal Group Preeclamptic Group 
 
Delay < 6 
hours: nr 
(%) 
Delay > 
6 hours: 
n (%) 
p- 
value 
Delay < 6 
hours: n 
(%) 
Delay > 6 
hours: n 
(%) 
p-
value 
NICU admission 18 (12.8) 9 (18.8) 0.32 52 (40.9) 44 (43.6) 0.69 
Stillbirth 0 (0) 1 (2.1) 0.96 19 (14.5) 6 (5.9) 0.03 
Low birth weight 
(<2500 grams) 
22 (15.7) 5 (10.4) 0.35 65 (50.0) 46 (46.0) 0.55 
APGAR <7 at 5 
min 
12 (8.5) 7 (14.6) 0.24 46 (35.1) 30 (29.7) 0.36 																																																								r	Survey participants were excluded who did not answer length of delay	
 
 
Summary of Quantitative Findings 
  
 Survey data indicates that many women in this study experienced long delays to 
access health care.  Almost one fifth of preeclamptic participants experienced a twenty-
four hour delay to access health care after their symptoms started.  Very long delays 
among some preeclamptic participants were due to long first delays at home.  Of 
participants who experienced long delays, there were few identified demographic, clinical 
or behavioral risk factors that were statistically associated.  Most women in this study 
accessed antenatal care with a doctor or nurse, and received the recommended four visits.  
Many women and infants in this study experienced poor clinical outcomes.  However, 
there were no statistical associations between longer delays and poor clinical outcomes.   
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CHAPTER 6: QUALITATIVE RESULTS 
 
 The quantitative survey results indicated that many preeclamptic women faced 
long delays in accessing emergency obstetrical care.  Qualitative interviews offered a 
subset of the survey participants the opportunity to reflect on the process of seeking care, 
difficulties they encountered, as well as how they managed to overcome them. 
 Qualitative interviews were conducted with eighteen women, and eight family 
member representatives, who had experienced a long (>6 hour) total delay to access care, 
as previously described in Chapter Four.  Although individual experiences varied by 
participant, many participants voiced common experiences, and identified additional 
common difficulties experienced by other Haitian women not identified in the 
quantitative results.  The themes discussed here were identified using a grounded theory 
approach, as discussed in Chapter Four, which allowed the participants' own words and 
experiences to guide the analysis of the data.  Themes have been organized into their 
effects on first, second or third delays to access care.   
Overview: Survival Techniques 
 Interview participants explored themes surrounding the experiences and decisions 
of having complications of pregnancy, and seeking and finding health care.  These 
women reflected on decisions to leave home, to travel to seek care, and to receive 
appropriate emergency care for their pregnancy problems.  Participants used their 
knowledge, experience and community support to devise creative solutions to the 
challenges of leaving home, of transport to the hospital, and of finding appropriate 
medical care.  In the words of one participant: "If you lack the technique to survive, you 
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can end up dying" (Interview 17).  Both of these words: "technique" and "survive" 
encapsulate several overarching themes that emerged from the interview data.  While the 
interview data was elicited in order to add insight into the understanding of delayed 
access to emergency care, in the women's own words and experiences, survival 
techniques were at the forefront.  These themes wound through the experiences of the 
first, second and third delays, as women navigated around and created solutions to the 
obstacles in their way.  These survival techniques influenced how the women and their 
families anticipated and reacted to obstetric emergencies, and the delays that resulted. 
At home: the First Delay 
 Being sick, financial constraints, as well as the cost of health care, were themes 
raised by many participants that affected their decisions about when to leave home to 
seek care.  God and participants' faith also played an important role in how problems 
were viewed, and the responses to those problems.  Devising solutions—participants' 
"techniques"—were crucial to overcoming or managing these problems.  Women and 
their families reflected on these challenges, and the solutions they devised, when 
describing how and when they decided to leave home. 
Financial difficulties 
 Many participants faced financial difficulties.  Several participants related 
experiences of extreme deprivation encountered during their pregnancies, including this 
23 year-old woman:   
I can barely take care of [my three children], and now I am about to have 
a fourth one... I think a lot when I’m pregnant, I think about if I die while 
giving birth how the other kids are going to survive. That’s all. (Interview 
10) 
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Another preeclamptic participant, twenty-eight years old, recounted the difficulties she 
faced feeding her children: "Sometimes in the morning you don’t know what your child 
will be eating. When you are a mother, you can choose to beg just for your kids" 
(Interview 17).  Another participant described her precarious living situation: "I, myself, 
feel that I have a lot of problems. I was living under a tent, however now a good friend of 
mine gave me a small place to live, but that place has no roof" (Interview 4).  
 Other participants recounted financial worries that were less stark, yet still 
difficult: "I was the only one providing, there are things that you would want to eat or 
things that you would like that you can’t afford" (Interview 15).  This thirty year-old 
preeclamptic participant paid five hundred Haitian Gourdes (about $10 USD) to travel 
several hours from her village to Port au Prince and the MSF Hospital. 
 Financial difficulties were understood by one participant as an overriding problem 
for most Haitian pregnant women.  This participant described the methods and systems 
that pregnant women must develop as "survival techniques":    
Well, in Haiti, some women are really happy being pregnant. Many 
times, for others, getting pregnant is the worst thing ever, because 
things are really hard in this country. Sometimes, after telling your 
partner that you are pregnant, he might walk away, then you really 
don’t know what to do, you have all kinds of problems. If you lack the 
technique to survive, you can end up dying of hunger. Life is really 
hard, it is so hard that someone should avoid getting pregnant. It will 
be better to have one or two children, but it is really not good for 
someone to have lots of kids with all the problems that can happen. 
(Interview 17) 
 
She explains the consequence of the lack of survival techniques in bleak terms: death 
from hunger.  This quote encapsulates this woman’s sense of desperation, as well as her 
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resilience and self-sufficiency. 
 A thirty year-old participant from the Petionville neighborhood explained the 
difficulty of pregnancy in Haiti: "There is no money, no work, you need to see the doctor 
every month, but to do so, and you need to have a job. This is why so many women 
ended up having miscarriages due to lack of care" (Interview 19).  For this woman, 
financial difficulties translated into poor access to health care for Haitian women in 
general, whom she believed suffered pregnancy complications as a result. While this 
woman describes the difficulty of accessing antenatal care, the costs of emergency care 
are even higher, and likely even more out of reach for many women.  Whereas survival 
techniques may gain a woman enough food to eat, perhaps they were not sufficient to 
overcome higher financial barriers to health care.  
 Many interviewees described financial pressure, and the struggle to have enough 
money, as a constant concern for them and the women they knew.  With most women in 
Haiti living below the international poverty line, this experience is likely to be 
widespread.  Deciding to leave home to seek care is also a financial decision, and one 
with which many participants struggled.  Women in this study described overcoming 
struggles not only to find money for health care services, but also for the basic necessities 
of life, including food and shelter. 	
Role of faith, God 
 Decisions to leave home to seek care were also affected by women's faith.  Many 
participants identified God as the primary agent in their health, both positively and 
negatively.  This feeling was summarized by this thirty-two year-old preeclamptic 
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participant, who stated:  
I did ask God to have a normal delivery, when I say normal I mean no 
C-section. But when God is working you can’t tell him what to do. 
That means whatever God wants, it’s what will happen" (Interview 
21).   
 
This woman had a healthy baby by cesarean section after being referred from St. 
Catherine Hospital to MSF. 
 Many participants thanked God for being alive after a difficult pregnancy, such as 
the thirty-seven year-old woman who said: 
I was ten days overdue and I still couldn’t deliver the baby, my feet 
were swollen, I practically could not do anything. It was not easy, it 
was not easy at all but God saved me, and I thank God for that 
(Interview 7).   
 
From the perspective of these participants, God played an active and direct role in the 
mode and outcome of their pregnancy and delivery.  What is not clear from the 
interviews, however, is how this faith may have impacted participants' decisions to hurry 
or to delay seeking health care.  Quantitative survey data did not support an increased or 
decreased delay among religious women (data not shown). 
 One participant reflected on the role of finances and faith in delaying access to 
health care for pregnant women.  The husband of a woman with eclampsia offered his 
perspective:   
[F]or pregnant Haitian women we realize there is more than one 
problem. Eclampsia is the most important one. Day by day it gets worse 
and more, it happens more in the low class because they stress more, 
they think a lot about what they are going to do, just for the baby to 
survive. And most of the time they say they will let God take care of it. 
Like La Fontaine had said « Help yourself, God will help you. » They 
could have made the effort to go to the doctor but sometimes they cannot 
afford it, and they just hope that God preserves their life.  (Interview 16) 
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This participant referenced a popular quote by Jean de la Fontaine, "Help yourself and 
heaven will help you".149 This participant seems to suggest that women delay seeking 
health care because of both financial constraints, as well as their hope and faith that God 
will help them.  Additionally, this participant raises an important concept: that stress is 
the cause of eclampsia, which was echoed by several other participants.  This couple 
traveled ten hours from another state in Haiti to reach the MSF hospital, passing by two 
other hospitals on the way.  Their journey included several hours of transport on foot, on 
a stretcher.   
 Other participants described feeling little personal agency in controlling the 
outcome of their pregnancy or birth, or of being able to provide for their family.   
I was thinking about how I will take care of the baby. The reason why, 
it’s because the dad does not take his responsibilities. I am deeply 
thinking how I will manage to feed ourselves, how I will be living 
because I do not have anything at all. Thank God MSF was here. God 
always comes to the rescue, but it’s really, really hard for me. (Interview 
17) 
 
This woman describes being thankful for God (and MSF) in her life, especially because 
she cannot count on her partner or others for support.  The lack of a sense of personal 
agency for her life likely affects decisions regarding when to leave home to seek care.  
Other participants described a nuanced relationship between their own actions and those 
of God.  "I had to leave the house with her and take her to a hospital. I could not have 
saved her. It’s the hospital that can do that.  If everyone could take care of themselves 
then everyone could stay home, but after God it’s the hospital that can save you, so I took 
her to the hospital" (Interview 13).   
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 God may be viewed as the ultimate authority, but people themselves have to work 
hard to ensure their own survival, in the eyes of many of the women and family members 
interviewed.  As the quote above illustrates, participants' faith in God may interact in a 
very personal way to either delay or facilitate care-seeking.  While most of the study 
participants did not explicitly link their faith with the decision on when to leave home, 
the belief and faith in God's support may play a role in how these decisions are made in 
this context.   
 
Cost of health care 
 Thinking, discussing and strategizing—i.e. devising "techniques" of how to pay 
for health care—were foremost in the minds of many participants.  The ability to pay, or 
not, for emergency care was linked inextricably with the decision and the delay to seek 
care.  Participants who went to other hospitals prior to MSF, or who did not know that 
MSF offered free care, may have been disinclined to seek care if they felt they could not 
afford it.  
 One participant explained this dynamic:  
[The private hospital staff] had asked how much money I had on me. I 
had 1500gdes, but they told me that I had to pay for the medication, 
therefore I told them that I didn't have all that money. I told them that I 
only had 750gdes with 1500gdes, so a total of 2250gdes. If I have to 
buy medicine, I would not have enough if I needed to buy an IV, and 
any other things, so then they transferred me here. (Interview 18) 
 
Despite leaving home and traveling to this emergency obstetric hospital, this twenty-three 
year-old woman experienced a long third delay as a result of being denied emergency 
services due to her lack of financial means.  At the time of these interviews, the exchange 
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rate between Haitian Gourdes and US Dollars was about 45:1, so this participant had the 
equivalent of about fifty US Dollars to spend on his wife's care, which was not sufficient 
for her emergency treatment.  This woman had an eclamptic seizure, and delivered a 
stillborn baby after being transferred to MSF from another hospital.   
 As the previous quote illustrates, the cost of treatment was identified as a major 
limitation to the ability to access care, and one that was repeated by many participants.   
Interviewer: Did you find healthcare while you were pregnant? 
Interviewee: No.  
Interviewer: Why did not you go see a doctor or a midwife?  
Interviewee: Because I did not have the means, the possibilities.  
Interviewer: You did not want to go, or did you want to go, but did not have 
money to do so?  
Interviewee: I did not have money to do so.   
(Interview 17). 
 
For this participant, even the cost of antenatal services, which are typically much less 
than delivery services, was still a barrier to receiving health care.   
 The cost of healthcare was also identified as a major source of family stress.  
When I was ready to give birth some people told me that the hospital 
charges for a C-section 20 000 gourdes and the normal delivery was 7 
500. [My partner] was really worried about all that, and sometimes he 
would leave me in the house for the whole day by myself. Until I told him 
that MSF does not require for you to pay, that other hospitals maybe, but 
not MSF. At the beginning he did not believe me. He was still bothered 
with this situation because he did not have all this money that they told us 
we would have to pay. So, I came to the hospital without him knowing 
and I called him while I was there to tell him that I was at the hospital 
and that it’s free, that is when he believed me and started coming more 
often and was standing by me (Interview 14).  
 
For this woman, pregnant with her third child, the prohibitive cost of health care, about 
four hundred and fifty US Dollars for a cesarean section, created distance from her 
partner, whom she felt was worried about paying hospital fees.  She interpreted his 
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absence as worry about paying these fees, and saw that he returned to be with her as soon 
as the free care of MSF was known.  This participant had a severely high blood pressure 
of 220/100 on her admission to the MSF hospital.  She received a cesarean section, and 
both she and her infant did well after surgery. 
 The high cost of medical treatment led some participants to believe that their 
diagnoses were a way for their providers to make more money.   
Some private doctors will tell you to eat certain type of food, or give you 
some specific medication. It’s only so they can make money off you, 
these medications are most of the time for the baby to grow very big, like 
that they have to do a C-section…[What kind of medications?] Some 
kind of big pills, vitamins, very big pills, so the baby can get bigger in 
the stomach, the person also gets swollen so when you get to the hospital 
the doctor usually say that the baby is too big and that she will not be 
able to push the baby, therefore the doctor has to proceed with a C-
section. And if you deny the C-section you will die. A lot of time they tell 
you that the baby is very big and it’s not true, sometimes it's twins that 
you are carrying. (Interview 15) 
 
Cesarean sections typically cost many times the amount charged for a vaginal birth 
(reports vary, but typically many hundreds of US Dollars for cesarean section, versus 
about one hundred US Dollars for a vaginal birth), and are very expensive for most 
Haitian women.  This participant's experience reflects not only the high cost of health 
care, but also many women’s mistrust of medical providers, and the seeming 
contradiction between profit from medical services and the well-being of the patient.   
 The cost of health care was a clear barrier to accessing obstetric care for many 
respondents, and likely contributed to delays in seeking emergency care when needed.  
Given high costs of delivery, in particular for cesarean section, many women were wary 
of needing this operation given the price they would likely pay. With cesarean section 
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being an important treatment modality for severe preeclampsia, the women in need of this 
lifesaving treatment may not be able to access it due to financial constraints. 
 
Interpreting their symptoms 
 Women described the symptoms that preceded their decision to leave home to 
seek health care.  This twenty-three year old participant having her second baby 
described feeling sick prior to leaving home: 
I was sick, all my body was swelling up, and I did not worry too much 
about it. Then on Thursday, I went to see a doctor.  There they realized 
that my blood pressure was high, and the doctor told me to quickly go to 
the hospital. I have been sent here by Santo 17, and then when I came 
here, I had a C-Section... 
Interviewer: What did you do when your body started to swell-up? 
Patient: I really did not worry about it too much, because when I got 
pregnant with my first child my feet were swollen, but when I realized 
that my feet and my body were swelling up I decided to go to the doctor. 
They advised me to come to MSF and they also told me not to waste time 
because I could lose the baby due to my blood pressure being too high. I 
needed to have a C-section done right away. 
Interviewer: What did you think [was the problem] when your body 
started to swell? 
Patient: I used to get upset quite often, I thought that was the main cause 
of it. (Interview 4) 
 
This woman reported a twelve-hour first delay prior to leaving home.  She attributed her 
stress, and being upset, as the cause of her edema.  Her blood pressure was severely 
elevated on admission, and she had a cesarean section.  Her baby had low APGAR scores 
and was admitted to the NICU. 
 Another participant, twenty-five years-old, reported her experience of preterm 
labor: 
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I started having some belly aches. I was like "wow," I have to go to the 
hospital, but the pain went away and I had some vegetables left to sell, 
so I went home after. When I got home I felt the pain again but this time 
it did not hurt much...I touched my stomach and I didn’t feel the baby 
move. The next morning I woke up with no pain, but in the afternoon I 
felt the pain again and still no movement from the baby, so I waited for 
my husband to come home. He came home around 8pm and I asked him 
to take me to the hospital. When I got here, they consulted me, but didn’t 
say anything to me. I was given a shot and also was put on an IV. I was 
transferred to another room, then suddenly I started feeling hot, very 
hot.  I was about to give birth. They passed a machine on my stomach, I 
was laying down and was told to push, and when I pushed the baby was 
still born. 
Interviewer: Do you understand what happened with the baby? 
Patient: No, I don’t understand because when I went to the hospital [for 
antenatal care] they told me my blood pressure was 120/80 [normal]. 
They also gave me some pills to drink. I did drink some but didn’t drink 
all. I also had a few infections, but on the 5th month I started swelling 
up and each time I’ve gotten pregnant in the past it was always like that. 
And I had said to myself that next time I get pregnant again, I would like 
to have enough money to see a private doctor. Like that, the doctor will 
remove the baby at the right time. (Interview 5) 
 
This patient, having her third baby, reported having symptoms of preterm labor for a day 
prior to seeking care.  However, she reported a first delay of four hours on the 
quantitative survey.  She described here that her need to sell her vegetables, as well as to 
wait for her husband, impeded her ability to leave home to seek care.  This patient reports 
a history of "swelling" with each pregnancy, which could indicate a previous history of 
preeclampsia with her other deliveries.  This woman also reported that she could not 
access the hospital closest to her home because it was too expensive.  She delivered a 
stillborn, very preterm baby. 
 These women report feeling pain, or feeling sick, and dealing with their 
symptoms by themselves, at home.  Only after the symptoms persist, or worsen, do these 
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women decide to leave home and see and doctor.  The woman who suffered a stillbirth 
explicitly links her financial situation to her poor outcome, and reports that her wish is to 
have enough money to afford private care, which she believes could help her deliver a 
healthy baby. 
 
Impressions of high blood pressure 
 In addition to their symptoms of pain or edema, women reflected on theirs and 
their doctors' views of high blood pressure that led to their admission at MSF.  As all of 
the interview participants had preeclampsia, many of them discussed the experience of 
having high blood pressure.  Many participants saw high blood pressure as a normal 
experience for themselves: "Every time I give birth, my blood pressure always gets high 
but always returns to normal after delivery", said this thirty-seven year-old preeclamptic 
woman having her fourth child (Interview 10).  Another participant stated that during her 
pregnancy "The problem I had was that every time they would take my blood pressure 
they would tell me that it was high but I didn’t feel anything was wrong" (Interview 21).  
With high blood pressure seen as a normal part of pregnancy, participants might be 
unlikely to realize the danger of worsening high blood pressure, perhaps increasing the 
first delay in these situations. 
 Another patient described the treatment offered by her doctor when she was 
diagnosed with high blood pressure:  
Interviewer: How did you manage your high blood pressure? What did you 
do?  
Patient: I took some high blood pressure pills. It went down, when I got 
here it was 150/100...  
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Interviewer: The doctor prescribed you some pills; did he explain to you 
the risks with high blood pressure?  
Patient: He told me not to worry too much, however the blood pressure 
stayed high.  
Interviewer: Did he give you a follow-up appointment?  
Patient: No.  
Interviewer: Did he prescribe you any medicine? Did you stay at home? 
Patient: He did not give me anything. 
(Interview 19).   
This woman's experience reveals a lack of provision of standard of care and follow-up for 
hypertension in pregnancy.  It also reflects the beliefs of several participants in this study, 
that high blood pressure is caused by "thinking too much" or "worrying".  Other cases of 
healthcare providers instructing women to "not get upset" were also noted.  One patient 
described that her doctor did not discuss her high blood pressure with her: "The doctor 
told me not to eat too much salt, and try not to get upset" (Interview 22). 
 The belief that stress was a cause of high blood pressure was echoed by other 
participants.  "The stress is a major problem, sometimes [women] get angry, it’s not that 
they want to get angry, but they can’t help it. They don’t see how tomorrow will get 
better so they get upset, and that causes the eclampsia" (Interview 16).  Another 
participant explained that her high blood pressure and "eclampsia" were due to family 
stress:  
Patient: I was about 8 months when I started having problems with some of 
my mom’s family, that’s when my blood pressure started getting high. So I 
went to the doctor when I turned 9 months.  I was told that my blood 
pressure was 200/110, they told me to be very careful that I could have an 
eclampsia attack. And when they checked it was exactly that... 
Interviewer: Did they explain to you what is high blood pressure? What did 
the doctor say?  
Patient: He did not tell me anything.  
Interviewer: So, how did you understand what it was?  
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Patient: I did not understand it; I just told myself that stress was the cause 
of the eclampsia attack. (Interview 19) 
 
Of note, this participant had preeclampsia, but according to her chart at MSF, did not 
suffer an eclamptic seizure.   
 Another participant reported a similar experience with family stress: "My 
parents did not make it easy for me; they ended up making me very stressed, and 
even caused some type of eclampsia that I did not even know about. Everybody 
saw me swelling up, and I had headaches all the time" (Interview 8).  This twenty-
one year-old patient, who was living with her parents at the time of her admission, 
was also diagnosed with preeclampsia (not eclampsia) and delivered preterm after 
admission with a blood pressure of 170/120. It seems from these quotes as though 
there was a lack of distinction made between preeclampsia and eclampsia, which 
may reflect an overall lack of knowledge about these problems. 
 Interview participants also described their medical providers' perceptions of high 
blood pressure.  One woman described what happened when she was diagnosed:  
So, I went to the clinic to see a doctor; no, not to see a doctor but to do a 
proteinuria exam that came out negative.  However, the doctor advised 
me to stay at the hospital because of my blood pressure being high. So, I 
stayed, and sent someone at home to get everything I needed, and they 
kept me under medications, but it never got better. On Sunday night, they 
checked me again, and the blood pressure got higher (Interview 6). 
  
This woman reported that she was kept in the hospital once her high blood pressure was 
discovered, and was given medication, tested for protein in the urine (a sign of 
preeclampsia), and monitored.  Her blood pressure was severely elevated when she 
arrived at the MSF hospital, but she delivered a healthy infant and did well postpartum.  
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Another woman described a similar process: "I was sick, all my body was swelling up, 
and I did not worry too much about it.  Then on Thursday, I went to see a doctor there, 
they realized that my blood pressure was high, and the doctor told me to quickly go to the 
hospital" (Interview 4).  This woman also had severely elevated blood pressure, and her 
infant was admitted to the NICU.  Delays to accessing emergency care were minimized 
in these cases due to prompt diagnosis and referral. 
 Other participants described a less-intensive, and more delayed process: 
Patient: Every time I would go [to the doctor], he would tell me that my 
blood pressure is high, and sometimes when I went back the blood 
pressure got higher.  
Interviewer: What did the doctor give you for that?  
Patient: He never used to give me pills, he used to prescribe me a small 
pink pill, and iron syrup.  
Interviewer: He did not give you pills for the blood pressure?  
Patient: He never gave me pills for the blood pressure, he just told me 
not to take in too much salt.  
(Interview 24) 
 
This woman describes a dangerous situation that seems perceived as much less serious by 
her doctor.  She describes having high blood pressure at each visit, yet was not given 
medication, testing, follow up, or appropriate counseling about the risks of her condition.  
She goes on to report that the doctor gave her a follow-up appointment once per month 
(Interview 24).  This woman's doctor did not perceive her high blood pressure as a 
problem to be addressed immediately.  This participant lived in Cite Soleil, one of the 
poorest neighborhoods of Port au Prince, where she first visited the local MSPP hospital.  
She went on to deliver preterm at MSF, after being admitted for severe preeclampsia at 
eight months gestation.   
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 Other participants also described being diagnosed with high blood pressure in an 
outpatient (antenatal care) setting, and not being referred for further treatment:   
Interviewer: During your follow-ups did they notice that your blood 
pressure was high?  
Patient: Mmm…mmm  
Interviewer: What did they do when they realized your pressure was high? 
Patient: Nothing, they only gave me two pills.  
Interviewer: Do you know what they were?  
Patient: No, I do not know the name; they just gave me two pills.  
(Interview 21) 
 
This participant describes an apparent lack of concern or urgency on the part of her 
medical provider when faced with a potentially dangerous situation.  In this case, this 
thirty-two year-old primiparous, preeclamptic patient visited three health centers when 
she was in labor before being admitted to MSF.  The sense of urgency, or not, on the part 
of medical providers might have had an impact on the decision of when to leave home to 
seek care.  Some women were referred directly to the hospital from antenatal care, 
limiting their delay, while others were left to make their own decisions about how to 
respond to their symptoms. 
 
The experience of eclampsia 
 Participants in this study described harrowing experiences responding to and 
finding treatment for eclampsia.  Many of these experiences were described by family 
members who witnessed an eclamptic seizure and struggled to respond to it.  Other 
family members described transporting women having eclampsia, or finding health care 
for a family member who was suffering from eclampsia.  Family members described 
intense scenes of finding a family member in the midst of an eclamptic seizure:  "I turned 
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on a flashlight and saw her on the floor foaming and bleeding in the mouth, her body 
stretching on the floor" (Interview 12).  Another participant described their experience: 
[O]n Friday around eight pm she started complaining of a stomach 
pain. Around ten we made her some oatmeal but she could not eat it, 
and all of a sudden she passed out. We automatically called a taxi 
motorcycle to take her to the hospital in Croix des Bouquets. When we 
got there she was unconscious, they immediately transferred her here. 
She was still unconscious, she was already having an eclampsia attack, 
and until now all the inside of her mouth is still sore from all the biting. 
(Interview 15) 
 
Another family member described the experience of witnessing a woman's eclampsia 
attack. 
We did not think it was a seizure she was having. We just heard the 
screaming, and she screamed louder and this time her cousin said that it 
is an eclampsia attack that she was having. (Interview 9) 
 
Family members in this scenario did not appear to understand the cause of the woman's 
screaming, until a cousin recognized the symptoms.  One mother described the 
experience of trying to help her daughter, and then watching her have a seizure. 
She was sick; she told me she had a headache, so I went outside to get a 
bag that had her medications... [A]ll of a sudden I heard a loud noise 
like something that fell. I called a guy named Jean-Baptiste, and I asked 
him what fell and that’s when he told me that it was my child that fell. 
She was trying to get off the bed and she fell. She was grinding her 
teeth; I’ve never seen anything like that before. (Interview 18) 
 
Family members who witnessed these eclamptic seizures and their aftermath spoke of the 
difficulty of watching their loved ones suffer, and the ensuing search for medical care.  
The fact that these participants experienced eclamptic seizures at home reflects a 
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breakdown in the system of antenatal care, which aims to identify patients at risk, and 
prevent these potentially deadly events. 
 
Second Delay 
 The second delay, and the process and techniques that the participants used to 
negotiate transport were described by many participants in the interviews.  The decision 
of where to seek care, finding ways to avoid heavy traffic, and the role of community 
supports were all key themes that emerged in participants' experiences of the second 
delay. 
Coming to the MSF Hospital  
 The choice of where to seek care was one of the key decisions faced by women 
leaving home and seeking emergency obstetrical care.  For some patients, they chose to 
come directly to MSF.  Others were referred by other hospitals or doctors.  For some 
patients, they were turned away at other sites, and eventually made their way to MSF.  
With several state maternity hospitals, as well as multiple NGO hospitals and clinics and 
private hospitals, pregnant women in Port au Prince have a variety of options.  The 
decision regarding where to go to seek care can have a momentous impact on the type of 
care given, the cost of care, and the delay to receiving appropriate care.   
 Some participants described seeking care at a structure that was found to be 
closed.  As one twenty-seven year-old primiparous patient's family member described, 
 We waited for daylight [after series of eclamptic seizures] to call a taxi. I 
explained the situation to the taxi driver and he agreed to take her to the hospital, 
so we went to a maternity clinic.  But when we got there they told us that the 
clinic was closed. (Interview 12).   
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By the time this participant arrived at MSF, after visiting both the General Hospital and 
the national maternity hospital (Maternité Isaie Jeanty), her blood pressure was severely 
elevated at 190/140, after suffering eclamptic seizures.  She was admitted to the ICU 
(Intensive Care Unit), and was comatose at the time of the interview.  Her baby had been 
admitted to the NICU (Neonatal Intensive Care Unit).  In this situation, the delay to 
access care was affected not only by the extended second delay due to the closed 
maternity clinic, but also by the longer first delay due to the decision to wait until 
daytime to leave home. 
 For some participants, the events that led to their admission to MSF seemed 
entirely out of their control.  For example, the family member of a twenty-three year-old 
having her fourth baby and suffering eclamptic seizures described a series of hospital 
visits and referrals based on security concerns, financial difficulties, and housing: 
I called on the neighbor for help.  We got two motorcycle taxis that took 
us to a hospital in Arcahaie where she got the emergency care that she 
needed, but the doctor told me that she could not stay there. They wanted 
to transfer her to a hospital in St. Marc but instead I requested that I go 
downtown to St. Catherine, only because I knew that it was where I was 
planning on taking her and that I have my sister that doesn’t live too far- 
I could easily sleep at her house. On my way to St. Catherine there was a 
lot of shooting, it was the police shooting and they made me go to a 
private hospital where I had to pay for every service I got. I explained to 
them that I did not have much money. I only had 750gdes so they gave 
her some first aid than they called an ambulance to transfer her to MSF 
(Interview 18). 
 
Despite receiving adequate emergency care at the first hospital visited, the patient was 
not allowed to stay at this hospital and was referred by her doctor, who did not ensure 
transport to another facility.  Knowledge of various hospitals allowed this family member 
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to request transfer to a hospital near where they could stay, but which put them at risk for 
violence (St. Catherine Hospital is located in a neighborhood of Port au Prince with a 
history of gang violence).  Even the third choice hospital was out of reach financially.  
Finally, the patient was transferred to MSF.  Her baby was born stillborn. 
 Women described situations in which referrals to MSF from other structures had 
been organized, as in the previous example where the private hospital called for an 
ambulance.  In other cases, women were simply given a referral letter and asked to 
proceed to MSF on their own, for example, the thirty-seven year-old preeclamptic 
participant who stated "It is the doctor that gave me a paper and told me to come straight 
here" (Interview 7).  This woman reported that it took her two hours to arrive at MSF 
from the referral hospital by private car. 
 A thirty-two year-old preeclamptic woman having her first child described the 
lack of appropriate care she received at the first hospital she visited: 
[W]e went to St. Catherine on Sunday in the afternoon around 4pm. There 
was no light; I fell asleep in the dark. They did not even turn on the 
generator. Imagine dealing with this pain and with mosquitoes at the same 
time. Monday morning, I was still in pain and it was when everyone was 
leaving their shift that I was told that I could not stay there. I felt like they 
were all going to leave, and leave me here, but they saw urgency of my 
case they transferred me here. I don’t think this place [St. Catherine] was 
a hospital. There were two nurses present at the time I got there, and you 
know when you are somewhere you can find someone to talk to you while 
you are waiting, but not one person spoke to us. They did not even start an 
IV line for me. Nothing was done except when my blood pressure started 
going up, they gave me two pills to help bring it down. That’s all until I 
was transferred here. (Interview 21) 
 
This woman felt disregarded by the medical staff, who did not provide what she felt was 
appropriate care.  When the staff were leaving, they arranged to transfer her to MSF.  The 
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hospital staff had a medical staff transport bus that dropped this patient off halfway to 
MSF; she reported having to find two taxis after that to bring her to the MSF hospital 
(Interview 21).   
 Another participant, the sister of a thirty-three year-old multiparous patient with 
eclampsia, described a series of visits to several MSPP hospitals around Port au Prince:   
On Thursday, I saw her on the ground foaming at the mouth and seizing. 
I went to the maternity clinic in Carrefour. They did not want to see her. I 
went to the General Hospital, they could not receive her due to 
overcrowding. Therefore, I went to Chancerelle [MoH facility in Port au 
Prince]. There, they took charge of her; the doctor went and got her 
medication although I had not yet paid. They gave her oxygen right away 
and a lot of medication like magnesium sulfate to get rid of the seizure...I 
also asked about the baby and I was told that the baby was doing well 
and that the heart beat is steady, that they were getting ready to transfer 
me to MSF. There she will have a C-Section done (Interview 3). 
 
Delays to receiving emergency care, crucial at the time of an eclamptic seizure, were 
lengthened due to closed hospitals, overcrowding, and a lack of capacity to handle 
emergencies.  Unfortunately, the family members' decision to seek care at a hospital that 
was closed, and one that was overcrowded, led to longer delays than if they had decided 
to go straight to MSF. 
 This family member was angry at the experience of being turned away from the 
General Hospital [a MSPP hospital] despite the fact that her sister was having an 
eclamptic seizure in front of the maternity center:    
 
The entire problem I had, I think it is because the health care system is 
missing something. A hospital should never refuse to treat a patient, 
especially a pregnant woman who is having a seizure. If she had died I 
would have stoned the general hospital (Interview 3). 
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This woman echoed themes of distrust and anger towards the medical system.  This 
participant also self-identified the problem of delay to care, and the negative effect this 
had on her family member, who could have died as a result.  This family visited four 
other hospitals prior to arriving at and being admitted to the MSF hospital.  The patient 
had three eclamptic seizures before admission, and her blood pressure was 180/120 on 
arrival.  She was admitted to the ICU, and her newborn was admitted to the NICU.  They 
were both still in intensive care at the time of the interview. 
 
Urban congestion and traffic 
 Unique to the experiences of urban pregnant women, traffic can significantly 
lengthen the second delay to access emergency obstetrical care.  Port au Prince has 
substantial urban congestion problems, where even short distances can be delayed by 
gridlock, poor road conditions, and the need to avoid unsafe neighborhoods. 
 The family member of an eclamptic patient recounted their experience getting 
from Petionville to Delmas, the neighborhood adjacent to where the MSF hospital is 
located. 
On the way to Petionville, she started having a seizure, everyone in the 
street told us to take her by car. So, we rented a car to take us here, but 
on our way there was a lot of traffic, therefore the driver had to take 
some shortcuts until we got here (Interview 9). 
 
Avoidance of the most direct route and the ensuing traffic jams between Petionville and 
Delmas is common; unfortunately, the "shortcuts" rarely result in substantially shorter 
arrival times. 
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 Other people managed traffic by calling an ambulance. 
[F]or sure the ambulance is way better than a private car, because 
even during heavy traffic, the ambulance will get by easier, whereas, 
the bus takes longer. The ambulance is always faster. (Interview 13) 
 
The ambulance's ability to navigate through traffic was a major advantage to this method 
of transport.  However, other participants indicated that the ambulance was not always 
available when needed.  "It’s very difficult when you call for an ambulance, and they tell 
you the ambulance is not working. It’s an emergency transport, it should be working" 
(Interview 16). 
 
Role of the community 
 Many participants spontaneously identified community members (as opposed to 
family members) as crucial supports for or hindrances to accessing emergency obstetrical 
care.  Many women reported relying on community members to arrange or facilitate 
transportation at the moment of the emergency.  "We came in a private car; my husband 
has a friend who owns a car. He had asked him to take me, and the friend did" (Interview 
7). Other participants relied on the spontaneous advice of community members when 
deciding where to access health care. For example, when asked why she decided to come 
straight to MSF, a family member of a twenty year-old preeclamptic patient responded, 
“The reason why we came here, it’s because while driving through the shortcuts [to 
another hospital] some people advise us to come to MSF. And when we got here they 
took care of her right away" (Interview 9).  This point also touches on the impact of 
urban congestion and traffic on the delay to access health care.   
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 Community members were also crucial means of financial support at the moment 
of the emergency.  The husband of a thirty year-old preeclamptic woman having her third 
child described how he was able to find the means to purchase needed medications during 
his wife's obstetric emergency: 
Once I got [to the hospital], they gave me a prescription to fill, I had to 
make lots of sacrifices. I even asked some friends to lend me some money in 
order to purchase the medicines. If I did not do that she would have not 
received any healthcare whatsoever. It was a list of medicine like: 
magnesium, ringer lactate, catheter, presoline [antihypertensive 
medication], methyl, syringe (Interview 2). 
 
With few financial means available, people rely on the generosity and reciprocity of their 
families and community members to raise needed funds. 
 Traditional birth attendants, known as "matrone" in Haiti, were also important 
community supports for women.  One participant answered affirmatively when asked 
whether she had seen a matrone for antenatal care: 
Interviewer: How was the consultation with the matrone? How many 
times did you see her?  
Patient: I saw her three times, and the baby was not in the right 
position.  
Interviewer: What do you think of the care that the matrone 
provided?  
Patient: She massaged my belly; put the baby in the right place…. 
Then she told me to go see a doctor. 
(Interview 4) 
 
Some women in this study used matrones as an adjunct to the medical care they received 
from trained providers.  They described seeing a woman who was present in their 
neighborhood, who offered reassurance or referral to the hospital.  The family member of 
a twenty-two year-old preeclamptic woman described the experience of seeking care 
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from the local matrone: 
[The matrone] soaps her belly; she really pays attention to details. 
She has her own medical box, but due to the fact that I met her on the 
street, she did not have time to go get her box. As I said we met on the 
street, she came, washed the belly, after the washing [the matrone] 
said that [the woman] is in labor, and everything looks good. She 
might take some time, but everything looked ok for a perfect 
delivery...She told me not to stay here with her; she encouraged me to 
take her to the hospital. (Interview 13) 
 
Despite the fact that the matrone told this family member that the birth would be perfect, 
she also referred this family to the hospital.  This woman suffered three eclamptic 
seizures and was admitted to the Intensive Care Unit. 
 Sometimes community members also seemed to present hindrances rather than 
help.  In one case, community members advised one person to keep her family member 
who was having eclamptic seizures at home.  "[S]ome people also told us not to worry 
about it because she was like that with her other pregnancy, she always had seizures and 
that’s when you usually go to the hospital; there is really nothing they will do to help, but 
I said no. I'd rather have her at the hospital than home" (Interview 9).   
 A thirty-three year-old preeclamptic woman pregnant for the fourth time 
described her experience with recurrent pregnancy loss, which led her to move based on 
her negative community experiences. "I moved because I wanted to have this baby. They 
used to make so much fun of me because every time I got pregnant I ended up losing the 
baby. I did everything to leave that place" (Interview 23).  This woman delivered a 
premature baby, who was doing well at the time of the interview. 
 The interconnectedness of community was explained by one interviewee, who 
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was asked if he had to pay the people helping him and his wife: "No, these people were 
people from the community. They are our neighbors, they were just helping because 
today it’s me that needed the help, and tomorrow it could be them. This is how we help 
each other" (Interview 16).  With little public information on the availability of 
emergency care, and with few financial resources, people in this study relied on 
community and family when deciding where to seek care, and finding resources to pay 
for care. 
 
Third Delay 
Gratitude to MSF 
 Many participants echoed themes of gratitude for the quality and affordability of 
care they received at the MSF hospital.  After experiencing delays at other facilities, or en 
route to the hospital, several participants noted that they were treated immediately upon 
their arrival to CRUO. 
 This thirty-seven year-old, who traveled from outside of Port au Prince, stated:  
I came [to MSF] because I had a private car, even though I was in a 
lot of pain but God made it happen. And once I got there they took 
care of me right away. (Interview 7) 
 
The family member of a twenty year-old with preeclampsia echoed a similar sentiment: 
"As soon as the triage nurse saw her she took her inside to another nurse, she was taken 
in a room, since she’s been in there, I have not seen her yet." (Interview 9) 
 In addition to minimizing the third delay to receive appropriate care, other 
participants also noted specifics about the quality of care from the MSF hospital.  The 
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family member of a thirty year-old woman who had traveled from a rural area outside of 
Port au Prince stated: 
The service is good; if it was not good she would have died because when 
she got here she was unconscious. They had to put her on oxygen, and a 
couple of IV's. I think she received really good care here. The only problem 
I encountered was that they do not want food to come in from home. Beside 
that the service was excellent. I don’t think I would find services as good as 
I got at MSF at any other hospital. (Interview 15) 
 
Another participant, a twenty-nine year old woman who identified as internally displaced, 
echoed the same themes of quality medical care:  
I wanted to give birth here because you get better care. I think the 
doctors are better, the way the hospital is functioning, it's cleaner, so 
that’s why I like it, it is better. In total I had 3 C-sections here, and I love 
it. (Interview 14) 
 
This participant mentioned the cleanliness of the hospital, in addition to the quality of the 
medical staff, and the functioning of the hospital. 
 
Affordability of care at MSF 
 With financial barriers and poverty being major stressors for many participants, 
the availability of free care at MSF was highlighted by many.  Participants who 
mentioned this free care also linked it with the quality of care.  Whereas charging for 
services seemed to be linked with distrust of other hospitals, participants seemed to trust 
the MSF hospital more for having no fees. 
 The feeling of gratitude to MSF for not charging fees was stated by this 
participant who said: 
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When someone has a C-section, some hospitals will over charge you, 
but here it was not much, you guys need a round of applause. Really, 
I would like to thank you for the good work that you guys are doing 
here. (Interview 13) 
 
This twenty-two year old woman paid 1 250 Gourdes (about twenty-eight US Dollars) to 
travel to the hospital, while suffering an eclamptic seizure.  She and her baby were both 
admitted to the intensive care unit.   
 In the words of another participant, a twenty-nine year old woman:  
What I would like to add, the care and compassion I received really 
made me feel better. MSF is helping a lot because there is a lot of 
people that cannot afford to pay 70 000gdes for a C-section and 50 
000 gdes for normal delivery, therefore this project really came in 
handy. (Interview 14) 
 
This woman had a cesarean section, after being admitted with a severely high blood 
pressure.  She describes the medical care at MSF as caring and compassionate, as well as 
being financially accessible.  This participant, and others, reflected on the difficulty of 
paying high prices for medical care at other facilities, and wondered what would happen 
to the many women that MSF served if the CRUO hospital were not there. 
 
Summary 
 Interview participants reflected on their experiences negotiating the first, second 
and third delays.  The range of constraints that they faced, from economic to urban 
congestion, was matched by the creative and hard-fought responses they brought.  Some 
participants used their knowledge to avoid or to shorten delays, while others reflected 
concern or anger over the problems that compounded the health issues they faced.  This 
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qualitative data complements the findings from the quantitative survey, and adds rich 
nuance to the experience of seeking and finding emergency obstetrical care for these 
women.  For instance, interview participants explained how the understanding of their 
symptoms, and the financial difficulties they faced, led them to stay at home for many 
hours prior to seeking care, adding to the understanding of long first delays identified in 
the quantitative data.  Despite reported shorter second delays in the quantitative data, 
interview participants described difficult journeys on foot, through traffic, and via many 
other health centers, to finally arrive at MSF.   
 The "technique" to survive that was evident in the interviews related to themes of 
using community supports, of overcoming financial difficulties, and of choosing a 
hospital for women’s care.  "Survival" for these patients meant identifying and 
responding to high blood pressure and eclampsia, hoping that God would help them 
negotiate the myriad obstacles in their way.  Together, survival techniques describe the 
preoccupations and decisions of Haitian women struggling to care for themselves and 
their families in the context of poverty, and in the face of life-threatening medical 
conditions.  Life for these Haitian women was not guaranteed; they were actively 
involved in finding ways to help themselves overcome the many obstacles they faced.  
 Both interview and survey data suggest that participants' major challenges 
included economic hardship, access to quality health care, and difficulty navigating the 
Haitian health care system.  Moreover, the stories of interview participants who faced 
long delays highlight the extremely dangerous medical situation of preeclampsia and 
eclampsia for both mothers and babies.   
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 Quantitative and qualitative data indicate that the participants' decisions about 
where to access health care, and how to manage high blood pressure and eclampsia, had 
important implications for the experience of these participants, and the delays they 
encountered before receiving appropriate treatment.  While some women reported 
receiving assiduous follow-up and referral services, others describe hospitals and health 
care providers that were much less intensive.   
 In a setting in which they themselves were sometimes the only one aware of, and 
responsible for, their healthcare, these women were forced to take the responsibility for 
their healthcare upon themselves.  In the interviews, many women reflected on this 
feeling of autonomy—noting that Haitian women have to be able to take care of 
themselves, as there is no one else to help them.  Almost all of these participants had 
received antenatal care, and most of them saw their antenatal care providers at least four 
times.  Medications of some kind were prescribed, and birth plans were discussed.  For 
many participants, however, it was their own decision, sometimes with input from family 
and friends, that led them to seek emergency care.  Negotiating these decisions, and 
finding the strength and means to do so, posed enormous challenges. 
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CHAPTER 7: DISCUSSION 
 
 
Summary of Essential Findings 
 This study aimed to quantify delays to care among preeclamptic women 
presenting at the MSF CRUO emergency obstetric hospital in Port au Prince, Haiti and 
identify predictors of these delays, as well as the clinical consequences of long delays. 
The goal was to use this information to make recommendations about how to reduce 
delays, and in turn hopefully reduce neonatal and maternal morbidity and mortality in the 
Haitian setting.   
 Past studies examining the Three Delays model of maternal mortality have 
identified several factors that have affected delays in other contexts, including distance to 
facility, cost, educational level, status of the woman in the family, perception of the 
gravity of the situation, transportation options, distribution of facilities, and the 
perception of quality at the facility.67,70,71,74,76,77,80,81,86,89,90,93,102,138,150–160  However, 
relatively few studies80,90,155,161 have examined how women in urban contexts access 
emergency care, and the specific delays they may encounter.  This study helps to clarify 
the relative importance of the factors that are associated with increased delay to access 
emergency obstetrical care for urban Haitian women.   
 A subset of preeclamptic women in this study had significantly longer delays to 
access emergency obstetrical care than normal women, with seventeen percent 
experiencing delays of more than twenty-four hours.  Median delays were much shorter, 
with a median total delay of five hours for preeclamptic women, and four hours for 
normal women (p < 0.01).    
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 Longer delays for preeclamptic women were due to longer delays at home prior to 
deciding to leave and seek care at the hospital (first delay).  Preeclamptic women waited 
an average of thirteen and one half hours after symptoms developed to make the decision 
to seek care. Third delays were also significantly longer in this group (fifty-nine minutes 
in the preeclamptic group versus thirty-eight minutes in the normal group).  Second 
delays, or transport delays, were comparable in the two groups.   
 Quantitative results also found that few of the behavioral, clinical or demographic 
factors we measured were associated with longer or shorter delay for women in this 
study.  Contrary to expectations, preeclamptic women who had a history of a health 
problems or doctor visits had longer average delays than those who did not.  One could 
expect that more familiarity with the health care system would lead to shorter, rather than 
longer, delays.  However, other published studies152,162 indicate that women who have a 
poor opinion of health providers or facilities are more likely to delay seeking care.   
 There were no demographic factors that were found to be associated with longer 
delays in this study.  The study had hoped to be able to identify the subgroups of women 
who were more likely to experience delays - whether by neighborhood, or age.  These 
results do not suggest that there are clearly identifiable subgroups of preeclamptic women 
who are more at risk for delay- but also that almost one fifth of preeclamptic women 
experienced delays of more than twenty-four hours.  Of the subset of women 
experiencing a twenty-four hour delay or longer, demographic indicators were similar, 
with the exception of economic status, where a smaller proportion of women in the very 
long delay group reported "doing well" or "good" economic status.   
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 Despite the fact that the vast majority of women reported seeing a trained health 
professional (doctor, nurse or midwife) for antenatal care, a substantial minority also 
reported having antenatal visits with a traditional birth attendant.  Twenty-one percent of 
women who received antenatal care from a doctor, also saw a traditional birth attendant 
for care.  Qualitative interview data indicated that women accessed care from matrones 
who were neighbors, and who were accessible to come to women's houses as needed for 
a consultation.  Women's experiences with possibly poor quality antenatal care from 
trained providers also could have influenced their decisions to seek additional care from 
locally available matrones.  Women may not have felt satisfied with the quality of care 
they received from the doctors and nurses they saw, leading them to seek out other 
providers.  Evidence from other studies163 shows that poor perception of quality or poor 
treatment by medical providers may motivate women to seek care from traditional birth 
attendants. 
 The qualitative portion of this study explored the barriers to accessing emergency 
obstetric care in urban Haiti.  Haiti is the poorest country in the Western Hemisphere, and 
a majority of its citizens live below the international poverty line164.  Study participants 
described a range of strategies and techniques they used to "stay alive" and find 
appropriate care during and after pregnancy.  Women in this study explained the effect of 
poverty on their lives, their pregnancies, their children, and their health care choices.  
Some of the interview subjects were destitute—living on the street, begging for food, or 
relying on the kindness of strangers to survive.  Those who were better off were still 
struggling.  Health care costs were a source of stress for women and their families.  
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Women were turned away from hospitals or referred to the MSF facility, because they 
were not able to pay for emergency services; the availability of free care was crucial for 
these women and their infants.    
 Data from both the survey and the interviews identify the many barriers these 
participants experienced in accessing emergency services.  In addition to financial 
barriers, women were turned away from closed emergency obstetric hospitals, and 
admitted to and then discharged from other facilities frequently.  Interview participants 
relied on word of mouth and referrals from friends and family when making their 
decision about where to seek care.  Despite the fact that most participants had discussed 
their birth plan with a medical professional during antenatal care, participants described 
ad hoc decision-making about where to go to find emergency obstetrical care.  These 
decisions about where to go were crucial in determining whether a woman received 
appropriate and timely care.  
 Problems with the health care system started during antenatal care for many 
participants.  Survey and interview data indicated that some women received inadequate 
or inaccurate advice from their antenatal providers regarding their hypertension and 
preeclampsia.  For example, several women reported being told to avoid salt in their diet, 
after being diagnosed with preeclampsia.  Women with preeclampsia were, in many 
cases, unaware of danger signs of worsening preeclampsia, despite having adequate 
numbers of antenatal visits.  Many participants reported that their antenatal providers did 
not adequately offer appropriate testing, referral or counseling when they were found to 
have high blood pressure.  Many women presented to the MSF CRUO hospital with 
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severe preeclampsia, having attended antenatal care visits, but not having been 
appropriately referred for care for their preeclampsia. 
 
Study Results in the context of the Three Delays Model 
 
 This study makes a vital contribution to the literature regarding the effects of the 
Three Delays.67,71,74,75,81,82,86,88,90,92,93,99,103,140,151,153,157–160,162,165–173  Specifically, this study 
identifies first delays to leaving home as the major contributor towards long delays in 
preeclamptic women in Port au Prince, Haiti.  It is the only study of delays to care among 
urban Haitian pregnant women.   
 A small number of studies80,159 have examined the three delays for women living 
in urban areas, and particularly how first and second delays may be experienced in the 
urban context, or when a woman lives close to a facility.  This research has found 
numerous factors that were associated with decreased access to care, including low 
educational attainment, difficulty finding transport, insecurity, financial constraints, and 
poor quality care at the facility.  In the current study, long transportation delays were 
uncommon among both the preeclamptic and normal groups.  However, difficulty in 
finding, arranging and paying for transport were key concerns identified in the qualitative 
interviews.   
 Prior studies of maternal mortality and the Three Delays model in a rural context 
have focused on the distance between women's homes and delivery facilities as a major 
factor in both first and second delays.67,75,78,89,152,154,167,174  The first delay, the decision to 
leave home, has been shown to be longer for women living farther away from health 
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facilities. The second delay, the transportation delay, is necessarily longer for women 
living farther away from health centers.  The current study, which found long delays 
among preeclamptic women living relatively close to the hospital, helps us understand 
how distance from the facility may impact women's decisions to leave home, and thus—
somewhat counter-intuitively—add to the total time it takes to receive emergency care.  
Some studies have found that women's tendencies to leave home for facility birth are 
unaffected by distance when health facilities are less than five kilometers, or two 
kilometers away.154,159  Despite living in an urban area, with relatively close access to 
several maternity hospitals, preeclamptic women in this study waited a median two hours 
to leave home to seek care, with about twenty percent (19.6%) of women waiting more 
than twelve hours.  Moreover, analyses of delays in this study by neighborhood and 
region of Haiti found no relationship between distance and length of delay.  Women 
living relatively close to the MSF facility had some of the longest delays to access care, 
even compared to women living outside of the Port au Prince area.   
 For women in this study, distance to the facility was clearly not the only relevant 
factor in deciding when to leave home and seek care.  Some prior studies have also found 
that distance was not a predictor of delay.150,154,168  In the Haitian urban context, distance 
to facility (measured here in time), is perhaps less salient of a factor than in rural 
settings.175  Most women in this study live within two to five kilometers of a hospital; 
however, other factors inhibit access for many women. 
 The Three Delays model was developed to conceptualize the problem of 
accessing emergency obstetric care for women living far away from health centers.  
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Women in urban areas, like those living in Port au Prince, may live quite close to 
emergency obstetric facilities.  As this study shows, however, access to emergency care is 
not straightforward, and many women nonetheless face delays to access care.  What other 
factors may be relevant to urban women, and how could these be incorporated into the 
Three Delays Model?  This study points to the importance of other factors, including the 
quality of antenatal care to identify, treat, refer and educate higher risk patients.  
Additionally, public safety concerns and traffic emerged as a concern among qualitative 
interview participants.  As one of the few studies examining the utility of the Three 
Delays model in an urban context, this study calls into question the model’s validity 
when applied in an urban context where women do not face long geographic distances to 
facilities, but who still encounter long delays.  However, in the more than twenty years 
since this seminal study was published, it has guided very important work to reduce 
maternal and neonatal mortality.  Updating this model to include urban women, and to 
focus less exclusively on distance to care and related transportation issues, can serve to 
include the experiences of these women who are also sometimes facing long delays to 
care. 
 More importantly than distance, women in this study were unclear about the 
danger signs of preeclampsia that might prompt the decision to leave.  Only a minority of 
women were able to identify any danger sign, including headache or edema, which would 
indicate worsening preeclampsia.  Other studies have found women's lack of knowledge 
of danger signs as a major contributor to delayed access to care.71,102  Despite the fact that 
many preeclamptic women in this study were diagnosed with hypertension during 
		 152 
antenatal care, and that many of these women received the recommended number of 
antenatal visits, they were unaware of which symptoms should prompt immediate 
medical attention.  Knowledge of preeclampsia danger signs was low, even among 
women who had been previously diagnosed with preeclampsia.  Other studies of women 
in low-resource settings have also found low levels of knowledge of preeclampsia danger 
signs.176,177 Knowledge of danger signs is an important component of women's readiness 
to deal with complications of pregnancy and childbirth.178 
 Women with preeclampsia in the current study were much more likely to have 
long delays at home after the onset of a problem compared to women without 
preeclampsia.  Given that preeclampsia is extremely dangerous for mother and infant, 
ideally women would have the knowledge, sense of urgency and ability to seek care 
immediately when faced with any danger sign.  However, we do not have data to 
compare rates of knowledge of danger signs between women with no antenatal care, and 
those with antenatal care.  There may be positive effects of antenatal care on knowledge 
of danger signs, though the overall percentage remains low.  The qualitative study 
findings also suggest that some antenatal care providers were providing incorrect and 
dangerous information to women diagnosed with preeclampsia, including advising them 
to avoid salt and stress as a method of managing their high blood pressure. There is 
limited published data about how frequently, and in what settings, antenatal providers 
themselves have incorrect information about preeclampsia, although it is clear from the 
research that does exist that Haiti is not the only example of poor quality antenatal 
care.179,180 
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 In addition to poor quality antenatal care, women in this study also encountered 
difficulties in accessing high quality emergency care.  The economic costs of seeking this 
care, including finding transport, calling on community and family networks for support, 
paying for services, and missing work are all prospective barriers.81 There is extensive 
evidence from numerous settings that financial barriers are a major limit to women’s 
access to emergency obstetrical care.75,81,90,93,152,157,158,181  This study adds to the growing 
evidence that the costs of seeking care prevent many women who need emergency care 
from accessing it.  Preeclamptic women in this study, most of whom described 
themselves as having limited financial means, described prohibitive costs of accessing 
emergency obstetrical care at the MSPP and private facilities where they sought care.  
Despite the fact that MSF offers free care, the hospital ideally functions as a referral 
facility; as such, MSF does not widely advertise their services to individuals.  For the 
women who were interviewed, financial stresses were common, were a disincentive to 
leaving home to seek care, and increased the delays to receive emergency care. 
 It is also possible that women living in Port au Prince delayed leaving home due 
to concerns about safety.  Several women in the qualitative interviews indicated that they 
waited until daylight to leave home for the hospital. One woman was stopped by the 
police from accessing care at the public hospital due to violence in the street, and was 
redirected to a private hospital where she was unable to pay for services.  Public safety 
dangers may have forced women to wait at home longer.  Studies from several countries 
indicated that private health care services were typically more expensive than public 
facilities.182–184  Women may have also had to take more circuitous routes to the hospital 
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to avoid traffic.  However, second delays were, on average, not lengthy for women in this 
study. 
  This study identifies potential areas for improvement in antenatal care practices. 
Survey data indicated that for women in this study, adequate antenatal care (four or more 
visits) was associated with lower risk of delay, but only among normal women. Women 
who had preeclampsia and also had four or more antenatal visits did not have shorter 
delays compared to those with less than four visits in this study.  One of the main 
indications for antenatal care practices is to identify women with preeclampsia during the 
prenatal period, in order to act expeditiously to prevent morbidity and mortality for 
mother and baby, and to schedule additional visits in order to follow their illness more 
closely.  Despite following WHO recommendations to attend four or more visits, sick 
women in this study were not able to avoid long, potentially dangerous delays to care, 
largely because many women had lengthy delays at home before leaving to seek care.  
According to mothers’ responses, a subset of antenatal care providers provided 
inadequate education or the wrong information about the danger signs and risks of 
preeclampsia to women in this study.  This lack of preeclampsia knowledge was 
widespread within the preeclamptic study population, with equal percentages of women 
with both very long (>24 hour) delays, and short (<6 hour) delays being able to report 
any preeclampsia danger sign.  This lack of education and information was also evident 
in the survey, finding that forty percent of participants took at least one medication 
prescribed by their antenatal provider, but had no idea of the name of the medication or 
its function.   
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 With apparently little attention paid to their hypertension by their medical 
providers, it would be extremely difficult for women themselves to understand its gravity.  
Additionally, many of these women delivered preterm as a result of preeclampsia; 
without a clear understanding of their disease and its treatment, they would have no way 
of knowing that they needed to access emergency obstetrical care months earlier than 
they were expecting, unless they were told so explicitly by their medical providers.  For 
many of these women, an eclamptic seizure was the event that prompted leaving home 
for the hospital; the fact that most of these women had what would be seen as adequate 
antenatal care is a failure of this system to protect women from this life-threatening 
event.   
 Fifty-one participants had an eclamptic seizure, 16.4% of the preeclampsia study 
population (though twenty-two were excluded from the study because of incomplete 
data).  Eclampsia is a rare complication of preeclampsia in the developed world. In one 
large study eclampsia occurred only three percent of the time among mothers with 
preeclampsia185 with prevention of seizures through the use of magnesium sulfate and 
delivery of the baby in most cases.  However, women must be appropriately diagnosed, 
treated and referred for care in order to prevent eclampsia.  Despite the vast majority of 
study participants who attended four or more antenatal visits, prevention of eclamptic 
seizures did not occur.  The fact that several women had an eclamptic seizure at home or 
en route to the hospital, speaks to a delayed decision to leave home to seek care—a long 
first delay.   
 Qualitative interview data highlighted and provided nuance to the indications 
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from survey data of participants receiving poor clinical care during their antenatal visits.  
On the survey questionnaire, many women reported discussing birth planning with their 
antenatal care provider.  However, data from interviews shows that in deciding where to 
seek care, some women asked strangers along the route, made guesses based on 
experiences of friends, and tried multiple hospitals in order to receive the appropriate 
care.  Additionally, interview data indicated that some providers seemed not to provide 
appropriate treatment, counseling, or follow-up for women diagnosed with preeclampsia 
or hypertension antenatally.  Multiple respondents described being advised by their nurse 
or doctor to avoid salt or stress in order to manage hypertension that had been identified; 
neither of these courses of action would have any effect on preeclampsia, however.  
Unfortunately, advising a woman that she could control preeclampsia actively 
discourages her from seeking appropriate medical monitoring of this dangerous 
condition.  By suggesting to women that their feelings or their nutrition were to blame for 
their hypertension, medical providers who provided inaccurate information shifted the 
burden of responsibility to the patients, rather than assuming the responsibility 
themselves to monitor and treat their condition.   
 With stress seen as the cause of high blood pressure by some patients, the obvious 
treatment from their perspective would be to reduce stress.  What may be less obvious to 
these women, is that high blood pressure is a dangerous, potentially lethal diagnosis for 
them, and for their infant.  Misunderstanding, or misinformation from their medical 
providers, could potentially cause delays in accessing emergency care for women with 
worsening hypertension.   
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 The apparent lack of appropriate concern by medical providers about 
hypertension in pregnancy is directly reflected in the lack of concern that some 
participants described.  However, this study cannot claim to understand the motivations 
or experiences of the medical providers treating these women.  Knowing now that many 
of these participants experienced severe complications of pregnancy, including eclampsia 
and stillbirth, clearly indicates the need for intensive and evidence-based interventions for 
other women with preeclampsia.  Further research needs to identify the perspectives and 
motivations of medical providers treating these patients.  Some interview participants 
reported being suspicious of the motives of their medical providers, believing that they 
were trying to profit from ordering tests or cesarean sections, though it is not clear from 
interview data how exactly this would occur.  This lack of trust could certainly compound 
the low efficacy of antenatal care for these participants. 
 Other survey findings also point to problems with participants' experiences with 
the Haitian health care system.  Study participants who had previously had a health 
problem, or visited a doctor, had longer delays to access care than those who did not. 
Lengthened delay for these women could indicate that they received poor quality care, or 
were unsatisfied in some way, leading them to delay transfer to the hospital in this 
pregnancy.  Previous research among pregnant women in Haiti found that perceived poor 
quality of medical services was associated with longer delays to access care.74 
 Survey data also provided insights into the nature of the third delay, which occurs 
at the hospital prior to the initiation of appropriate treatment.  In this study, the time that 
women spent in the triage department prior to being admitted was used as a proxy 
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measure for this delay.  Preeclamptic women in this study had a longer third delay (mean 
delay forty-eight minutes), despite the fact that they and their infants were more at risk 
than their normal counterparts (mean delay eleven minutes).  Normal women admitted to 
CRUO were typically admitted because they were about to deliver.  Their time spent in 
triage would therefore be expected to be expedited due to the medical necessity of 
moving the patient to the delivery room.  However, very quick care is also absolutely 
essential for preeclamptic patients as well, just as for a woman imminently delivering.  
The total delay of forty-eight minutes for preeclamptic women appears relatively short 
given the acuity and population served by the MSF CRUO hospital.  The system in place 
in the triage department of CRUO may have prioritized imminent delivery over a 
relatively stable preeclamptic patient.  Both situations require urgent treatment; however, 
normal deliveries do not require as much decision-making or analysis by the triage staff 
as the decision to admit and treat for preeclampsia.  Lab work, such as proteinuria exams, 
may have also delayed the admission of these preeclampsia patients.  The sub-analysis of 
eclamptic patients also indicated that staff at MSF CRUO correctly prioritized eclamptic 
patients, who had a significantly shorter third delay (mean delay of 22 minutes), than 
preeclamptic patients (48 minutes).  
 
Study Limitations 
 
 Study limitations include the self-reporting of delay, skewed data patterns 
impacting statistical analysis, and study design issues with the collection of neonatal 
outcomes.   
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 The delays identified in the quantitative component of this study were self-
reported by participants.  As with all self-reported data, it is unclear to what extent study 
participants accurately reported delays.  Although the interviewers attempted to identify 
and clarify the amount of time with the participants, it is certainly possible that the length 
of delays that were reported do not correspond to the true length of delays experienced by 
the participants.  There was also a clustering of delays around twenty-four and forty-eight 
hours, indicating a tendency to report round figures among participants.  It is possible that 
due to the inability of some eclamptic patients to report on first and second delays, and 
the need to exclude some of these participants because of this non-response, that the total 
delay for preeclampsia patients was inaccurately reported, and would likely be longer.  In 
this case, this would increase the already significantly longer delay to access care that 
was identified by preeclamptic participants compared to normal participants. 
 The first delay presents particular challenges for measurement.  The onset of the 
first delay corresponds to the onset of the emergency, which is subjective and specific to 
the experience of each participant.  For women without preeclampsia, who were in labor, 
the onset of the first delay typically corresponded with the onset of strong contractions, or 
when their water broke.  For women with preeclampsia, however, there was much more 
variation in how women understood the onset of the problem.  For twenty-two 
participants, an eclamptic seizure or loss of consciousness marked the onset of the 
emergency.  It is quite likely that these women who had an eclamptic seizure had other 
signs or symptoms of preeclampsia prior to the seizure that they were either unaware of, 
or did not consider to be an emergency.  For those women who did not seek treatment for 
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symptoms occurring earlier, their reported delay to access care would appear to be 
artificially short.  Data from the qualitative interviews reinforces the possibility that some 
preeclamptic women reported artificially short delays.  
 Ideally, all women in this study would have sought emergency obstetric care at 
the onset of any danger sign, such as headache, edema, or epigastric pain.  However, in 
this sample, a minority of women were aware they were experiencing a danger sign, 
making it impossible to identify when they were truly at risk.  Women's lack of 
knowledge of danger signs meant that they were unable to identify the start of the delay, 
leading to artificially shorter delays. 
 In addition to misjudging the timing of the first delay, participants may have also 
struggled to accurately identify the length of time for the second and third delays.  More 
than three hundred participants rounded delays to one hour for transport, for instance.  
Without a second measure from which to triangulate the self-reported delays, it is 
difficult to know how accurately women reported these times.  Self-report of delay is a 
limitation affecting many research studies that have attempted to measure the first and 
second delays. 
 Research personnel attempted to minimize these self-report limitations by 
carefully questioning women about the timing of the events leading to their admission to 
MSF CRUO.  Research assistants led women through a verbal review of the events that 
had transpired, to attempt to help women identify and correctly establish the timing of 
each stage of the process.  This process likely allowed some women to more accurately 
report and identify the events and delays that occurred prior to their admission. 
		 161 
 However, reliable measurement of delays was difficult to achieve for women who 
had been unconscious or suffering eclamptic seizures upon arrival to the hospital. For the 
women who had suffered an eclamptic seizure, remembering and reporting delays were 
difficult, if not impossible.  Eighty-two additional study subjects were added to account 
for higher than expected non-response rates among preeclamptic participants, including 
those who had eclamptic seizures.  It is possible that preeclamptic women misreported 
delays, given the difficulty for them to remember accurately events leading up to their 
hospitalization.  Additionally, twenty-two eclamptic women were excluded from the 
study because they were unable to answer study questions. More than half of the 
preeclamptic women who had eclamptic seizures were excluded from the analysis, 
because they could not report first or second delays, or because they were withdrawn 
from study participation due to their inability to answer study questions.  These women, 
who suffered some of the worst effects, may be underrepresented in the data.  Efforts 
were made by the research team to improve the reporting of delays for participants, by 
triangulating with family members who were present at the survey administration, but 
this was not always possible.  Moreover, as described above, research assistants also 
attempted to help the participants themselves talk through the events that transpired prior 
to leaving home or during transport, while helping them to assign times to each event, in 
order to improve accuracy.   
 Another potential limitation of this study is that the shorter delays reported among 
the normal women may be partly due to the fact that they were, as a group, closer to 
delivery than their preeclamptic counterparts.  While preeclamptic women had to 
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interpret the meaning of symptoms such as headache or visual disturbances, normal 
women had likely much less interpretation necessary, or possible.  As labor progressed 
towards delivery, these normal participants would have no choice but to quickly move to 
the hospital if that was their intended place of birth.  Without qualitative interview data 
on this group, it is difficult to understand how the first delays were experienced by the 
normal study participants. 
 Another limitation of this study is that it asked women to retrospectively report on 
prenatal events after she gave birth.  The outcome of that birth, and the fact of having had 
complications, may bias participants' recollections of their experiences prior to delivery.  
Specifically for preeclamptic participants, who were universally being treated for a 
dangerous medical condition, this may have influenced their memory or reporting of the 
events that transpired during antenatal care, or their own actions in leaving home for the 
hospital.  It is not clear from the data in which direction this could have biased the data.  
Did women potentially report shorter delays, knowing the gravity of the situation they 
faced once admitted?  Or did women possibly lengthen delays to include symptoms that 
had previously gone unnoticed?  Further research would be needed to elucidate the 
potential self-report issues in first delay for this population.  
 Prior studies have identified demographic risk factors, such as age, education, or 
economic status, as predictors of delayed access to care.67  Those demographic factors 
were not found to affect the length of delay in this study.  Some factors that might be 
expected to confer some benefit, such as secondary school education or good economic 
status, were not found to affect the length of delay for women in this study.  Women who 
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experienced other factors that could be expected to lengthen delay, such as being an 
internally displaced person (IDP), also did not have longer delays to care.   
 However, statistical power may have been insufficient to see differences in these 
areas.  There was a trend towards shorter delay among preeclamptic women with "doing 
well" or "good" economic status (4.9 hours versus 15.2 hours), though this did not reach 
the level of statistical significance, probably given the small number of women in this 
group (n=25) faring well economically.  This trend was reversed among the normal 
group, with longer delays among the women with good economic status (12.1 hours 
versus 6.6 hours, n=12), although the differences were also not statistically significant.  It 
is difficult to understand how better economic status could lead to longer delays, as 
studies in many settings have found the opposite to be true.    
 This study aimed to identify the role of delayed access to care in poor clinical 
outcomes for mothers or babies.  However, the association between long delays to care 
and poor clinical outcomes was not clearly evident from the data.  Several factors have 
affected the lack of association in this study.  Difficulties in assessing delay may have led 
to an under-reporting of delay for preeclamptic women.  The study sample size may have 
been insufficient to find real associations that do exist.  Additionally, the generally low 
economic status and difficulty to find health care for all participants may have minimized 
differences between the delayed and not delayed groups.  Finally, neonatal death was not 
able to be accurately identified in this study, due to the inability to track neonatal 
outcomes after the time of survey administration.  However, it is likely that neonatal 
deaths, even if accurately reported, would have been too rare to have seen major 
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differences among the groups.  
 Inability to accurately document neonatal outcomes was a limitation of this study.  
The study was designed to be anonymous.  Therefore, there was no way to track neonatal 
outcomes after the survey questionnaire was completed, which was oftentimes on the first 
postpartum day.  Birth outcomes were recorded (APGAR score, admission to NICU), as 
well as any other outcomes (neonatal death) up to the time of administration of the 
questionnaire.  Many infants born to preeclamptic mothers were either born preterm, 
were low birth weight, or both.  These babies would have a higher risk for neonatal death, 
which could have occurred after their first day of life, when the outcome was recorded.  
Some of these babies may have initially responded to resuscitative measures and had a 
good APGAR score.   However, problems with respirations, infections or other newborn 
problems that are initially managed at birth can cause increasing problems after the first 
day of life.186  
 Without being able to identify which babies survived, and which did not, it is 
impossible to measure the full effect of delayed access to care on this outcome.  A 
different study design would need to be used to track the outcomes of babies over the 
course of their hospitalization to ensure an accurate reporting of neonatal death.  
However, this outcome may not have been different even if neonatal deaths were 
accurately recorded.  Haiti reports a neonatal mortality rate of 27/1,000 live births.1  Even 
if there were twice as many neonatal deaths for women in the preeclampsia subgroup, 
there would still not be enough power to observe differences among women with long 
delays.  More common outcomes, where differences should be more likely, such as low 
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APGAR score, were not significantly different for infants of mothers with long delays. 
 Another study limitation is the possibility that some women who were truly 
preeclamptic were misclassified as normal, and that other women who were not 
preeclamptic but merely had hypertension, were classified as preeclamptic.  Fifteen 
participants in the normal group stated that they had been diagnosed with preeclampsia 
during that pregnancy, and some of them had elevated blood pressure readings on 
admission to MSF.  If these women were on the verge of delivering their infant, it is 
possible that staff did not have the time to distinguish between blood pressures that can 
be normally elevated during delivery, and those indicating preeclampsia. 
Misclassification of women by preeclampsia diagnosis could have biased the delays 
reported by these groups, by artificially lengthening delays in the normal group. 
 Many of the study participants had no history of medical care prior to their 
pregnancy.  Another limitation of this study was the possibility that women who had 
chronic hypertension were misdiagnosed as preeclamptic, because they only sought 
medical care during their pregnancy.  When hypertension is identified during antenatal 
care, it is difficult to differentiate between hypertension caused by pregnancy, and 
hypertension that is preexisting pregnancy.  MSF CRUO attempted to accurately 
diagnose cases of preeclampsia by testing for proteinuria, which is specific for 
preeclampsia.  However, it may be true that some women who received preeclampsia 
diagnoses during antepartum visits were misdiagnosed. 
 Finally, ten percent of normal women in this study also reported a previous 
history of preeclampsia, roughly double the expected percentage of preeclampsia in most 
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settings, according to published estimates49.  Several possibilities could explain this 
relatively high rate of preeclampsia history among the normal subgroup.  Haiti has a very 
high prevalence of hypertension, which may contribute to higher than expected cases of 
preeclampsia.  For the women in this study, they may have truly had preeclampsia, but 
were fortunate to not develop it in this pregnancy.  They may also have been 
misdiagnosed in this pregnancy and their preeclampsia may have been missed.  
Regardless of personal history, testing for preeclampsia at antenatal care should be 
standard for all women.  Additionally, these women may have misunderstood the 
question and answered affirmatively in error.  Self-reported preeclampsia histories may 
be subject to some error due to self-reporting187, as is seen in this finding.  
  
Summary 
 This study adds to the knowledge about how the Three Delays model is relevant 
to pregnant women living in urban areas.  Despite having much shorter distances to 
travel, preeclamptic women in this study had long average delays to access emergency 
obstetric care.  These delays would be expected to have negative consequences for both 
maternal and neonatal morbidity and mortality.  However, in this study, longer delays 
were not associated with poorer clinical outcomes for mother or baby when compared to 
a sample of mothers without preeclampsia.  This finding could be the result of inaccurate 
self-report of delay, or a study design that did not accurately capture longer-term neonatal 
outcomes.  Overall high levels of poverty, low access to health care, and poor health 
status among both groups could have minimized differences between the preeclamptic 
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and normal groups, masking the effects of delays. 
 What is clear from both survey and interview data is that antenatal care, which 
was widely attended by participants in this study, was of limited usefulness to this study 
population.  Despite their reported assiduous attendance, preeclamptic participants were 
unable to identify danger signs of preeclampsia, and had long delays at home before 
seeking care for danger signs.  Women who had shorter (<6 hour) or longer (>24 hour) 
delays had equivalent attendance at antenatal care visits, and were equally unlikely to 
remember any preeclampsia danger signs.  Many antenatal care providers did not 
appropriately manage hypertension in these patients, leading to dangerous situations for 
these mothers and babies.  This study highlights the urgent need for training of antenatal 
care providers on correct methods to screen, treat, refer and educate patients with 
preeclampsia. 
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CHAPTER 8: CONCLUSIONS AND RECOMMENDATIONS 
 
Summary 
 This paper has presented the findings of a mixed methods study of delayed access 
to emergency obstetrical care for preeclamptic women in Port au Prince, Haiti.  This 
study found long delays to accessing care for these sick women.  Long delays were 
primarily the result of the first delay, when some women stayed at home for many hours 
prior to seeking care.  This study did not identify demographic risk factors associated 
with delayed access to care.  Women's health prior to pregnancy apparently did not affect 
their delays to accessing care, with the exception of preeclamptic women who had 
previously had a health problem; these women did experience significantly longer delays.  
Adequate antenatal visits during pregnancy were not associated with shorter delays for 
preeclamptic women.  First delays longer than six hours for preeclamptic and normal 
women were not associated with poorer clinical outcomes, although neonatal death was 
not included in the analysis. 
 Interviews with women and family members of women affected by preeclampsia 
highlighted the effects of poverty on these women's lives, and on their ability to access 
timely emergency care when they became ill.  Financial barriers to care affected where 
and how women with preeclampsia were able to access emergency care.  Overwhelming 
poverty added stress to the lives of women already dealing with substantial medical 
issues. 
 Despite the fact that most participants had accessed antenatal care, this was not 
associated with shorter delays to care, increased knowledge of preeclampsia, or better 
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referral or treatment of this dangerous syndrome before delivery.  Lack of knowledge of 
preeclampsia, its danger signs, and its devastating consequences led many women to stay 
at home for many hours after the onset of worsening symptoms and before seeking care.  
Many of these participants reflected on the importance of having high quality, accessible, 
free care for obstetric emergencies, such as the care provided by the MSF hospital in Port 
au Prince. 
 
Conclusions 
 Pregnant women in Port au Prince who develop preeclampsia must navigate a 
complex, difficult to understand, and prohibitively expensive system of health care to 
receive appropriate, high quality emergency obstetric care.  While this study was not 
designed to study the impacts of antenatal care on delayed access to intrapartum care, our 
findings suggest lost opportunities for patient education, birth planning, prevention of 
preeclampsia in high risk women, appropriate testing and treatment of hypertension, and 
appropriate referral of high risk cases.  Women with preeclampsia in this study often 
delayed leaving home for the hospital for many hours after the onset of their symptoms; 
even after leaving, many had to visit several hospitals before being admitted and 
appropriately treated.   
 High quality, free obstetric care, such as that being offered by MSF, is essential to 
treat the life-threatening complications of preeclampsia and eclampsia and to prevent 
maternal and perinatal mortality.  With the end of the "Maman Ak Timoun An Sante" 
(Healthy Mothers and Babies) program in 2013, access to obstetric care has become 
much more difficult for many women in Port au Prince, as funding for staff and supplies 
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dried up, and patients were forced to pay large sums of money for care.  MSF CRUO 
hospital fills a vital role in this situation, by continuing to offer high quality, free care to 
sick pregnant women.  Because the MSF CRUO hospital is meant to serve as a referral 
facility, and not as a duplicate or parallel system to the MSPP, its services and criteria for 
admission are not widely advertised to the public at large.  However, given the 
breakdown of the public hospital system, women may not be able to access other 
facilities that could initiate treatment, and then refer them to MSF. 
 
Recommendations for future research 
 Very few published studies have examined the unique health problems of Haitian 
pregnant women, including the prevalence of preeclampsia among this population.  Small 
studies suggest a high prevalence of preeclampsia188, which may be linked to documented 
high rates of hypertension in the general Haitian population108,146.  As one of the major 
causes of maternal mortality worldwide, and likely in Haiti, preeclampsia should be 
studied to identify incidence and prevalence, in order to accurately assign resources to 
aiding women with this problem. 
 The scope of the problem of preeclampsia in Haiti is unknown; prevalence studies 
can help public health researchers, MSPP staff, and clinicians to assign appropriate 
resources and time to address it, as needed.  The first recommendation is that further 
research should examine the prevalence of hypertension and preeclampsia among women 
seeking antenatal care services, as well as the types of services and care that are 
provided to them.  The costs of this treatment, and its efficacy based on international 
norms, should also be investigated. Research should also identify the specificity of 
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preeclampsia in the Haitian setting: a screening of women in antenatal care, along with a 
survey of women with preeclampsia should examine the prevalence of chronic 
hypertension, preeclampsia, eclampsia, preterm birth, and maternal and neonatal 
morbidities and mortality in order to inform a public health strategy to combat this 
syndrome.   
 This study also identified potential problems with the provision of antenatal care 
services in Port au Prince.  Although most women attended the recommended number of 
visits, the content of these visits was apparently not sufficient to appropriately manage 
these women's preeclampsia, as evidenced by low comprehension of preeclampsia danger 
signs, long first delays at home once symptoms arose, and limited occurrences of timely 
referral from outpatient settings.  Merely meeting the four visit threshold is not adequate 
to effectively diagnose and treat preeclampsia patients, according to mothers’ responses.  
Preeclampsia patients, who are by definition high risk, need at a minimum closer 
monitoring, more antenatal visits, and careful planning for the time and place of delivery 
to ensure prevention of morbidities and mortality.  A second recommendation is that 
further studies examine the content of these antenatal visits and provide targeted 
recommendations essential to devising a plan for improving the quality of these 
prevention services. 
 A third recommendation is for researchers to undertake a prospective study of 
pregnant women in Port au Prince, to monitor the quantity and quality, as well as the 
costs, of the antenatal care they receive, and the resulting outcomes of their pregnancies.  
A mixed method design, which incorporated interviews with antenatal providers, could 
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add to the understanding about the experience and understanding of providers who are 
treating women with preeclampsia.  Understanding where women seek care, the 
providers they see, the content of visits, the financial costs of care, and mechanisms 
currently in place to treat sick women would be the next step to address some of the 
issues identified in this study.  There are several large obstetric hospitals in Port au 
Prince; surveys of women admitted to these hospitals could identify the names and 
locations of antenatal care providers, including public and private facilities, hospital or 
clinic based services, who could then, in turn, be mapped and surveyed themselves.  
What training do these providers have?  What supplies and medications are available for 
the diagnosis and treatment of preeclampsia?  What is the content of patient education 
regarding hypertension and preeclampsia?  What happens when a woman is found to 
have hypertension or preeclampsia?  Interviews with antenatal care providers, to 
understand their perspective, would represent an essential component to have a more 
comprehensive picture of the issues at play. 
 Our study found that women still endured long delays to access emergency 
obstetrical care, even in an urban setting, and despite living relatively close to hospitals.  
This study calls into question the appropriateness of the Three Delays model for urban 
settings.  Most of the Three Delays research has focused on women in rural areas, and has 
examined how the distance to facilities has affected delays to care.  With increasing 
urbanization in contexts around the globe, researchers need to focus attention on 
understanding the specific barriers and delays faced by women in these growing cities.  
As a fourth recommendation, researchers should examine how the specific context and 
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challenges of urban living can impact access to emergency obstetrical care by 
researching the delays, and causes of delays, for pregnant women.  An expanded Three 
Delays model that includes experiences of urban women, or a new model of delays to 
care, needs to incorporate the experiences and difficulties faced by these women who 
may live close to a facility, but still struggle to receive appropriate medical care for 
obstetric emergencies.  Qualitative data in this study indicate that transport options, 
traffic, public safety issues, and the organization of public health hospitals all have the 
potential to delay women's access to emergency obstetrical care. 
 MSF CRUO provides care to hundreds of sick women every month who have few 
other options for life saving care.  As part of their mission in Haiti, and as a fifth 
recommendation, MSF should consider funding a prospective study to follow outcomes of 
women admitted with preeclampsia and eclampsia.  While this study has established the 
difficulties faced by many women prior to admission, little is known about the 
morbidities faced by women after delivery.  Specifically, the prevalence of chronic 
hypertension among this population is not known, as well as their continued need for 
treatment and follow up.  Knowledge of maternal morbidities following delivery can help 
orient the MSF program towards appropriate care for this population, as well as to inform 
MSPP efforts for this vulnerable population. 
 
Recommendations for MSF CRUO program 
 MSF CRUO created and funded a position of maternity surveillance officer in 
2014.  This post was formed to create linkages among obstetric facilities, in order to 
gather information about maternity care issues in Port au Prince, and also to share 
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information about the MSF CRUO hospital with referring facilities and providers.  
Because CRUO is designed to operate as a referral facility, ideally admitting most 
patients from other maternity centers not able to handle their cases, creating linkages and 
networks with obstetric providers is key.  The initial goals for the position included the 
creation of forums for discussion amongst MSPP staff, sharing of information about 
ambulance services, and providing information about CRUO admission criteria and 
services to staff from public obstetric hospitals.  The maternity surveillance officer, if 
staffed by a qualified and trained person, can be key in addressing some of the 
recommendations generated from this study. 
 The maternity surveillance officer can work to identify the main sources of 
antenatal care for women admitted to CRUO, so as to enable more direct referrals from 
outpatient care facilities.  Primary health care services, like emergency services, are 
poorly organized and not transparent in Port au Prince; it is not clear where the majority 
of women are seeking services.  Some women may receive antenatal services from the 
outpatient department of local MSPP hospitals, some from NGO services or missionary 
clinics, and others from private services.  After surveying women in CRUO, the 
surveillance officer can create a map of antenatal care providers.  Once this mapping 
exercise is complete, MSF staff can work to create linkages with these antenatal care 
providers, enabling more effective and direct referrals to the CRUO hospital, ensuring 
timely treatment for women diagnosed with preeclampsia. Ultimately, more systematic 
referrals from antenatal providers to MSF CRUO hospital could bypass some of the 
problems that were identified by interview participants about referrals from local 
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hospitals.  Mapping of antenatal care access of MSF patients could also augment similar 
activities done for research purposes, to further understanding of how women access 
antenatal care.   
 A conference on maternity care in Port au Prince, organized by MSF in Spring 
2014 represents one notable success of the maternity surveillance and advocacy program.  
This conference brought together many players from the MSPP, NGO partners, and the 
national ambulance service to discuss emergency obstetrical care.  In this same mode, 
MSF should consider convening a conference targeting antenatal care providers.  This 
conference could include components of medical education for providers, focusing on 
preeclampsia in the antenatal period in the Haitian context, as well as opportunities to 
share information and encourage earlier and more timely referrals for preeclamptic 
patients.  This conference could also highlight for the public and the press the importance 
of improving antenatal care quality, which could then in turn ensure that the Ministry 
continues to focus attention on this subject. 
 As MSF has done continually in Haiti, it should continue to advocate strongly for 
free emergency obstetric care for Haitian women.  The end of the Maman Ak Timoun An 
Sante program has left Haitian women struggling to pay user fees for services.  
Particularly problematic is the fact that cesarean section, a necessary and important life-
saving component of emergency obstetric services, is typically beyond the financial reach 
of most Haitian families.  Free, high quality services, like those offered by MSF, are 
essential to saving the lives of mothers affected by preeclampsia and their babies, as well 
as other obstetric emergencies.  MSF should continue to advocate with the government of 
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Haiti to fund public hospitals appropriately.  Additionally, MSF should also advocate for 
stronger medical education and supportive supervision for antenatal care providers. With 
the demise of the countrywide free obstetric program, the MSF program is providing high 
quality, financially accessible emergency obstetrical care, which is not found at any other 
hospital in Port au Prince today.   
 CRUO care is predicated upon the hospital being a referral facility.  However, the 
referral network upon which CRUO relies is barely functional.  Multiple interview 
respondents indicated that it is difficult or impossible to find any care outside of MSF 
CRUO.  Other women reported that they were referred to MSF only after spending large 
amounts of money at a referring facility, further limiting access.  Although women can 
also self-identify and present individually for care, the model of CRUO is built on the 
assumption that most patients will be referred from facilities not equipped or staffed to 
handle acute emergencies.  This study calls that model into question.  Given our findings 
that women have difficulty accessing and paying for care at public hospitals, MSF should 
continue to use a broad-based advocacy strategy, including direct talks with the MSPP, 
news articles, patient testimonies, and internal publications to push the Haitian 
government and donors to fund emergency obstetric programs fully, and to monitor them 
for quality.  In the absence of free governmental obstetric care programs, however, and 
given the eventual end of its presence, MSF will need to develop a unique strategy for 
devolving emergency obstetrical care programs back under government control. MSF has 
to continually choose between continuing long-running programs that are successful in 
savings lives, versus opening new projects in the myriad of emergency contexts around 
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the world. As with all MSF programs, the continued existence of the CRUO program 
depends on a complex analysis of the state of "emergency" in that context, and the 
program’s effects on mortality reduction.  MSF's current five-year plan to continue this 
program will come under review in 2019.   
 MSF runs hospitals with maternity programs in many urban areas throughout the 
world.  The results of this study can help MSF reflect on the need for these hospitals' 
presence, oftentimes in the vicinity of Ministry of Health hospitals.  As MSF makes 
decisions about where to open and where to continue obstetric programs, the results of 
this study can provide evidence about the importance of free, high-quality emergency 
care for women with obstetric complications.  Other MSF programs can also use these 
findings to ensure that the quality care they offer is timely, and that women do not face 
long delays to reach it, in part by not assuming that geographic presence and proximity 
equals timely access.  As has been found in other contexts, the presence of health 
facilities is not enough to ensure that women will have access to their services.161  
 A further recommendation for the MSF CRUO staff comes from the analysis of 
the third delay.  The results of the quantitative data analysis found that preeclamptic 
women have a statistically longer wait in the triage department of CRUO than their 
normal counterparts.  Some of this difference is likely due to the nature of the normal 
women's admission criteria; for most: imminent delivery.  However, even eclamptic 
women in this study had a longer wait than women imminently delivering.  Eclamptic 
patients require emergent supportive care to lower the risk of maternal and perinatal 
mortality, and to minimize resulting morbidities. CRUO staff should consider reviewing 
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the protocols for staff in triage, and how they prioritize their workload and patients in 
order to reduce these waiting times for very sick patients.   
 With almost a third of admissions due to preeclampsia and eclampsia, and based 
on the limited studies showing a very high prevalence of this syndrome in Haiti, CRUO 
should target staff education and training on prevention and treatment.  These study 
results can help focus attention on the specific care needed for these vulnerable women 
and infants, and ensure that the quality of care being offered is consistently high.  The 
data about third delay for preeclamptic patients can inform training for triage staff, for 
instance.  MSF should also work to improve the continuity of care for women discharged 
from CRUO, to ensure they have the minimum of information about their condition, and 
their risks in future pregnancies.  Referral for continued treatment of essential 
hypertension is likely difficult due to health system constraints, but crucial for these 
women's long-term health. 
 Finally, this study showed that for many women, decisions about when, how, and 
where to seek care are based on a poor understanding of the signs and dangers of 
preeclampsia.  Public health campaigns targeting pregnant women themselves could 
circumvent some of the problems associated with poor quality antenatal care, by giving 
women the tools to make better decisions about when to seek emergency care, and 
hopefully lessen delays to care.  Of course, in order to make public health campaigns  
effective, women need high quality, accessible options for receiving care, both before and 
during birth. 
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Recommendations for other settings 
 The results of this study may also help focus attention on the problems facing sick 
pregnant women in other urban, low-income settings around the world.  While 
researchers and public health officials have worried, with good reason, about reaching 
women who live far from facilities, and who must travel great distances to reach services, 
this study, as well as other literature,189 also indicates a vital need for attention to urban 
women, particularly given the rapid urbanization of developing countries.  Some research 
has found higher levels of health risks such as obesity, exposure to pollutants, and effects 
from natural disasters among urban residents.18  Specific health risks among urban 
pregnant women are largely unknown; our results indicate that proximity to health care is 
not enough to ensure access to care.  This study adds to the public health literature calling 
for attention to the specific issues facing urban women, finding that despite geographic 
proximity to services, urban pregnant women are suffering from preventable morbidities 
and mortality. 
 The problems that women in this study overcame to find care, such as traffic or 
gang violence, are not unique to Haiti.  The manifestation of how delays to care affected 
Haitian women are specific to this context; the sites and relative importance of how these 
and other issues play out in Port au Prince make inquiry into these and other issues 
critical.  How do these same issues impact obstetric care, and what is their specific 
contextual expression in Lagos, or Managua, or any other growing metropolis in a poor 
country around the world?  Research into delayed access to care is important for urban 
women, as well as rural women.  With increasing population movements, and explosive 
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urbanization in many parts of the world, this issue will only grow in importance in the 
coming years.   
 The Three Delays model has been instrumental in drawing attention to the 
obstacles faced by many women in accessing emergency obstetrical care.  This study 
draws attention to the applicability of this model for urban settings, and highlights the 
need to include urban women's experiences and barriers.  Understanding and 
conceptualizing how women as sick as those identified in this study, who live within 
walking distance to a hospital, and who still have long delays, is crucial to finding 
solutions. 
 
Summation 
 Pregnant women with preeclampsia in Port au Prince, Haiti overcome poverty, 
ineffective antenatal care, poorly organized health care systems, and even overwhelming 
traffic to access emergency obstetrical care.  The MSF CRUO hospital offers free, high 
quality emergency care to these women and their infants.  The resilience and grit of these 
Haitian women is impressive, and it should be matched by perseverance and 
determination on the part of the medical system to address the myriad needs of these 
vulnerable patients.  Haitian government officials must work to improve medical 
education and supervision for antenatal care providers and emergency obstetric providers, 
as well as to improve the accessibility and affordability of public hospitals in Port au 
Prince.  Researchers should continue to work to illuminate the scope and nature of the 
problem of preeclampsia for Haitian women.  
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Annex 1: Consent form - Survey  
 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask you 
some questions from a survey.  About 400 women who delivered a baby at this hospital 
will be asked to participate in the research study.  Your care will not be affected by your 
decision to take part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you about 40 questions.  It will take about 30 minutes. 
The study will also use information routinely gathered from you and your baby’s hospital 
chart.  
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems.  We would like to ask you about your life before you arrived 
here to the hospital. Your answers can help us to understand which factors might lead to 
problems for women or babies.  The information we gather may help improve care in the 
future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
You will be one of approximately 400 subjects to be asked to complete a survey as part 
of the research study.  
The research will take place here at The Emergency Obstetric Referral Hospital (CRUO), 
the hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask you about 40 questions.  It will take about 30 
minutes.  We will ask you questions about your life, your health, your pregnancy, and 
what you did before you came to the hospital.   
The study will also use information routinely gathered during for you and your baby’s 
hospital chart.  The researcher will record some information, including yours and your 
baby's medical diagnoses, from your medical chart after the interview.  
		 182 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting to talk about 
your pregnancy or delivery if you or your baby had a problem.  We can refer you to a 
mental health counsellor if you feel upset during the survey.  You can also decide not to 
participate, or to stop your participation, if you think you will feel upset.  The time to 
participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that you tell us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down your name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your health, welfare, or decision to 
stay in this study. 
 
Potential Benefits 
 
You will receive no direct benefit from your participation in this study. However, your 
participation may help the investigators better understand why some women have 
problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write your name or address down, and we will not be able to 
identify you from the answers you give us.   Only people working on the study will be 
able to view your information.  All of your answers, and this form, will be kept in a 
locked file here at the hospital, and then destroyed 3 years after the end of the research. 
Information from this study and from your medical record may be used for research 
purposes and may be published; however, your name will not be used in any publications.  
 
Subject's Rights  
 
By consenting to participate in this study you do not waive any of your legal rights. 
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Giving consent means that you have heard or read the information about this study 
and that you agree to participate. You will be given a copy of this form to keep.  
If at any time you withdraw from this study you will not suffer any penalty or lose any 
benefits to which you are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study for any reason. If you decide to be in the study and then change your mind, you 
can withdraw from the research at any time, and for any reason. Your participation is 
completely up to you. Your decision will not affect your being able to get health care at 
this institution or payment for your health care.  
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study.  
 
 
 Signing this consent form indicates that you have read this consent form (or have had it 
read to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed consent form. 
 
    
 ----------------------------------------------------------------------------------------------------- 
 Subject (Signature and Printed Name)                                          Date 
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----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)         Date 
  
 
 ----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                      Date 
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Annex 2: Consent Form - In-depth Interview  
 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask you 
some questions.  About 30 women who delivered a baby at this hospital will be asked 
participate in the research study.  Your care will not be affected by your decision to take 
part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you questions about yourself and your life.  It will take about 60 
minutes. 
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems.  We would like to ask you about your life before you arrived 
here to the hospital.  Your answers can help us to understand which factors might lead to 
problems for women or babies.  The information we gather may help improve care in the 
future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
You will be one of about 30 women to be asked to complete an interview as part of this 
research study.  
The research will take place here at The Emergency Obstetric Referral Hospital (CRUO), 
the hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask you questions about yourself and your life.  It will 
take about 60 minutes.  We will ask you about what you did before you came to the 
hospital, how you made the decision to come, what barriers you may have faced, and who 
helped you. 
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Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting to talk about 
your pregnancy or delivery if you or your baby had a problem.  We can refer you to a 
mental health counsellor if you feel upset during the survey.  You can also decide not to 
participate, or to stop your participation, if you think you will feel upset.  The time to 
participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that you tell us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down your name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your health, welfare, or decision to 
stay in this study. 
 
Potential Benefits 
 
You will receive no direct benefit from your participation in this study. However, your 
participation may help the investigators better understand why some women have 
problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write your name or address down, and we will not be able to 
identify you from the answers you give us.   Only people working on the study will be 
able to view your information.  All of your answers, and this form, will be kept in a 
locked file here at the hospital, and then destroyed 3 years after the end of the research. 
Information from this study and from your medical record may be used for research 
purposes and may be published; however, your name will not be used in any publications.  
 
Subject's Rights  
 
By consenting to participate in this study you do not waive any of your legal rights. 
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Giving consent means that you have heard or read the information about this study 
and that you agree to participate. You will be given a copy of this form to keep.  
If at any time you withdraw from this study you will not suffer any penalty or lose any 
benefits to which you are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study at any time. If you decide to be in the study and then change your mind, you can 
withdraw from the research for any reason, at any time. Your participation is completely 
up to you. Your decision will not affect your being able to get health care at this 
institution or payment for your health care.  
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study.  
 
 
 
Signing this consent form indicates that you have read this consent form (or have had it 
read to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed consent form. 
 
    
 ----------------------------------------------------------------------------------------------------- 
 Subject (Signature and Printed Name)                                          Date 
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----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)         Date 
  
 
 ----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                      Date 
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Annex 3: Consent - Survey, Legally Authorized Representatives 
 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask you 
some questions about your relative from a survey.  About 400 women or their legal 
representatives who delivered a baby at this hospital will be asked to participate in the 
research study.  The health care of your relative will not be affected by your decision to 
take part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you about 40 questions.  It will take about 30 minutes. 
The study will also use information routinely gathered from your relative and her baby’s 
hospital chart. 
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems.  We would like to ask you about your relative's life before 
she arrived here to the hospital. Your answers can help us to understand which factors 
might lead to problems for women or babies.  The information we gather may help 
improve care in the future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
You will be one of approximately 400 subjects to be asked to complete a survey as part 
of the research study.  
The research will take place here at The Emergency Obstetric Referral Hospital (CRUO), 
the hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask you about 40 questions.  It will take about 30 
minutes.  We will ask you questions about your relative's life, her health, her pregnancy, 
and what she did before she came to the hospital. 
The study will also use information routinely gathered from your relative and her baby’s 
hospital chart.  The researcher will record some information, including her and her baby's 
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medical diagnoses, from the medical chart after the interview.  
 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting to talk about 
your relative's pregnancy or delivery if she or her baby had a problem.  We can refer you 
to a mental health counsellor if you feel upset during the survey.  You can also decide not 
to participate, or to stop your participation, if you think you will feel upset.  The time to 
participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that you tell us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down your or your relative's name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your relative's health, welfare, or 
decision to stay in this study. 
 
Potential Benefits 
 
Neither you nor your relative will receive direct benefit from your participation in this 
study. However, your participation may help the investigators better understand why 
some women have problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write yours or your relative's name or address down, and we will 
not be able to identify you or your relative from the answers you give us.   Only people 
working on the study will be able to view your information.  All of your answers, and this 
form, will be kept in a locked file here at the hospital, and then destroyed 3 years after the 
end of the research. 
Information from this study and from your medical record may be used for research 
purposes and may be published; however, yours or your relative's name will not be used 
in any publications.  
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Subject's Rights  
 
By consenting to participate in this study you do not waive any of your legal rights. 
Giving consent means that you have heard or read the information about this study 
and that you agree to participate. You will be given a copy of this form to keep.  
If at any time you withdraw from this study you will not suffer any penalty or lose any 
benefits to which you or your relative are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study for any reason. If you decide to be in the study and then change your mind, you 
can withdraw from the research at any time, and for any reason. Your participation is 
completely up to you. Your decision will not affect your relative being able to get health 
care at this institution or payment for your health care.  
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study.  
 
 Signing this consent form indicates that you have read this consent form (or have had it 
read to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed consent form. 
 
  
 ---------------------------------------------------------------------------------------------- 
 Legally Authorized Representative (LAR) (Sign and Name)   Date 
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----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)         Date 
  
 
----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)             Date 
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Annex 4: Consent - Survey, Legally Authorized Representatives of Minors 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask your 
relative some questions from a survey.  About 400 women or their legal representatives 
who delivered a baby at this hospital will be asked to participate in the research study.  
The health care of your relative will not be affected by your decision to take part in the 
study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask her about 40 questions.  It will take about 30 minutes.  She will 
be interviewed in private, and you would not be present. 
The study will also use information routinely gathered from your relative and her baby’s 
hospital chart.  
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems. We would like to ask about your relative's life before she 
arrived here to the hospital. Her answers can help us to understand which factors might 
lead to problems for women or babies.  The information we gather may help improve 
care in the future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
She will be one of approximately 400 subjects to be asked to complete a survey as part 
of the research study.  
The research will take place here at The Emergency Obstetric Referral Hospital 
(CRUO), the hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask your relative about 40 questions.  It will take about 
30 minutes.  We will ask her questions about her life, your health, her pregnancy, and 
what she did before she came to the hospital. 
The study will also use information routinely gathered from your relative and her baby’s 
hospital chart.  The researcher will record some information, including your relative and 
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her baby's medical diagnoses, from her medical chart after the interview.  
 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting for your 
relative to talk about her pregnancy or delivery if she or her baby had a problem.  We can 
refer her to a mental health counsellor if she feels upset during the survey.  You can also 
decide not to let her participate, or she can stop her participation, if you think she will 
feel upset.  The time to participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that she tells us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down her name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your health, welfare, or decision to 
stay in this study. 
 
Potential Benefits 
 
Neither you nor your relative will receive direct benefit from her participation in this 
study. However, her participation may help the investigators better understand why some 
women have problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write your relative's name or address down, and we will not be 
able to identify her from the answers she gives us.   Only people working on the study 
will be able to view her information.  All of her answers, and this form, will be kept in a 
locked file here at the hospital, and then destroyed 3 years after the end of the research. 
Information from this study and from your relative's medical record may be used for 
research purposes and may be published; however, her name will not be used in any 
publications.  
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Subject's Rights  
 
By consenting to participate in this study you do not waive any of your legal rights. 
Giving consent means that you have heard or read the information about this study 
and that you agree for your relative to participate. You will be given a copy of this 
form to keep.  
If at any time you withdraw from this study neither you or your relative will suffer any 
penalty or lose any benefits to which you are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study for any reason. If you decide to be in the study and then change your mind, you 
can withdraw your relative from the research at any time, and for any reason. Your 
participation is completely up to you. Your decision will not affect your relative being 
able to get health care at this institution or payment for your health care.  
If you choose to take part, your relative has the right to stop at any time. If there are any 
new findings during the study that may affect whether you or your relative want to 
continue to take part, you will be told about them as soon as possible. 
 
The investigator may decide to discontinue your relative's participation without your 
permission because he/she may decide that staying in the study will be bad for your 
relative, or the sponsor may stop the study.  
 
 
Signing this consent form indicates that you have read this consent form (or have had it 
read to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed consent form. 
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----------------------------------------------------------------------------------------------------- 
Legally Authorized Representative (LAR) (Sign and Name)   Date 
 
 
----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)                Date 
  
 
----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                             Date 
  
 
 
 
  
		 197 
Annex 5: Consent - In-depth interview, Legally Authorized Representative 
 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask you 
some questions during an interview about your relative.  About 30 women or their legal 
representatives who delivered a baby at this hospital will be asked to participate in the 
research study.  The health care of your relative will not be affected by your decision to 
take part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you questions about your relative and her life.  It will take about 
60 minutes. 
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems.  We would like to ask you about your relative's life before 
she arrived here to the hospital. Your answers can help us to understand which factors 
might lead to problems for women or babies.  The information we gather may help 
improve care in the future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
You will be one of about 30 women or legal representatives to be asked to complete an 
interview as part of this research study.  
The research will take place here at The Emergency Obstetric Referral Hospital (CRUO), 
the hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask you questions about your relative and her life.  It will 
take about 60 minutes. We will ask you questions about your relative's life, her health, 
her pregnancy, and what she did before you came to the hospital.  We will ask you about 
what she did before she came to the hospital, how she made the decision to come, what 
barriers she may have faced, and who helped her. 
The study will also use information routinely gathered during for your relative and her 
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baby’s hospital chart.  The researcher will record some information, including her and her 
baby's medical diagnoses, from the medical chart after the interview.  
 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting to talk about 
your relative's pregnancy or delivery if she or her baby had a problem.  We can refer you 
to a mental health counsellor if you feel upset during the survey.  You can also decide not 
to participate, or to stop your participation, if you think you will feel upset.  The time to 
participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that you tell us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down your or your relative's name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your relative's health, welfare, or 
decision to stay in this study. 
 
Potential Benefits 
 
Neither you nor your relative will receive direct benefit from your participation in this 
study. However, your participation may help the investigators better understand why 
some women have problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write yours or your relative's name or address down, and we will 
not be able to identify you or your relative from the answers you give us.   Only people 
working on the study will be able to view your information.  All of your answers, and this 
form, will be kept in a locked file here at the hospital, and then destroyed 3 years after the 
end of the research. 
Information from this study and from your medical record may be used for research 
purposes and may be published; however, yours or your relative's name will not be used 
in any publications.  
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Subject's Rights  
 
By consenting to participate in this study you do not waive any of your legal rights. 
Giving consent means that you have heard or read the information about this study 
and that you agree to participate. You will be given a copy of this form to keep.  
If at any time you withdraw from this study you will not suffer any penalty or lose any 
benefits to which you or your relative are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study for any reason. If you decide to be in the study and then change your mind, you 
can withdraw from the research at any time, and for any reason. Your participation is 
completely up to you. Your decision will not affect your relative being able to get health 
care at this institution or payment for your health care.  
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study.  
 
 Signing this consent form indicates that you have read this consent form (or have had it 
read to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed consent form. 
 
  
 ---------------------------------------------------------------------------------------------- 
 Legally Authorized Representative (LAR) (Sign and Name)   Date 
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----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)         Date 
  
 
----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                     Date  
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Annex 6: Consent - In-depth interview, Legally Authorized Representative of Minor 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask your 
relative some questions during an interview.  About 30 women or their legal 
representatives who delivered a baby at this hospital will be asked to participate in the 
research study.  The health care of your relative will not be affected by your decision to 
take part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you questions about yourself and your life.  It will take about 60 
minutes.  She will be interviewed in private, and you would not be present. 
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems. We would like to ask about your relative's life before she 
arrived here to the hospital. Her answers can help us to understand which factors might 
lead to problems for women or babies.  The information we gather may help improve 
care in the future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
Your relative will be one of approximately 30 subjects to be asked to complete an 
interview as part of the research study.  
The research will take place here at The Emergency Obstetric Referral Hospital 
(CRUO), the hospital where your baby was born. 
The study will take place in a private place here in the CRUO hospital. The study 
involves an interview where we ask your relative questions about herself and her life.  It 
will take about 60 minutes. We will ask her questions about her life, your health and her 
pregnancy- including about what she did before you came to the hospital, how she made 
the decision to come, what barriers she may have faced, and who helped her. 
 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting for your 
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relative to talk about her pregnancy or delivery if she or her baby had a problem.  We can 
refer her to a mental health counsellor if she feels upset during the survey.  You can also 
decide not to let her participate, or she can stop your participation, if you think she will 
feel upset.  The time to participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that she tells us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down her name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your relative's health, welfare, or 
decision to stay in this study. 
 
Potential Benefits 
 
Neither you nor your relative will receive direct benefit from her participation in this 
study. However, her participation may help the investigators better understand why some 
women have problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write your relative's name or address down, and we will not be 
able to identify her from the answers she gives us.   Only people working on the study 
will be able to view her information.  All of her answers, and this form, will be kept in a 
locked file here at the hospital, and then destroyed 3 years after the end of the research. 
Information from this study and from your relative's medical record may be used for 
research purposes and may be published; however, her name will not be used in any 
publications.  
 
Subject's Rights  
 
By consenting to participate in this study you do not waive any of your legal rights. 
Giving consent means that you have heard or read the information about this study 
and that you agree for your relative to participate. You will be given a copy of this 
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form to keep.  
If at any time you withdraw from this study neither you or your relative will suffer any 
penalty or lose any benefits to which you are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study for any reason. If you decide to be in the study and then change your mind, you 
can withdraw your relative from the research at any time, and for any reason. Your 
participation is completely up to you. Your decision will not affect your relative being 
able to get health care at this institution or payment for your health care.  
If you choose to take part, your relative has the right to stop at any time. If there are any 
new findings during the study that may affect whether you or your relative want to 
continue to take part, you will be told about them as soon as possible. 
 
The investigator may decide to discontinue your relative's participation without your 
permission because he/she may decide that staying in the study will be bad for your 
relative, or the sponsor may stop the study.  
 
Signing this consent form indicates that you have read this consent form (or have had it 
read to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed consent form. 
 
   
  
 --------------------------------------------------------------------------------------------------- 
 Legally Authorized Representative (LAR) (Sign and Name)   Date 
 
 
----------------------------------------------------------------------------------------------------- 
 Person Obtaining Consent (Signature and Printed Name)                 Date 
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----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                         Date 
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Annex 7: Assent - Survey, Minor Participants 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask you 
some questions from a survey.  Because you are under age 18, we will ask both you and 
your legal guardian for consent for your participation.  About 400 women who delivered 
a baby at this hospital will participate in the research study.  Your care will not be 
affected by your decision to take part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you about 40 questions.  It will take about 30 minutes. 
The study will also use information routinely gathered from you and your baby’s hospital 
chart. 
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We think 
women who have less education, less financial support, or use a traditional midwife 
might have more problems.  We would like to ask you about your life before you arrived 
here to the hospital.  Your answers can help us to understand which factors might lead to 
problems for women or babies.  The information we gather may help improve care in the 
future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
You will be one of about 400 women to be asked to participate at this location.  
The research will take place at The Emergency Obstetric Referral Hospital (CRUO), the 
hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask you questions about yourself and your life.  It will 
take about 30 minutes. We will ask you questions about your life, your health, your 
pregnancy, and what you did before you came to the hospital. 
 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting to talk about 
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your pregnancy or delivery if you or your baby had a problem.  We can refer you to a 
mental health counsellor if you feel upset during the survey.  You can also decide not to 
participate, or to stop your participation, if you think you will feel upset.  The time to 
participate may be an inconvenience.   
There is a small risk that confidential but anonymous information that you tell us could 
be mistakenly shared with someone outside the research team.  We will minimize this 
risk by not writing down your name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your health, welfare, or decision to 
stay in this study. 
 
Potential Benefits 
 
You will receive no direct benefit from your participation in this study. However, your 
participation may help the investigators better understand why some women have 
problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write your name or address down, and we will not be able to 
identify you from the answers you give us.   Only people working on the study will be 
able to view your information.  All of your answers, and this form, will be kept in a 
locked file here at the hospital, and then destroyed 3 years after the end of the research. 
Information from this study and from your medical record may be used for research 
purposes and may be published; however, your name will not be used in any publications.  
 
Subject's Rights  
 
By assenting to participate in this study you do not waive any of your legal rights. 
Giving consent means that you have heard or read the information about this study 
and that you agree to participate. You will be given a copy of this form to keep.  
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If at any time you withdraw from this study you will not suffer any penalty or lose any 
benefits to which you are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study for any reason. If you decide to be in the study and then change your mind, you 
can withdraw from the research for any reason, at any time. Your participation is 
completely up to you. Your decision will not affect your being able to get health care at 
this institution or payment for your health care.  
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study.  
 
 
 Signing this assent form indicates that you have read this assent form (or have had it read 
to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed assent form. 
 
    
 ----------------------------------------------------------------------------------------------------- 
 Child Assent (Signature and Printed Name)                                          Date 
    
 
----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)                      Date 
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----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                         Date 
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Annex 8: Assent - In-depth interview, Minor Participants 
Background  
 
The researchers, with the permission of Médecins Sans Frontières (MSF), the Ministry of 
Health (MSPP), and the Haitian National Bioethics Committee, would like to ask you 
some questions during an interview.  Because you are under age 18, we will ask both you 
and your legal guardian for consent for your participation. Women who delivered a baby 
at this hospital will participate in the research study.  Your care will not be affected by 
your decision to take part in the study or not. 
The study will take place in a private place here in the hospital. The study involves an 
interview where we ask you questions about yourself and your life.  It will take about 60 
minutes. 
 
Purpose  
 
Pregnant women and newborn babies have a bigger risk of dying in Haiti than in many 
countries around the world.  Problems that can happen during pregnancy or delivery can 
cause illness or death for a woman or baby.   
At this time, we don't know why some women in Haiti have problems during their 
pregnancy or birth.  We think there may be some factors that happen during the 
pregnancy that can affect whether or not she or her baby develops a problem.  We would 
like to ask you about your life before you arrived here to the hospital.  Your answers can 
help us to understand which factors might lead to problems for women or babies.  The 
information we gather may help improve care in the future for pregnant women in Haiti. 
 
What Happens In This Research Study  
 
You will be one of about 30 women to be asked to participate at this location.  
The research will take place at The Emergency Obstetric Referral Hospital (CRUO), the 
hospital where your baby was born. 
 
The study will take place in a private place here in the CRUO hospital.  The study 
involves an interview where we ask you questions about yourself and your life.  It will 
take about 60 minutes. We will ask you questions about your life, your health and your 
pregnancy - including what you did before you came to the hospital, how you made the 
decision to come, what barriers you may have faced, and who helped you. 
 
 
Risks and Discomforts  
There are very few risks to participating in this study. It may be upsetting to talk about 
your pregnancy or delivery if you or your baby had a problem.  We can refer you to a 
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mental health counsellor if you feel upset during the survey.  You can also decide not to 
participate, or to stop your participation, if you think you will feel upset.  The time to 
participate may be an inconvenience.   
There is a small risk that confidential information that you tell us could be mistakenly 
shared with someone outside the research team.  We will minimize this risk by not 
writing down your name or address on any forms. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your health, welfare, or decision to 
stay in this study. 
 
Potential Benefits 
 
You will receive no direct benefit from your participation in this study. However, your 
participation may help the investigators better understand why some women have 
problems during their labor or delivery.   
 
Alternatives  
Your alternative is to not participate in the study. 
 
Subject Costs and Payments  
 
There are no costs to you for participating in this research study. You will not be paid to 
participate in this research study. 
 
Confidentiality  
 
Personal information will be kept confidential and will not be shared with anyone outside 
the study.  We will not write your name or address down, and we will not be able to 
identify you from the answers you give us.   Only people working on the study will be 
able to view your information.  All of your answers, and this form, will be kept in a 
locked file here at the hospital, and then destroyed 3 years after the end of the research. 
Information from this study and from your medical record may be used for research 
purposes and may be published; however, your name will not be used in any publications.  
 
Subject's Rights  
 
By assenting to participate in this study you do not waive any of your legal rights. 
Giving consent means that you have heard or read the information about this study 
and that you agree to participate. You will be given a copy of this form to keep.  
If at any time you withdraw from this study you will not suffer any penalty or lose any 
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benefits to which you are entitled.  
You may obtain further information about your rights as a research subject by calling 
the Office of the Institutional Review Board of Boston University Medical Center at 
001-617-638-7207. You can also contact the Haitian Ethical Review Board at +509 
3701 5166, or the office of Médecins Sans Frontières at +509 2811 0110. 
The investigator or a member of the research team will try to answer all of your 
questions. If you have questions or concerns at any time, or if you need to report an 
injury while participating in this research, contact Katharine Hutchinson, BA, MSN, 
CNM, at +509 4892 7531 during the day or after hours. 
 
Right to Refuse or Withdraw 
 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study. If you decide to be in the study and then change your mind, you can withdraw 
from the research. Your participation is completely up to you. Your decision will not 
affect your being able to get health care at this institution or payment for your health 
care.  
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study.  
 
Signing this assent form indicates that you have read this assent form (or have had it read 
to you), that your questions have been answered to your satisfaction, and that you 
voluntarily agree to participate in this research study.  You will receive a copy of this 
signed assent form. 
 
    
----------------------------------------------------------------------------------------------------- 
Child Assent (Signature and Printed Name)                                           Date 
    
 
----------------------------------------------------------------------------------------------------- 
Person Obtaining Consent (Signature and Printed Name)                      Date 
  
 
----------------------------------------------------------------------------------------------------- 
(In case of illiterate subjects)  
Witness (Signature and Printed Name)                                                   Date 
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Annex 9: Survey Questionnaire  
 
Identifying Behavioral, Demographic and Clinical Risk Factors for Delayed Access to 
Emergency Obstetric Care in Preeclamptic Women in Port au Prince, Haiti 
 
QUESTIONNAIRE NO: 
 
DATE OF INTERVIEW:   TYPE OF RESPONDANT: 
PATIENT/LEGAL REPRESENTATIVE 
 
DEMOGRAPHIC QUESTIONS 
First we would like to ask you some questions about your background and your family. 
 
What is your age?:   
 
Where do you live? (Neighborhood, not exact address)  
write response: _____________ 
 
What is your marital status?  
Never married  
Married  
Divorced/separated  
Widowed  
Co-habitating 
 
What is your highest educational level attained?: 
No formal education  
Primary education  
Secondary Education  
University  
 
What is your religion: 
Catholic  
Lutheran  
Anglican  
Protestant 
Pentecostal  
Seven Days Adventists (SDA)  
Jehovah Witness  
Traditional/Voudou  
Muslim  
No religion  
Other, specify________________ 
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What is your occupation?: 
Housewife 
Informal business 
State employee  
Employee 
 
What is your housing situation?: 
Owner 
Renter 
Squatter 
Live with family/friends 
 
Do you live in an IDP camp? 
Yes  
No 
 
How would you describe your economic status? 
Well-off 
Middle class 
OK 
Very poor 
 
Clinical Questions Prior to this Pregnancy 
Now we will ask you some questions about your health before you were pregnant with 
the baby you delivered here. 
 
Before this pregnancy, did you ever visit a doctor or hospital for a health problem? 
Yes 
No 
Don’t know/not sure 
 
Before this pregnancy, were you ever diagnosed by a medical doctor with a health 
problem? 
Yes  
No 
Don’t know/not sure 
 
If yes, what was/were the problem/s?  
__________________ 
__________________ 
__________________ 
 
(for women with a previous pregnancy- otherwise skip to next section- Current 
Pregnancy)   
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Did you ever get diagnosed with preeclampsia or high blood pressure during a previous 
pregnancy? 
Yes 
No 
Don’t know/not sure 
 
Did you ever have any other major complication of pregnancy requiring hospitalization 
during a previous pregnancy? 
Yes 
No 
Don’t know/not sure 
 
If yes: ___________________ 
 
For your most recent pregnancy before this one, where did you deliver? 
Home 
Health center 
Hospital 
TBA house 
Other: ____________ 
 
For your most recent pregnancy, if you did not deliver at the hospital or health center, 
why not? 
Preferred to be at home 
Preferred to be with matron 
No hospital or health center available 
Hospital or health center too expensive 
Hospital or health center too far away 
Too dangerous to access health center or hospital 
Baby came too fast 
Other: 
 
Before this pregnancy, did you ever have a baby with one of the following problems? 
 
Born prematurely 
Yes  
No 
Don’t know/not sure 
 
Born too small 
Yes 
No 
Don’t know/not sure 
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Needed resuscitation at delivery 
Yes 
No 
Don’t know/not sure 
 
Born dead 
Yes 
No 
Don’t know/not sure 
 
Current Pregnancy Clinical Questions 
Now we will ask you some questions about this pregnancy. 
 
Did you receive prenatal care from a nurse or doctor during this pregnancy? 
Yes 
No 
Don’t know/not sure 
 
How many times did you see a nurse or a doctor for a prenatal visit? 
1 
2 
3 
4 
More than 4 times 
 
Were you diagnosed with preeclampsia or high blood pressure during this pregnancy 
before you arrived to CRUO? 
Yes 
No 
Don’t know/not sure 
 
Did a doctor or nurse diagnose you with any other problems during this pregnancy? 
Yes 
No 
Don’t know/not sure 
 
If yes, what was/were the problem/s?  
_____________ 
_____________ 
_____________ 
 
Did a doctor or nurse advise you to go to the hospital for delivery? 
Yes 
No 
Don’t know/not sure 
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Did you visit a matrone (TBA) during this pregnancy? 
Yes  
No 
Don’t know/not sure 
 
How many times did you see a matron during this pregnancy? 
1 
2 
3 
4 
More than 4 times 
  
Did the matrone advise you to go to the hospital for delivery? 
Yes 
No 
Don’t know/not sure 
 
Did you take any medications during this pregnancy?   
Yes (if yes, skip next question) 
No 
Don’t know/not sure 
 
If you did not take medications during this pregnancy, why not? 
(if they did not take medication, skip next question) 
Didn’t have a health problem needing medicine 
Did not see a doctor to get medicine 
Did not know where I could get medicine 
Could not afford medicine 
Other: ____________ 
 
If you did take medication during this pregnancy, did a doctor or nurse prescribe this 
medication? 
Yes 
No 
Don’t know/not sure 
 
Did a doctor or nurse tell you about danger signs of complications during this pregnancy? 
Yes 
No 
Not sure/don't know 
 
Will you please tell me some danger signs of high blood pressure (preeclampsia) in 
pregnancy? 
(Check all given responses) 
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Headache 
Swelling in hands or face 
Visual changes 
Epigastric pain (abdominal pain) 
Convulsions 
Other: 
 
Utilization questions: 
We will ask you some questions about what you did before you arrived here at the 
hospital. 
 
While you were at home, before came to the hospital, did you realize you had a 
complication of pregnancy? 
Yes 
No 
Not sure/don't know 
 
Before you delivered the baby, how did you know you needed to access health care? 
Feeling contractions 
Feeling sick 
Family member told me to come 
Doctor/nurse told me to come 
Felt the baby coming 
Other: ___________ 
 
After that decision, how long did it take before you left your house? 
___________ (in hours) 
 
Who made the decision to go to the hospital? 
I did 
My husband/partner 
A family member 
Matrone 
Other: 
 
Were there any tasks or events that delayed your leaving? 
Yes 
No 
Not sure 
 
If yes, please state: _____________ 
Did anyone in your family (parents, partner, sister) encourage you to go seek care? 
Yes 
No 
Unsure 
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Did anyone in your family discourage you from seeking care? 
Yes 
No 
Unsure 
 
Did you have to find money before traveling to the hospital? 
Yes 
No  
Unsure 
If yes, how much money?____________ 
 
After the decision to seek care, who was the first medical person you consulted? 
Nurse 
Doctor 
Matrone 
Did not consult medical person 
Other: ___________ 
 
After you decided you needed health care, did you visit another hospital or health center 
before you arrived here to this hospital? 
Yes- one  
Yes- more than one 
No 
Don’t know/not sure 
 
If yes, which hospital(s) or health center(s): 
 
Did a medical person or medical structure refer you to this hospital? 
Yes 
No 
Don’t know/not sure 
 
If yes, who or where referred you to this hospital? 
Matrone 
Doctor 
University Hospital 
Private hospital 
NGO hospital 
Public health clinic 
Private health clinic 
If you went to another medical structure, how long did you wait there to be seen by a 
doctor or nurse? 
Was seen immediately  
 More than 30 minutes  
Over 1 hour  
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Over 2 hours  
No service  
 
How many hours after you decided to see medical care did you arrive at the CRUO 
hospital (where you are now)? _____ (hours) 
 
How did you travel to this hospital? (choose all that apply) 
Walking 
Taptap or other public transit 
Motorcycle 
Ambulance 
Private car 
 
How long does it generally take you to travel to this hospital from your home? 
Less than 30 minutes 
30 – 60 minutes 
1 hour – 2 hours 
More than 2 hours 
 
How much does it cost for you to travel to this hospital from your home? 
 
What is the closest hospital to your house that treats pregnant women with complications 
of pregnancy?  ____________________ 
 
(If the woman went to a different hospital)  Why did you not go to this hospital when you 
had a complication? 
Too expensive 
Too long to wait 
Health care not good quality 
Too far away 
I don't like that hospital 
Problem with transport 
There was no one to go with me 
My family did not want me to go there 
I didn't know where to go 
Other: __________ 
 
 
Before you arrived here, did you know this hospital offered free care? 
Yes 
No 
Don’t know/not sure 
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Protection Questions: 
 
Of the following, which is your greatest concern for yourself? 
Access to health care 
Security 
Access to food 
Access to housing 
Not concerned 
 
Do you feel safe at home? 
Yes 
No 
Don’t know/not sure 
 
  INTERVIEWER: Thank you very much for the information and your time! 
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Annex 10: Qualitative Interview Guide 
 
Identifying Behavioral, Demographic and Clinical Risk Factors for Delayed Access 
to Emergency Obstetrical Care in Preeclamptic Women in Port au Prince, Haiti 
 
Qualitative In-depth Interview Guide, Adapted from Johns Hopkins Bloomberg 
School of Public Health materials 145 
 
Background to the study:  
This study is trying to understand why some women in Port au Prince have a problem 
during their pregnancies.  Some women have health problems for themselves or their 
babies.  This research is trying to understand why some women have these problems.  I 
will ask you some questions about what happened before you arrived at the hospital- you 
can stop at any time if you are uncomfortable. 
 
General interview guidelines:  
The topics and questions below should be used to guide the interview but can be adapted 
as necessary to each interview. Keep in mind when conducting the interview to respond 
to the answers provided by the respondent by asking additional questions to those 
proposed below or adapting to more appropriate questions. 
Please offer to stop the questions if any woman appears upset by the conversation.  
Remind subjects that they can withdraw at any time with no consequences to themselves.  
  
Initial Question: “I would like to learn from you about the situations that pregnant 
women face. Please tell me about what happened before you arrived to the hospital?" 
 
Follow up themes: 
What the woman thought was happening to her before she arrived, what was her 
problem? 
 
Home care practices, including traditional medications and religious customs, 
medications bought without prescriptions during the pregnancy? 
 
The sequence and timing of home care practices. 
 
Duration of symptoms prior to seeking care; symptoms that were given as the main 
reason for seeking care. 
 
Name, location of the first health care facility to which the woman visited (first provider 
visited). 
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Who made the decision to first seek care? Did the woman decide herself? Did her partner 
or parents decide? Was there some discussion about when and where to go? How much 
time was spent on this? Who actually went with the woman for care? 
 
Were there any obstacles to seeking care as quickly as the mother would have liked? (for 
example, lack of money, no transportation, etc.) 
 
If more than one provider was visited, what was the sequence and timing of care seeking? 
What were the reasons for seeking care from more than one provider? When and how 
was the decision made to visit other providers? 
 
What treatments did providers give? (Also note the use of any home remedies that were 
taken at the same time as medicines acquired from providers). 
 
Were there any changes in symptoms (improving or worsening) after treatment from the 
first provider? 
 
Was the mother satisfied with the care received from the different providers? 
 
Did anyone give them advice about what to do for the woman (home care and care 
seeking)? Who? What advice did they give? Was there any other place the woman went 
for information or advice? 
 
How does the woman explain the problem she or her baby had?  What does she think is 
the cause?  What could have made the situation different for someone else with the same 
problem to have a better outcome? 
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Annex 11: Medical Records Data Collection Form 
 
Identifying Behavioral, Demographic and Clinical Risk Factors for Delayed Access 
to Emergency Obstetrical Care in Preeclamptic Women in Port au Prince, Haiti 
 
Questionnaire Number: 
 
Woman's Information 
 
Age at admission:  
Gravity/Parity: 
Preeclampsia:  Yes/No 
Eclampsia: Yes/No       if yes, # of eclamptic seizures:          If yes: in hospital / prior to 
admission 
Blood pressure on admission: 
Admission to delivery interval (hours): 
ICU admission:  Yes/No 
Blood transfusion: Yes/No 
Cesarean section: Yes/No 
Coma:  Yes/No    Glasgow coma score:  
Multiple Gestation:  Yes/No 
Diabetes: Yes/No 
Obesity: Yes/No 
 
Infant Information 
NICU admission:  Yes/No 
Gestational age (weeks) at Delivery: 
Weight in grams: 
APGAR score at 1 min/5 min: 
Fetal heartbeat on admission:  Yes/No 
Fetal heartbeat at delivery:  Yes/No 
Death after delivery of live infant:  Yes/No 
If yes, death after how many days of life:	  
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Annex 12: Map of Port au Prince Neighborhoods 
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Annex 13:  Description of Training for Research Assistants 
 
 The research assistants underwent a weeklong training in research ethics, study 
protocols, and qualitative interview techniques.  The research ethics training was an 
open-source, online curriculum in French, “Introduction to Clinical Research”, developed 
by the Global Health Trials Network.  This global network is managed by a consortium 
of research universities around the world, and offers high-quality online courses in 
research methods and ethics.  The course consisted of the following modules: 
1. Introduction To Clinical Research 
1. Course Recognition 
2. Acknowledgements 
3. Course Objectives and Contents 
4. What Is Clinical Research? 
5. How Does Clinical Research Differ From Standard Care? 
6. Why Do We Perform Clinical Research (a)? 
1. Why Do We Perform Clinical Research (b)? 
7. Introduction: Key Points To Remember 
8. What Are The Main Principles Of Research Ethics (a)? 
1. What Are The Main Principles Of Research Ethics (b)? 
9. What Is Informed Consent And Why Is It Needed (a)? 
1. What Is Informed Consent And Why Is It Needed (b)? 
2. What Is Informed Consent And Why Is It Needed (c)? 
3. What Is Informed Consent And Why Is It Needed (d)? 
4. What Is Informed Consent and Why Is It Needed (e)? 
10. Why Do People Participate In Clinical Research And What Are The 
Benefits And Risks Involved (a)? 
1. Why Do People Participate In Clinical Research And What Are 
The Benefits And Risks Involved (b)? 
11. Research Ethics: Key Points To Remember 
12. Study Designs 
13. Cohort Studies 
14. Case Control Studies 
15. Cross Sectional Surveys 
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16. Case Reports 
17. Clinical Trials (a) 
1. Clinical Trials (b) 
18. Study Designs: Key Points To Remember 
19. Maintaining High Ethical Standards, Data Quality And Uniformity In A 
Study (a) 
1. Maintaining High Ethical Standards, Data Quality And Uniformity 
In A Study (b) 
20. Key Points To Remember 
21. References And Resources 
22. Quiz 
 
 The research assistants completed the online modules in French, and passed the 
quiz at the end.  Prior to starting data collection, both research assistants engaged in role-
playing activities with the PI, to ensure adequate comprehension of study survey 
protocols, informed consent procedures, data collection forms, confidentiality measures, 
and withdrawal procedures for the survey. 
 The qualitative research methods training is a 7-module course for Non-
Governmental Organizations developed by the Johns Hopkins Bloomberg School of 
Public Health.  Of the 7 modules, five were relevant to this study and were translated into 
French.  The five modules include:  
Section 1: Introduction to the Training in Qualitative Research Methods for 
PVOs/NGOs 
Section 2: Overview of Qualitative Research 
Section 3: Interviewing in Qualitative Research 
Section 4: Qualitative Research Methods 
Section 5: Management of Qualitative Data 
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Annex 14.  Frequency distribution of first delay by preeclampsia status 
 
Table 22. Frequency distribution of first delay by preeclampsia status 
Hours of first delay Normal 
Frequency Count 
n = 207 
Preeclamptic 
Frequency Count 
n = 285 
0 31 100 
1 43 32 
2 27 12 
3 23 12 
4 18 14 
5 18 7 
6 12 5 
7 - 10 9 26 
11-20 11 25 
21-30 10 21 
31-100 5 25 
>100  - 6 
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ICS/Integrare, Barcelona, Spain   
Researcher, Doctoral Practicum - August, September 2013 
Consultant - November, December 2013 
Worked collaboratively to develop and elaborate Midwifery Services Framework for 
the International Confederation of Midwives, by researching tools and resources to 
increase women's access to quality maternity services in low resource settings.  
Researched and consolidated evidence based antenatal and postnatal care for Gates-
funded grant.  Development of conceptual framework to guide research of care 
practices. 
 
Mt. Auburn Hospital, Cambridge, USA  
Midwife - September 2012-present 
Full-scope, independent management of midwifery patients in outpatient and inpatient 
settings.  
 
Cambridge Health Alliance, Cambridge, USA 
Midwife - March 2006-September 2009 
Independent management of obstetric and gynecologic caseload of low risk women, 
management of high risk cases collaboratively with physician colleagues.  
Intrapartum practice in a hospital and an out-of-hospital birth center with largely 
immigrant and low-income population.  Initial newborn care and infant resuscitation 
in birth center practice.   
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RESEARCH EXPERIENCE 
 
Doctoral Dissertation.  "Identifying Behavioral, Demographic and Clinical Risk 
Factors for Delayed Access to Emergency Obstetrical Care in Preeclamptic Women 
in Port au Prince, Haiti."  Quantitative survey and qualitative in-depth interviews. 
 
Graduate Thesis, 2005.  Qualitative study of midwives’ responses to client demands for 
technology and intervention during the birth process. Recommendations for midwives in 
discussing elective primary cesarean sections. 
 
Undergraduate Thesis, 2000.  Qualitative study of UNFPA education program for 
adolescents in Kathmandu, Nepal.  
              
FACULTY EXPERIENCE  
 
Yale University School of Nursing, New Haven, USA  
January 2008- May 2009 
Preceptor of Yale University midwifery students in full scope midwifery practice 
  
HONORS AND AWARDS  
 
Boston University Women's Guild, Katherine Connor McLaughlin Scholarship for 
doctoral dissertation research 
 
Tinker Field Research Grant for master’s thesis research in Esteli, Nicaragua  
 
Eugene M. Lang Summer Initiative Award, William L. Huganir Summer Research 
Stipend for Population Research for undergraduate thesis research in Nepal 
 
LANGUAGES  
 
Native English speaker   
Excellent verbal and written communication in French 
 
LICENSING  
 
Current Nursing and Midwifery License in Massachusetts  
Current Drug Enforcement Administration (DEA) License 
 
